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UK  United Kingdom 
ICD 11 International Classification of Diseases 11 
mRs  modified Rankin scale 
OHS  Oxford Handicap Scale 
GBD  Global Burden of Disease Study 
IPC  Intermittent pneumatic compression 
CLOTS 3 Clots in Legs or sTockings after Stroke Trial 3 
FOOD  Feed Or Ordinary Diet trial 
IST3  International Stroke 3 trial 
NG  Nasogastric 
PEG  Percutaneous gastrostomy 
HRQoL Health related quality of life 
VAS  Visual analogue scale 
BI  Barthel Index 
WHO  World Health Organisation 
SAH  Subarachnoid haemorrhage 
6CIT  Six item cognitive impairment test 
DNAR  Do not attempt resuscitation form 
smRsq Simplified modified Rankin scale questionnaire 
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NIHSS National Institute of Health Stroke Scale 
GP  General Practitioner 
SD  Standard deviation 
TIA  Transient ischaemic attack 
TACS  Total anterior circulation stroke 
PACS  Partial anterior circulation stroke 
LACS  Lacunar stroke 
POCS  Posterior circulation stroke 
GCS  Glasgow Coma Scale 
SSV  six simple variables 
IQR  Inter quartile range 
COREC Consolidated criteria for reporting qualitative research 
CPR  Cardio pulmonary resuscitation 
PPV  positive predictive value 
AUC  Area under the receiver operating curve 
ROC  Receiver operating curve 
CI  Confidence interval 




Patients may be significantly disabled after a major stroke but two patients in 
the same disability level according to outcome scales such as the modified 
Rankin scale (mRs) can vary with respect to their specific abilities (e.g. ability 
to walk, talk and eat) and therefore may have different views on their quality 
of life. Treatment decisions after major stroke are often made based on 
predictions of survival and independence. Many treatments can prolong the 
survival of patients who may be significantly disabled. Knowledge of patient 
abilities and preferences for such treatments are needed to make treatment 
decisions in keeping with their wishes. However, shared decision-making 
after major stroke can be challenging.  
Aims 
First, to understand how patients may vary with regards to their specific 
abilities and reported quality of life after major stroke. Second, to understand 
the experiences, preferences, needs and involvement in decision-making 
regarding treatments by patients (who retained mental capacity) and family 
members (where the patient lacked capacity) in the early period after major 
stroke and their feelings six months later. Third, to develop ways to 
communicate diagnosis and prognosis after major stroke better. 
Methods 
I used a range of clinical research methodologies: i) A prospective cohort 
study (n=403) to investigate the progress and outcomes of patients admitted 
with a major stroke with respect to several domains (disability, quality of life 
and specific abilities e.g. walking, talking, eating.) ii) Qualitative interviews to 
explore the experiences, views, needs (information and support) and shared 
decision-making approaches of patients admitted with a major stroke who 
retained mental capacity (n=15) and family members where the patient 
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lacked capacity (n=24). iii) Questionnaires to evaluate communication 
between doctors (n=9) and participants (n=24). iv) Statistical modelling to 
develop (n=13,117) and externally validate (n=403) models predicting 
specific abilities after stroke. 
Results 
Patients varied with respect to their specific abilities even though they may 
be in the same disability level according to global outcome scales (e.g. mRs). 
In the early period after major stroke, patients looked for hope and were not 
ready to participate in shared decision-making. However, six months later 
they wished they had been better prepared for the impact of major stroke by 
having been given realistic information and psychological support. Family 
members who were involved in decision-making considered the patient’s 
state of health and preferences before stroke. Some found communication of 
specific abilities after major stroke useful to decision-making. Based on our 
expert judgement, longitudinal cohort and qualitative interviews, we 
developed and externally validated prognostic models to predict six specific 
abilities after stroke. These models have limitations and need further 
evaluation. In the future, they may be useful for doctors as a sense check of 
their judgement of the patients’ prognosis, and to provide hope or information 
to understand impact of major stroke and/or make treatment decisions. This 
thesis details the challenges of communicating prognosis and involving 
patients and families in shared decision-making after major stroke and will 









There are over 1.2 million stroke survivors in the UK. About a third are living 
with significant disability and may require help from others (e.g. family 
members or carers) to be able to carry out day-to-day activities (e.g. to walk 
or to wash and dress) but does not take quality of life components into 
account. Each person may vary with respect to their abilities (e.g. to walk, to 
talk or to eat normally) and therefore, may have different views of their 
individual quality of life.  
Many treatments offered to people in the early period after major stroke may 
extend the person’s life but increase the chance of the person being 
disabled. At present, we do not fully appreciate the impact of major stroke on 
people and their families or how patients and families are involved in making 
decisions to accept or decline treatments.  
We need to find ways to understand how people progress after a major 
stroke and the impact of this diagnosis on them and their family. We also 
need to find ways to provide people with stroke and their families with the 
necessary information and support they may need to prepare for the 
consequences of major stroke and make treatment decisions that are in 
keeping with their wishes. 
The research 
By interviewing people who had capacity after major stroke and their family 
members, where the person with major stroke did not have capacity, I aimed 
to understand their experiences of major stroke and how doctors can support 
them better. I used their experiences and views and my observation of a 
group of 403 people with major stroke to develop ways that doctors may 




Outcomes and expected benefits 
I found that individual people who had had a major stroke varied with respect 
to their abilities (e.g. to walk, to talk). They were looking for hope that they 
would get better in the early period after major stroke. However, six months 
later, they wished they had been given information and psychological support 
to have helped them prepare for the impact of stroke. Family members 
(where the patient did not have capacity) who were involved in the decision-
making process considered how the patient’s health was like before the 
stroke and if the patient had expressed any wishes. They looked for 
information from doctors. Based on this, I have developed a method of 
predicting patient abilities after major stroke which, once further evaluated, 
may be able to be used to provide people with major stroke and their families 
with information on the likely impact of major stroke. Doctors may also find 















I have compiled this thesis based on published manuscripts (which have 
formed some chapters), work that has been submitted for consideration for 
publication and original work that has not been submitted for publication but 
is relevant to informing my future intervention. I have indicated this at the 
start of each of my chapters.  
My thesis is a result of a programme of mixed methods research which I 
conducted in the last three years (2017-2019).  
In Chapter 1, I provide an overview; on which my work for this thesis is based 
on, and list my aims. In Chapter 2, I describe the recruitment and follow up of 
a longitudinal cohort of patients with major stroke, aiming to report patient 
progress and outcomes with respect to various domains including disability, 
quality of life and specific abilities (e.g. walking, talking and eating). These 
findings indicate how individual patients varied and informed my interviews 
with family members and the development of predictive models. Chapters 3 
and 4 report the experiences, views, needs and involvement in shared 
decision-making regarding treatments by patients (with mental capacity) 
admitted with major stroke and family members (where the patient lacked 
capacity) respectively. These indicate varying information and support needs 
which informed the development of predictive models (Chapter 7), highlight 
implications for clinical practice and inform my future intervention. (Chapter 9) 
In Chapters 5 and 6, I describe feedback from doctors and family members 
regarding current communication between them and report the feedback 
received from family members with regards to various aspects of 
communicating diagnostic and prognostic information. These inform my 
approach towards developing predictive models (Chapter 7) and future 
intervention (Chapter 9). In Chapter 7, I describe the development and 
validation of new statistical models to predict specific abilities (e.g. walking, 
talking) after major stroke. This was based on my findings from Chapter 2 
and Chapters 3-6. Chapter 8 provides an exploration of ways in which our 
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models may be improved. Chapter 9 brings together some of my findings 
which have implications for future interventions and clinical practice. I also 
detail the strengths and limitations of my research, further areas of research 
my work has highlighted and my next steps in pursuing my work further.   
Keywords: Major stroke, hope, preferences, support, information, 
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Chapter 1  
1.1 Introduction: Shared decision-making after major 
stroke  
Since there is no standardised definition of a major stroke, we have 
defined this as people with a modified Rankin scale score (mRs) of 3-5 
after stroke and/or those who had two of their functional abilities (e.g. to 
walk, to talk, to eat normally) affected as a result of the stroke. I have 
detailed this in Chapter 2.   
My work focuses on:  
1) Observing the progress of patients admitted with a major stroke with 
respect to their specific abilities (e.g. to walk, to talk) and relating this 
to widely used outcome scales e.g. modified Rankin scale (mRs), BI 
(Barthel Index) and Health related quality of life (HRQoL). 
2) Exploring the experiences, views, needs (information and support) and 
involvement in decision-making (focusing on life-extending treatments) 
of patients (with mental capacity) admitted with major stroke and 
family members (where the patient lacked capacity).  
3) Obtaining feedback from patients/ family members on doctor-patient 
communication, thereby aiming to develop strategies to improve 
communication and shared decision-making between them in the 
context of major stroke.  
In the sections that follow, I focus on aspects relevant to decision-making 
regarding life-extending treatments in the context of a major stroke. This 
chapter is only intended as a brief overview, as each chapter contains an 
introduction with literature relevant to that chapter.  
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1.2 Publication status and acknowledgement of 
contribution 
This chapter contains extracts from my published manuscript in the 
International Journal of Stroke: ‘Shared decision making after severe stroke- 
how can we better involve patients and families?’ 2017 (Appendix A). 
I wrote this chapter and publication and incorporated changes following 
comments from my supervisors. 
1.3 The importance of stroke 
1.3.1 The definition of stroke 
In 1988, the World Health Organisation (WHO) defined stroke as a clinical 
syndrome consisting of rapidly developing clinical signs of focal (or global in 
case of coma) disturbance of cerebral function lasting more than 24 hours or 
leading to death with no apparent cause other than of vascular origin.(1)  
Recently, the International Classification of Diseases- 11 (ICD-11) divided the 
term ‘stroke’ into four categories:  
a) Cerebral ischaemic stroke; defined as acute focal neurological dysfunction 
caused by focal infarction at single or multiple sites of the brain or retina. The 
evidence of this acute infarction may come either from symptom duration 
lasting more than 24 hours or neuroimaging / other technique in the clinically 
relevant area.  
b) Intracerebral haemorrhage; acute neurological dysfunction caused by 
haemorrhage within the brain parenchyma or in the ventricular system. This 
includes non-traumatic haemorrhage only.  
c) Subarachnoid haemorrhage; acute neurological dysfunction caused by 
subarachnoid haemorrhage.  
d) Stroke not known if ischaemic or haemorrhagic; acute focal neurological 
dysfunction lasting more than 24 hours (or leads to death in less than 24 
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hours), but subtype of stroke (ischaemic or haemorrhagic) has not been 
determined by neuroimaging or other techniques.  
 
1.3.2 Burden of stroke 
1.3.2.1 Incidence and prevalence 
Each year, approximately 15 million people globally suffer a stroke. In their 
lifetime, 1 in 6 people worldwide will have a stroke. In 2016, there were 
greater rates of stroke in men between the ages of 55 and 75 years but 
women and men had similar incidences below the age of 55 and above the 
age of 75. (2) In the same year, the highest incidence of stroke was in East 
Asia. Latest figures from the global burden of disease (GBD) study report that 
there are more than 80 million stroke survivors worldwide. (3) Due to 
improved stroke survival and a growing and ageing population, the number of 
stroke survivors is only likely to rise. (3)  
In the United Kingdom, approximately 150,000 people have an acute stroke 
each year and there are over 1.2 million stroke survivors.(4–6)  
1.3.3 Impact 
1.3.3.1 Death 
There were around 5.5 million deaths globally due to stroke in 2016. (2) 
Stroke remains the second leading cause of death worldwide, though rates 
vary between developed and developing countries. (7) In the UK, stroke is 
the third highest cause of mortality and premature death; there were over 
37,000 deaths due to stroke in 2016.(4)  
1.3.3.2 Disability 
Stroke is the third major cause of disability worldwide (8) and fifth major 
cause of death and disability in the UK. (9) In these contexts, disability refers 
to physical aspects of disability, measured by scales such as the modified 
Rankin scale (mRs), (10) the Oxford Handicap Scale (OHS) (11) or Barthel 
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Index (BI) (12) without consideration of quality of life components. These 
scales have been widely used in stroke trials for evaluating patient outcomes 
including recovery (10) and as an end point in randomised controlled trials of 
emerging stroke treatments. (13)  
 
1.3.4 Burden of major stroke 
After a major stroke, patients often face the reality of two likely outcomes: 
death or survival with significant disability. In this situation, the possibility of 
being independent is often small.  
Over a third of stroke survivors in the UK are living with significant 
disability.(14) Stroke care accounts for approximately 3-5% of all healthcare 
expenditure. (9,15) In the UK, the cost to society is around £26 billion a year; 
£15.8 billion from the informal care sector (relatives and friends providing 
care) and the rest for NHS funded and formal social care. (16)  
Furthermore, approximately 5-15% of patients who have had a major stroke 
and have significant disability are discharged from hospital to care homes. 
(17,18)  Many of these patients have ongoing physical and psychological 
needs. (4)  
1.3.5 Treatments after major stroke 
There have been advances in stroke treatments. In comparison to 20 years 
ago, people have better access to treatments and care.(19,20) 
Treatments after stroke can be broadly divided into categories according to 
the timing after stroke at which they are delivered and their likely effect on 
patients’ outcomes. Where the healthcare team feel it is appropriate, each of 
these treatment categories may be considered for the patient admitted to 
hospital with a major stroke.  
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a) Hyperacute treatments e.g. thrombolysis, (21) mechanical 
thrombectomy (22): improve functional outcome but as yet, have not 
been shown to influence short term survival 
b) Acute (and some ongoing) treatments e.g. decompressive 
hemicraniectomy, enteral tube feeding and intermittent pneumatic 
compression (IPC). These treatments are life-extending; i.e. they 
extend survival, predominantly in a disabled state but do not appear to 
improve functional recovery.(23–25) 
c) Symptom management e.g. using morphine for pain and midazolam 
for agitation (26) 
d) Multidisciplinary care in designated stroke units: improves both 
survival and functional recovery of stroke patients. (27) 
e) Secondary prevention e.g. anti-platelets, statins: reduces risk of 
further strokes. (28) 
 
In the early period after a major stroke, patients and/or their family members 
are often involved in discussing their preference for treatments such as those 
described in (a) and (b) above. As I mentioned above and will detail below, 
these categories of treatments have different impacts with respect to survival 
and functional outcome. It is important for patients and families to understand 
this when involved in making decisions which are in-keeping with their 
preferences. (29,30)   
1.3.5.1 Hyperacute treatments  
Intravenous thrombolysis refers to revascularisation of the blocked artery by 
using intravenous drugs e.g. alteplase which enhances breakdown of the 
occluding thrombus. A meta-analysis of pooled data from individual trials 
showed that earlier intravenous thrombolysis is associated with less patient 
disability at three months among patients with large vessel occlusion. 
Certainly, shorter door to needle times (time between patient arriving at the 
department to getting thrombolysis delivered) of less than 30 minutes had 
better functional outcomes. (21) 
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Endovascular thrombectomy refers to clot retrieval (by various techniques 
including large bore or flexible aspiration catheters and stent retrievers) to 
restore normal blood flow to the brain by removing the blood clot blocking the 
artery. A meta-analysis of pooled individual patient data from five randomised 
trials showed significant reduced disability at 90 days compared with control. 
However, mortality at 90 days, risk of parenchymal haematoma and 
symptomatic intracranial haemorrhage did not differ between 
populations.(22) This meta-analysis also reported significant favourable 
effects (on functional outcome) of endovascular thrombectomy in patients 
older than 80 years, those randomised more than 300 minutes after symptom 
onset, and in patients who did not receive thrombolysis with intravenous 
alteplase.  
While meta-analyses of thrombolysis and mechanical thrombectomy have 
reported improvements in functional outcome (but not survival) of stroke 
survivors, a prospective cohort study of over 7,000 patients has shown that 
functional status six months after an ischaemic stroke is associated with 
long-term survival. Therefore, in the future, studies may be able to 
demonstrate positive effects on long-term survival of early interventions that 
reduce dependency. (31) 
1.3.5.2 Acute and ongoing treatments 
While the treatments above (i.e. thrombolysis and mechanical thrombectomy) 
have been shown to improve functional outcome of stroke survivors, other 
treatments such as decompressive hemicraniectomy, the use of enteral tube 
feeding and IPC in the early period post stroke are ‘life-extending’, i.e. they 
mainly increase the likelihood of survival of patients who are disabled after a 
stroke. Therefore, patients who are disabled after a major stroke are alive for 
longer with the net effect of a greater proportion of patients being alive with 
significant disability.  
Decompressive hemicraniectomy is offered where there is cerebral oedema 
after a middle cerebral artery infarction, resulting in increased intracranial 
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pressure. This is a neurosurgical procedure where a part of the skull is 
removed and the dura is opened to allow a swelling brain to expand. A meta-
analysis of seven randomised controlled trials (n=338) found that, at a year 
post procedure, while decompressive hemicraniectomy resulted in an 
absolute reduction in death by 39%, it increased the number of patients with 
disability by 39%. [i.e. all those who survived were disabled] There was an 
increase of 13% in those with slight to moderate disability (mRs 2-3), 22% 
increase in those with severe disability (mRs 4) and 4% increase in those 
with very severe disability (mRs 5). (32) These results are based on all 
patients aged 18 and above; with six trials reporting outcomes to 12 months 
and 1 trial to six months. [Of note, the results from five trials reporting 
outcome to six months were similar]. This is illustrated in Figure 1.1. 
 
Figure 1.1 Functional outcome one year after a hemicraniectomy compared to medical 
treatment according to mRs [Based on all patients, aged 18 and above] 
 
IPC devices use cuffs around the legs that fill with air and squeeze the legs 
to increase blood flow through the veins. In the Clots in Legs Or sTockings 
after Stroke 3 trial (CLOTS 3), IPCs reduced the likelihood of deep venous 
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thrombosis after a stroke. At six months, the use of IPC reduced deaths by 
2.6% (25.8% in the no IPC group compared with 23.2% in the IPC group) but 
there was an increase in disability (measured by the OHS and defined as 
OHS 3-5) of 2.4% in the IPC group. [missing values excluded] (33–35) Figure 
1.2 illustrates this.(35) 
 
 
Figure 1.2 Death and dependency (measured by OHS) at six months post stroke; No 
IPC versus IPC 
 
 
Enteral feeding refers to the intake of food via the gastrointestinal tract; either 
through the mouth or through a tube. This tube may be inserted via the nose 
into the stomach (nasogastric tube (NG)) or transcutaneously into the 
stomach (percutaneous gastrostomy (PEG)) or small intestine (jejunostomy).  
Enteral tube feeding is often used either to support or complement nutrition 
after a stroke. In the Feed Or Ordinary Diet 2 (FOOD 2) trial, early NG 
feeding (within the first week) after stroke reduced the likelihood of death by 
5.7% but increased the likelihood of severe disability (mRs 4-5) by 4.7% 
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(36.6% in the NG fed group versus 31.9% in the non- NG fed group) at 
around six months post stroke. (36) Figure 1.3 illustrates this.  
 
Figure 1.3 Outcomes six months after stroke; early NG feeding versus avoidance of 
NG feeding. 
 
 Table 1.1 summarises the absolute risk differences (between death and 
disability*) of life-extending treatments (decompressive hemicraniectomy, 
IPC and early enteral tube feeding) on survival and functional outcome. 
(23,32,36) 
Table 1.1 Effects of life-extending treatments on disability* in stroke patients: absolute 
risk differences (between death and disability*) 














>65 year  




6 +2.4  -2.6 -0.2 
Early tube feeding  6 +4.7  -5.7  -1.0 
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*where disability is defined using the modified Rankin Scale (0-2 as 
‘independent’ and 3-5 as ‘dependent’) 
The effects these treatments have on survival and functional outcome may 
influence patients’ decisions on accepting or declining these treatments. This 
may depend on what each individual patient regards as an ‘acceptable’ 
outcome. For example, some may consider survival at all costs to be 
acceptable and hence accept all treatments. However, others may decide 
that any disability would be a suboptimal quality of life for them, and hence, 
decline all treatments.   
1.3.6 Health related quality of life (HRQoL) after major stroke 
Health related quality of life (HRQoL) reflects the impact of a health state (in 
this case, stroke) on a person’s ability to lead a fulfilling life. It covers an 
individual’s perception of and satisfaction with their physical health, mental/ 
emotional health, family and social functioning.(37) An accepted method of 
reporting patient-centred outcome measure or HRQoL is the utility, which is a 
value derived based on values assigned to healthy individuals in the UK. This 
value indicates the desirability of a specific health outcome to the patient. 
Using the EQ5D questionnaire where participants (patients or proxies) 
indicate their responses on five dimensions (mobility, self-care, ability to 
perform usual activities, pain/discomfort and anxiety/depression), each with 
the option of five levels, a combined score is obtained. This is used to derive 
a utility value. A utility value can be between -1 and 1, where values less than 
0 indicate a health state which is worse than being dead. The other 
component of the HRQoL assessment is the visual analogue scale (VAS) 
which is a scale from 0 to 100 where participants indicate their health state 
from ‘worse health state imaginable’ (score 0) to ‘best health state 
imaginable’ (score of 100). (38,39) 
To relate physical disability to HRQoL in the stroke setting, several attempts 
have been made to assign utility scores to mRs levels. (40–43) These 
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indicate a general trend where patients with higher mRs after stroke tend to 
have lower utilities.  
However, when considering treatments on an individual patient basis, we 
would need to ascertain how the individual patient perceives his or her quality 
of life.  
A ‘shared decision-making’ approach would be appropriate when considering 
life-extending treatments after major stroke.   
1.4 Shared decision-making in the context of major 
stroke 
The treatments patients with major stroke accept or decline may increase the 
chance of the patient surviving with significant disability, or dying. (Section 
1.3.5) Even if ‘disabled’ (generally based on widely used outcome scales 
such as the mRs), each patient may rate their quality of life differently. It is 
therefore important to explore patient’s views about their physical state and 
HRQoL when deciding on treatment options, and offer treatments that are 
more likely to achieve the outcome they would prefer.  
To facilitate informed decision-making, healthcare professionals should be 
able to communicate the patient’s diagnosis, likely prognosis and effects of 
different treatments on the patient’s prognosis. Patients, and/or their family 
members, should be able to express their preferences for treatments based 
on likely outcomes. Subsequently, patients and their family members, along 
with their healthcare professionals, should weigh up the pros and cons of 
treatments and collaboratively, arrive at a decision. This process, ‘shared 
decision-making’ is regarded the gold standard of care. (30,44–46) Specific 
to treatments that are life-extending, for the use of IPCs, revised national 
guidelines have recommended the use of this treatment (with caveats of 
shared decision-making). (47,48) 
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However, in the context of major stroke, implementing effective shared 
decision-making may be difficult. (49) 
For instance, patients may lack capacity or not be well enough to participate 
in decision-making. Families may also not know patients’ views on survival 
and disability (50,51) and even if they did, they may struggle to voice 
preferences which may result in decisions that are not life-extending.(52) 
Healthcare professionals find it difficult to confidently predict likely outcomes 
for individual patients after a major stroke (53) and there is further uncertainty 
about the specific abilities of patients who do survive (e.g. their ability to walk, 
eat normally or live at home). Communicating this uncertainty may be difficult 
for health professionals. (53)  
Exploring the views, experiences and challenges faced by patients and their 
family members with respect to decision-making regarding treatments in the 
context of major stroke goes to the heart of the issues considered in this 
thesis. Here, I briefly detail the areas which I will explore in my chapters. I will 
revisit these areas in my conclusions chapter. (Chapter 9) 
1.4.1 Patient management in keeping with their preferences 
Healthcare professionals are encouraged to discuss patient needs, priorities 
and preferences at every stage of care. (30,44,46) However, there are five 
considerations: 
First, people may have varying health beliefs and may therefore value 
outcomes differently. (54,55) For example, some patients may value survival 
at all costs, whereas others may regard surviving with any disability to be 
unacceptable.  
Second, judgements made by patients regarding their preferences result 
from cognition, experience and reflection on potential outcomes.(56)  
Therefore, an individual needs to be able to project to a situation (e.g. being 
significantly disabled), when they may never have been faced with this 
situation before. (57) (A process called affective forecasting) 
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Third, the concept of ‘participation preference’- the willingness to get involved 
in the decision-making process: i.e. does a patient want to decide alone, or 
should the physician decide, or both. While literature suggest that most 
patients wish to participate (58–60) and are more likely to have higher 
treatment adherence and satisfaction with outcomes if treatments are 
matched to their preferences, (61–63) most of this evidence is from studies 
involving patients in outpatient settings who are generally less unwell  (in 
comparison to inpatients with a major stroke). Evidence from the intensive 
care setting also suggests that patients who are critically unwell are less 
likely to be able to participate as they are in shock by their diagnosis (64) and 
therefore, often wish doctors to make treatment decisions on their behalf.  
(65) 
Fourth, the concept of ‘treatment preference’; i.e. a preference for one or 
another treatment or a preference for no treatment at all. Treatment 
preferences can contain preferences for different settings (outpatient or 
inpatient), preference for specific medication, or a treatment goal. (66) 
Ascertaining this requires the patient to be able to understand their illness 
and implications of treatments.   
Fifth, people may change their preferences over time; this is because they 
may change their self-assessment of quality of life. (A concept called 
‘response shift’) (67) For example, when healthy adults are asked about 
living with significant disability, they would view this prospect as ‘worse than 
death’ (68–70) and many may say that they would refuse life-extending 
treatment if they were faced with a situation where they would be left 
significantly disabled. (68,71) However, literature has shown that those who 
had a decompressive hemicraniectomy after a severe stroke, and survived, 
reported a satisfactory level of psychological well-being in spite of their 
severe physical deficits. (72)  
In the context of a major stroke where it is highly likely that the patient who 
had survived the stroke may be significantly disabled, and some treatments 
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are life-extending, the knowledge of patient preference would be important to 
guide treatment decisions. 
However, eliciting patient preferences in the context of a major stroke may be 
challenging.  
First, similar to other acutely unwell patients (e.g. those in intensive care), 
patients who have suffered a major stroke may be in shock and distress; 
therefore, due to their emotional state, they may not be ready to discuss their 
wishes or to weigh up the potential benefits or risks of available treatments. 
(64,65,73)  
Second, some patients may have dysphasia or cognitive impairments as a 
result of stroke, preventing them from either communicating, or considering 
(or both) their preferences. (49)  
Third, even if they are able to voice their preferences, it is possible that they 
may change their preferences regarding acceptable treatments over time.  
I explore some of these challenges by engaging patients who retained mental 
capacity after a major stroke in qualitative interviews. (Chapter 3)  
1.4.2 Legal aspects of proxy decision-making 
Where patients are unable to be involved in shared decision-making due to 
lack of capacity (either due to mental illness, learning disability, dementia or a 
related condition, or an inability to communicate), the Adults with Incapacity 
Act is often consulted. This provides a framework for safeguarding the 
welfare and managing the finances of adults who lack capacity. As I describe 
below, the legislation differs between Scotland and England and Wales.  
In Scotland, the Adults with Incapacity Scotland Act 2000 aims to protect 
people who lack capacity to make particular decisions, but also to support 
their involvement in making decisions about their own lives as far as they are 
able to do so. The individual with capacity (known as the ‘granter’) may also 
have appointed a power of attorney to deal with aspects of the granter’s 
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affairs e.g. financial/ property matters and/or personal welfare. In the context 
of immediate life-saving treatments, staff will act based on what would be 
considered best for the person. Where a welfare attorney or guardian with 
the power to give, or refuse, consent to treatment is available, doctors should 
consult them before treatment is administered. If they refuse consent, the 
doctor can ask the welfare commission to appoint an independent doctor to 
give an opinion. In the absence of a legally appointed attorney, proxies (often 
family members or others close to the patient) are consulted on what they 
think the person’s likely wishes and preferences might be, but in this 
situation, ultimately, decisions that seem to be of greatest benefit to the 
person at that time have to be made by the professional team. (74) 
In England and Wales, the Mental Capacity Act 2005 provides a legal 
framework for decision-making on behalf of people aged 16 and over who 
cannot make decisions for themselves. Where a person has made a valid 
and applicable advance decision to refuse treatment which applies in the 
person’s clinical situation, this must be respected and no best interest 
decision by the professional team applies. Also, where the person has made 
a lasting power of attorney with the power to consent or refuse treatment, the 
attorney is the lawful decision-maker. (75) 
1.4.3 Proxy decision-making in major stroke 
As described above, in the circumstance where it is not possible to elicit 
patient preferences, doctors often ask the patient’s family member(s) what 
the patient’s preferences may be with regards to potential outcomes (i.e. 
survival and disability) and therefore, life-extending treatments. 
There are several reasons to justify the involvement of proxies (usually family 
members) in decision-making after major stroke. (76) 
First, this allows healthcare professionals to extend patient autonomy by 
incorporating their values and previously expressed treatment preferences to 
guide their medical care at a time when the patient themselves are unable to 
express their preferences and wishes. (77,78) Certainly, evidence has shown 
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that proxies are able to predict patients’ preferences accurately in the 
majority of cases (79) in different settings including dementia (80), stroke (81) 
and in the context of using or withholding life extending treatments. (82,83) 
Second, involving family members in decision-making manifests respect for 
the family unit and most proxies also wish to be involved in decision-making. 
(84–86) 
Third, many patients do want their families to be involved in their treatment 
decisions. (87)  
However, family members may find shared decision-making challenging, and 
potentially distressing, especially when decisions may result in life or death. 
(52)  
First, where patients’ preferences are unknown, they would need to consider 
what the patient would have wanted if s/he were able to make decisions. [A 
process called substituted judgement] (50) This can be difficult as they would 
need to ensure that they are making decisions based on the patient’s wishes 
rather than their own. (50,51)   
Second, they may find it emotionally difficult to voice preferences for 
treatments that are potentially not life extending even if these may be 
consistent with what the patient may have expressed in the past. (52)  
Third, family members may be overwhelmed, in shock and feel unprepared 
for a potentially life-changing diagnosis. Therefore, they may wish to receive 
information and support from health professionals to be guided on what 
treatments may be appropriate for the patient. (88–90).  
To explore the experiences and needs of family members involved in shared 
decision-making where the patient lacked mental capacity, I will report results 
from qualitative interviews with family members. (Chapter 4)  
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1.4.4 Prediction of outcomes after major stroke 
The knowledge of likely outcomes after major stroke may be useful to 
patients and their families. This may help them prepare for potential 
consequences of stroke (e.g. the need for extra care at home, or adaptations 
to enable patients to live at home) and may even help them make treatment 
decisions. (91)  
Many prognostic models exist in stroke (92) and generally predict survival or 
independence. Few are of any use due to their limited generalisability and 
lack of external validation.(92,93) There are prognostic models predicting 
specific abilities after stroke e.g. mobility, recovery of arm function and 
depression, but many also have limited use due to lack external validation. 
(94–97) 
However, the six simple variables (SSV) models developed from the Oxford 
Community Stroke project (OCSP) have been widely studied and used in 
audit (98) and in clinical trials. (99) The models consist of six easily collected 
variables (age, living alone pre-stroke, being independent pre-stroke, normal 
verbal score of the Glasgow coma scale (GCS) post stroke, being able to lift 
arms post stroke and walk post stroke) and predict survival, independent 
survival and ability to live at home. (100) The model predicting independent 
survival at six months is validated for use in the acute (100) and hyperacute 
(101) stroke settings (for clinical trials). I detail this further in Chapter 7. 
Communicating prognosis to patients and their family members by using 
terms such as dependence or disabled may have varied meanings to them. 
Also, the communication of poorer outcomes (i.e. dependence rather than 
independence) may also have an impact on any hope of recovery which they 
may be holding onto. Therefore, it is possible that describing prognosis by 
specific abilities (e.g. to walk, talk, live at home) may be more easily 
understood.     
How ‘correct’ predictions are determine their use in clinical practice. Different 
terms have been used to define how ‘correct’ predictions from a statistical 
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model would need to be to guide patient management; e.g. accuracy and 
precision. This is often related to the sensitivity and specificity of the model, 
with a trade-off between the two.  While predictions from models would 
ideally be ‘very correct or very accurate’ to guide patient management, (102)  
this is unlikely to be possible. Furthermore, different individuals (either 
patients or their family members) may decide to accept or refuse life-
extending treatments based on different accuracies of information. Therefore, 
it may be more useful to provide prognostic information to individuals at the 
level of accuracy they may wish for. I will explore this in Chapter 6. 
1.4.5 Presentation of prognostic information to patients and 
families 
Existing literature has recommended that health professionals provide 
information to patients in a variety of formats based on the patient’s stroke 
specific impairment and preference. (103) Graphical risk displays (104) (of 
various types) e.g. bar charts, grouped icon displays (dot or face diagrams) 
and flow diagrams have been suggested as best ways to communicate 
prognosis to patients. (105–108) 
However, relatively few studies have explored the use of different graphic 
formats for presenting prognostic information for the purpose of shared 
decision-making. (109–112) Limited data has suggested that different types 
of charts e.g. bar charts and icon displays are more effective than simple 
numeric statements for decision-making, (113,114) and are well understood 
by patients over 75 years old. (115) 
However, these formats have been evaluated in outpatient settings where 
patients are less medically unwell and patients and their family members may 
be less distressed. The transferability of these findings to the major stroke 
setting has not been studied.  
Because of varying individual preferences and stroke specific impairments, 
health professionals may need to present multiple formats of prognostic 
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information to patients and families in the major stroke setting. (104,107) I will 
explore this in Chapter 6. 
1.4.6 The influence of doctors on treatment decisions made 
for the patient with major stroke  
Doctors may have different preferences when accepting treatments for 
themselves when compared to patients. (116) It is also possible that differing 
communication styles of doctors may influence information that is perceived 
by patients.  
However, it is unclear if doctors’ preferences and behaviours influence the 
treatment(s) received by the patient admitted with major stroke. I will explore 
this in Chapter 5 using a brief questionnaire study.  
1.5 Summary of literature 
From my review of existing literature, I have found that there are several 
areas relevant to shared decision-making regarding treatments in the context 
of a major stroke where further work is required.  
Specifically,  
 Patient outcomes are defined by levels of physical disability based on 
outcome scales such as mRs, rather than their specific abilities (e.g. to 
talk, walk) and quality of life.  
 The experiences of patients admitted with a major stroke and their 
family members are under-reported though integral to understanding 
how, and why, certain treatment decisions are made.  
 The most effective method of presenting information (especially that of 
prognosis) to patients and their family members is unclear.   
 We do not know if doctor’s views and communication influences 
decisions made regarding treatments in the context of major stroke.  
 Many prognostic models have limited use in practice due to their lack 
of generalisability and external validity. 
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While shared decision-making in stroke is a team approach, where 
various members of the multidisciplinary team (e.g. doctors, nurses, 
physiotherapists, occupational therapists, speech and language therapists 
and dieticians) have input into patient management, the focus of my 
thesis is on decision-making regarding treatments that are life-extending. 
These discussions are primarily conducted between the patient/ their 
family and the hospital doctor. Therefore, in the rest of my thesis, I have 
used the term ‘doctor’ rather than a more general term such as ‘health 
professionals’ which could include other members of the multidisciplinary 
team.  
1.6 Aims of thesis 
a. To report how patients admitted with a major stroke progress over 
time with respect to several specific abilities (e.g. to walk, to be 
continent, to eat normally) and relate these to outcomes on scales 
such as mRs, BI and EQ5D (HRQoL). 
b. To understand the experiences, views regarding survival and 
significant disability, needs (information and support) and approaches 
towards shared decision-making of patients admitted with major stroke 
who had retained their mental capacity; and how and why any of these 
views may have changed over time 
c. To explore the experiences, views and needs (information and 
support) of family members who are involved in decision-making 
regarding treatments  after major stroke where the patient  lacked 
capacity; and their ongoing thoughts and feelings at six months on 
reflection of their time in hospital  
d. To evaluate current communication of patient diagnosis and prognosis 
between doctors and patients/family members and determine if the 
doctors’ views regarding appropriateness of treatments for an 
individual patient influences decisions taken about those treatments.  
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e. To determine the best way of presenting information (specifically that 
of prognosis) to patients and families to help their understanding 
and/or decision-making regarding life-extending treatments 
f. To develop and externally validate new prognostic models which 
predict specific abilities after a major stroke at accuracies defined 
useful by individuals.  
g. To explore how our models, and any future prognostic models may be 
improved. 
 
I performed a mixed-methods study to address my aims.  
Specifically,  
1. I recruited a longitudinal cohort of patients admitted with major 
stroke and followed them up for six months to address aim (a). I 
detail this in Chapter 2. 
2. By performing qualitative interviews at two time points (early period 
after stroke and at six months), I explored the experiences, views 
and needs of patients with major stroke (aim (b)). I detail this in 
Chapter 3.  
3. By performing qualitative interviews at two time points (early period 
after stroke and at six months), I explored the experiences, views 
and needs of family members involved in decision-making where 
the patient lacked capacity (aim (c)). I detail this in Chapter 4.  
4. I used questionnaires to evaluate current communication between 
doctors and family members of patients admitted with major stroke 
and to ascertain if the doctor’s views on treatment influenced 
treatment decisions (aim (d)). I detail this in Chapter 5.  
5. By using a combination of an informal feedback exercise and 
questionnaires, I attempted to determine the views of family 
members on the presentation of information (specifically that of 
prognosis) (aim (e)). I detail this in Chapter 6.  
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6. By using data from large trials, we developed prognostic models 
predicting six specific abilities after major stroke which I externally 
validated in the cohort I recruited. (aim (f)) I detail this in Chapter 7.  
7. I tested if our developed models, and any new models may be 
improved by using data from my cohort. (aim (g)) I detail this in 
Chapter 8. 
8. In Chapter 9, I discuss my conclusions, detail the implications of 
my findings to clinical practice, strengths and limitations of my 
study and future plan. 
Below is a flow diagram of my study. In each chapter, I will use this 
diagram to indicate which part of the study the chapter relates to.  
Figure 1.4 Study schematic 
 
 
While this thesis is written as a narrative based on my aims listed 
above, initially, the study was planned differently. My work began with 
analysis of available, large trial datasets to develop prognostic models 
to predict specific abilities at six months after stroke. (Chapter 7) This 
led to the recruitment of a prospective cohort of people with major 
stroke and collection of variables similar to those identified in our large 
trial datasets to externally validate these models and observe patient 
progress. (Chapter 2) We then identified samples of patients with 
Qualitative substudy
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capacity and family members where the patient lacked capacity for 
participation in qualitative interviews (Chapters 3 and 4) and doctors 
and family members to participate in a small questionnaire study to 
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Chapter 2 Outcomes after major stroke: a 
longitudinal cohort study 
2.1 Publication status and acknowledgement of 
contribution 
A paper from this chapter has been accepted by the ‘Journal of Stroke and 
Cerebrovascular Diseases’. This can be found in Appendix A. I wrote this 
chapter and publication following comments from my supervisors. 
2.2 Introduction 
The World Health Organisation (WHO) defines disability as an umbrella term 
covering impairments, activity limitation and participation restrictions. (117) 
Dependency is where a person requires support from others to be able to 
manage their day to day activities. As I described in Chapter 1, a large 
proportion of patients who have a major stroke may die. Those who survive 
with significant disability may be largely dependent on others for their daily 
activities (e.g. showering and dressing). In practice, these two terms 
(dependency and disability) are often used interchangeably, and may have 
varied meanings to patients and families.  
Patient outcome in clinical trials is often expressed using scales such as the 
mRs and BI to describe dependency or disability. The mRs is one of the most 
widely used outcome scales which stratifies patient outcome into levels of 
disability from 0 (no disability) to 6 (dead). (118) 
Patients who may be considered dependent or disabled may differ with 
respect to their specific abilities e.g. to walk, to talk. Therefore, it may be 
more appropriate to describe patient prognosis in terms of specific abilities. 
Patient and family members may also engage better with communication of 
positive information i.e. ‘abilities’ rather than ‘disabilities’ as this may offer 
them hope of recovery. (119) 
As I described in Chapter 1, different individuals may regard their quality of 
life differently and therefore, even within a single disability level (e.g. based 
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on mRs), HRQoL may vary greatly. This may be due to variation in the 
patient’s specific abilities. 
To understand the relationships between disability, HRQoL and specific 
abilities of patients with a major stroke, I recruited a longitudinal cohort of 
patients who had been admitted to hospital with major stroke.  I followed 
them up 7-10 days after their stroke to determine their early progress and 
treatment, and at around six months. I recorded their function by using global 
scales (mRs and BI), their HRQoL (using EQ5D-5L) and derived their specific 
abilities either from single items from these scales (e.g. continence from BI) 
or by asking specific questions (e.g. no dysphasia, mild dysphasia, etc.) 
about their abilities. This longitudinal cohort was also recruited for the 
purpose of external validation of prognostic models (which I describe in 
Chapter 7) and therefore, the decision to collect certain variables and/or use 
certain outcome scales was based on already available data that was used to 
develop these models. I will indicate this in the sections that follow.  
The specific abilities I determined were: to be independent, to walk, to be 
continent of urine and/or bowels, to talk without major problems, to eat 
normally, to live without severe pain, to live without major anxiety or 
depression, without major cognitive problems and to live at home. I chose to 
document these specific abilities based on expert opinion of stroke 
professionals in the hospital where recruitment took place and that was 
already available to us for the purpose of development of new prognostic 
models (Chapter 7). The dichotomies we chose to report whether patients 
had the specific ability (or not) was also based on expert opinion. I will detail 
this below. The final follow up time of six months was chosen to allow enough 
time for data analysis based on the length of my fellowship. 
In this chapter, I describe our longitudinal cohort of patients with a major 
stroke. I report my methodology and results as per the STROBE 
(Strengthening the Reporting of Observational Studies in Epidemiology) 
guidelines for cohort studies.(120) 
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The flow diagram below (boxes coloured in yellow) indicates the part of my 
study this chapter relates to.  
Figure 2.1 Study schematic: Chapter 2 
 
2.3 Aims 
1) To describe the baseline characteristics of a cohort of patients 
admitted with major stroke  
2) To describe patient progress after major stroke at three time points 
(baseline, 7-10 days and at around six months) 
3) To relate patients’ BI, HRQoL and specific abilities to their mRs at six 
months. 
2.4 Approvals 
The Scotland A research ethics committee which has responsibility for 
studies involving adults with incapacity provided ethical approval. (Reference: 
17/SS/0029).  
The NHS Lothian Research and Development Office also provided their 
approval. (Project number: 2017/0116) 
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2.5.1 Study design 
I prospectively recruited patients with major stroke into a longitudinal cohort 
study with follow up at 7-10 days (early follow up) and at around six months 
(final follow up). 
2.5.2 Setting 
 I recruited patients from the medical admissions unit, the acute stroke unit, 
and other wards in the New Royal Infirmary of Edinburgh, NHS Lothian 
between 10th May 2017 and 25th May 2018. 
2.5.3 Participants 
2.5.3.1 Inclusion criteria 
Patient were eligible if  they were over 18 years old, and had had a stroke (as 
defined by the WHO (121) and described in Chapter 1).  
I only recruited patients with major stroke, which, as described in Chapter 1, I 
defined as having an mRs of at least three or mRs 0-2 but being unable to 
carry out or maintain at least two specific abilities as a result of their stroke: 
walking, talking, eating, continence.  Recruitment criteria for these specific 
abilities was based on a simple ‘yes’ for affected and ‘no’ if not affected.  If 
the patient already had an mRs of 3 or were unable to maintain two specific 
abilities before their current admission, I included them if there had been a 
further deterioration in their functional abilities as a result of the stroke (and 
therefore, they were not at their pre-stroke level of function).  
2.5.3.2 Exclusion criteria 
I excluded: 
 Patients with subarachnoid haemorrhage (SAH) due to its different 
aetiology. Also, in the city where recruitment took place, patients with 
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SAH were looked after by the neurosurgical team at a different 
hospital site.  
 Diagnosis was uncertain and stroke was not considered as the most 
likely diagnosis 
 Patients where they did not have capacity, and no close family, friends 
or legal representative (proxies) were available to provide consent.  
 Patients or proxies who were unable to understand English or 
communicate in English. This is because I could not be certain that 
translated information would sufficiently explain the processes 
involved in the study.  
2.5.3.3 Screening 
I made efforts to ascertain all patients, as soon after their admission into 
hospital as possible. I identified patients by screening admissions 
electronically twice a day. I discussed with medical staff seeing these 
patients and liaised with nurses and doctors on the relevant wards. Since I 
single-handedly recruited patients into this study, screening (and recruitment) 
ceased when I was on annual leave and at weekends. 
2.5.3.4 Recruitment 
Medical staff responsible for patients’ care mentioned the study to eligible 
patients (if they had capacity) or their proxy (for those patients without 
capacity) and invited them to take part. If they were agreeable to be 
approached by me to receive more information about the study, I provided 
the patient or proxy with an information sheet and answered any questions 
about the study. Where they were amenable, I then obtained informed written 
consent. At the time of consent, I collected baseline data (first data collection) 
and this was also the time of recruitment into the study. To maintain 
consistency in the rest of this chapter, I will use the term ‘baseline’ to 
describe the time of recruitment/ consent / of first data collection. 
I tried to recruit all patients as soon as possible, aiming days 0- 6 after the 
patient’s stroke. Where the date of stroke was not known, I made a 
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judgement of the date based on the last time the patient was seen to be well. 
The date of stroke was day 0, and all subsequent follow up times were based 
on this. However, within the first two weeks into the study, I found that in 
some cases, patients presented late, some were very unwell in the first few 
days in hospital, I was unable to find the relevant proxy or some patients and 
families needed time to think about participation and consult relevant others. 
Therefore, on discussion and agreement with my supervisors, I extended the 
recruitment window to days 0 to 10 after stroke. However, this meant that 
there may be potential overlap between collection of baseline data and early 
follow up data of patients. To account for this, I ensured that there was at 
least one day (minimum of 24 hour) difference between collection of baseline 
and early follow up data.   
2.5.4 Data collection  
I assessed patients at three time points. As described above, these time 
points were relative to the date of stroke. I aimed for first data collection (i.e. 
baseline)  between days 0 and 10 after stroke, second data collection to be 
between days 7 and 10 (i.e. early follow up) and at least 24 hours after the 
baseline data collection and third data collection (i.e. final follow up) at about 
six months after stroke. All baseline assessments and early follow ups were 
done in person. I checked patient electronic records to check if the patient 
was alive before carrying out six month assessments over the telephone. 
I collected variables that described the cohort (e.g. demographics and other 
baseline characteristics), that which described patient early progress, their 
outcomes at six months and variables which might be useful in predicting 
some of these outcomes. Based on one of my aims which was to externally 
validate prognostic models, I tried to collect variables that were similar to 
those collected in large trials which was used to develop new prognostic 
models. (Described in Chapter 7) 
2.5.4.1  Baseline 
I recorded: 
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 Basic demographics (e.g. age, sex), recruitment details, date of stroke 
and consent details. These variables were collected to describe my 
cohort. Sex was also collected as a potential predictor variable- being 
male has been associated with increased odds of depression after 
stroke, while being female has been associated with increased odds of 
anxiety after stroke. (122) 
 The patient’s marital status, pet ownership, smoking and alcohol 
status and the highest level of education achieved. Marital status was 
collected to describe my cohort, but also as a potential predictor 
variable- being married has been reported to be associated with lower 
odds of depression after stroke.(123,124) ‘Pet ownership’ was 
collected as a potential predictor variable based on evidence that this 
improved psychological well-being. (125,126)  The other variables 
were collected to describe my cohort.  
 Charlson co-morbidity index (127): This includes 18 specific domains 
with a maximum score of 33. A score of 0 indicates no pre-existing 
comorbidity, 1-2: mild, 3-4: moderate and 5 or more: severe. I 
confirmed patient reports by inspecting their medical records (where 
available) at initial assessment. This was collected to describe my 
cohort and also because it has been described as a potential predictor 
variable of mortality and functional outcome six months after stroke. 
(127) 
 Bamford or Oxford Community Stroke Project (OCSP) classification 
for ischaemic strokes (as recorded by medical staff): Total anterior 
circulation stroke (TACS), Partial anterior circulation stroke (PACS), 
Lacunar stroke (LACS) and Posterior circulation stroke (POCS). (128) 
This was collected to describe my cohort. 
 Glasgow Coma Scale (GCS) (129,130): This is a general measure of 
neurological state and level of alertness determined by three areas: 
eye opening (scored 1-3), motor function (scored 1-6) and verbal 
response (scored 1-5). Therefore, the highest GCS is 15/15 and 
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lowest 3/15. This was collected to describe the baseline 
characteristics of my cohort. 
 Six simple variables (SSV) (91): These six easily collected variables 
have been widely used in research (91,131)  and audit (98) and 
predict survival at 30 days after stroke, survival and independence at 
six months and being able to live at home at six months and a year 
after stroke. The variables are: age, being independent before stroke, 
living alone before stroke, being able to walk unaided after stroke, 
being able to lift arms off the bed after stroke and normal verbal 
component of the GCS after stroke. I will describe the use of these 
variables in prognostic modelling in Chapter 7. The SSVs were 
collected as predictor variables as they were available in our large trial 
datasets for modelling and validation purposes.  
 Barthel Index (BI)(12): This a scale measuring functional ability of the 
patient. This includes the patients’ ability to self-care, mobilise, feed 
and be continent. I calculated a total score between 0 (fully 
dependent) and 100 (fully independent) from the individual 
components. Where information was not recorded in the patients’ 
records, I asked nursing staff looking after the patient. I recorded the 
BI to describe the specific functional abilities of patients in my cohort. 
Urinary incontinence has also been reported to be associated with 
higher rate of institutionalisation two years after stroke. (132) 
 Simplified modified Rankin questionnaire (smRsq): This questionnaire 
enables a rapid determination of the mRs score both in person and 
over the phone. (133) Since my follow ups were to be done over the 
telephone at six months, I used this questionnaire at all my follow up 
points to be consistent with data collection. (Figure 2.2)   
 
Figure 2.2 smRsq for determination of mRs 




  HRQoL using EQ5D: this questionnaire consists of two parts: a visual 
analogue scale (VAS) and a descriptive system (EQ5D-5L) covering 
five dimensions (mobility, self-care, ability to perform usual activities, 
pain/ discomfort and anxiety/depression), each with the option of five 
levels. Wherever possible, I encouraged patients to complete this 
questionnaire. However, if they were unable to do so (e.g. due to lack 
of capacity, medically unwell), proxies were invited to complete this on 
the patient’s behalf.  I decided to use the EQ5D-5L rather than the 
EQ5D 3L (which has been widely used and tested in multiple clinical 
trials) because the 3L version is not sensitive to the important quality 
of life impacts of all conditions (134,135) and may not be sensitive to 
smaller changes in health as it only has three response levels in each 
dimension. (136) In contrast, the 5L version offers more levels of 
options for participants to choose from. Also, the 5L version has better 
discriminatory power for the reported measure of anxiety/ depression. 
(137) I decided to use the EQ5D rather than other patient reported 
outcome scales because this scale was used in the large trial datasets 
that we used to develop our prognostic models (Chapter 7). 
Could you live alone without help from another person? This means being 
able to bathe, use the toilet, shop, prepare or get meals, and manage 
Are you able to do everything that you 
were doing right before your stroke, 
even if slower and not as much?
Are you able to walk without help from 
another person?
Are you able to walk without help from 
another person?
Are you bedridden or needing constant 
supervision?





0 1 4 5
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 Six item cognitive impairment scale (6CIT): In the absence of a 
validated brief cognitive assessment tool for use in the hyperacute 
stroke phase, (138) I chose the 6CIT due to its brevity and simplicity. 
(139) The test (assesses temporal orientation, attention and short term 
memory) has been used in a broad range of settings including primary 
care (140), acute care (141) and Alzheimers disease. (142) I 
performed this test with the patient at the follow-up times where 
possible (I.e. patient had capacity and did not have severe stroke 
related deficits e.g. severe dysphasia). Scores ranged from 0 to a 
maximum of 28 with higher scores indicating worse cognition. This 
was performed to describe my cohort.   
2.5.4.2 Early follow-up  
I recorded:  
 Treatments and complications: if the patient had used intermittent 
pneumatic compression (IPC) for at least 24 hours, received at least 
24 hours of parenteral fluids, had been treated with a course (at least 
48 hours) of antibiotics, had been escalated to the high dependency or 
intensive care area for extra care, monitoring or circulatory support, 
had received (at least for 24 hours or had two or more trials of) enteral 
tube feeding via nasogastric tube (NG) or percutaneous gastrostomy 
(PEG), had a urethral catheter inserted (either for urinary incontinence 
or retention) or had a hemicraniectomy. I recorded if they had any 
form of infection (e.g. chest, urine, skin) which was diagnosed 
clinically. This diagnosis may or may not have been confirmed 
radiologically or from blood tests or cultures, and may or may not have 
been treated. I also recorded if they had another stroke between their 
initial stroke and follow up.  I recorded these treatments and 
complications as each may influence patient progress and outcome. 
 Do not attempt resuscitation (DNAR) decision: if patients had a DNAR 
form in their notes and if this was from the community or placed in 
hospital by day 10 of the patient’s stroke.  
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 Assessments to determine progress: smRsq, BI, EQ5D-5L and 6CIT.  
2.5.4.3 Six months after major stroke 
I recorded: 
 mRs using the smRsq  
 BI  
 EQ5D-5L and VAS 
 6CIT 
 Ability to talk: By providing options (i.e. using our specific questions- 
no dysphasia, mild to moderate dysphasia, severe dysphasia or 
mute), I asked the patient/family member or GP about the patients’ 
ability to talk. I took account of any speech and language therapy 
assessments in the patient’s hospital electronic records, and/or my 
assessment when speaking to the patient. I recorded the responses, 
based on language assessments only, into no dysphasia/ mild to 
moderate dysphasia/ severe dysphasia and mute. This was similar to 
the ‘best language’ assessment on the National Institutes of Health 
Stroke Scale (NIHSS). (143) 
 Ability to eat normally:  By asking specific questions, I recorded 
responses of normal diet/ oral modified diet/ Nasogastric (NG) fed, 
percutaneous gastrostomy (PEG) or Radiologically inserted 
gastrostomy (RIG) fed. 
 Ability to live at home: By asking specific questions, I recorded the 
place of residence of the patient at six months by either speaking to 
the patient or their proxy (usually family member), checking their 
records on the hospital electronic system or clarifying with their 
General Practitioner (GP).  
 
Table 2.1 summarises the data I collected over the three time points: 
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Table 2.1 Summary table of assessments at three time points after major stroke 





Demographics  +    
Eligibility criteria  +    
Age   +   
Date of birth   +   
Gender   +   
Medical history  +   
Social history  +   
Stroke classification  +   
Six simple variables   +   
Glasgow Coma 
Scale  
 +   
Early treatment    +  
Complications    +  
smRsq (mRs)  + + + + 
Barthel index (BI)  + + + 
EQ5D-5L + VAS  + + + 
Cognition (6CIT)  + + + 
Talking +   + 
Eat normally +   + 
Capacity  + + + 
Place of residence  +  + 
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2.6 Definitions of specific abilities at six months 
To maintain consistency of reporting results, I defined ‘good’ and ‘poor’ 
outcomes as shown in Table 2.2. This is used as a convenient short hand 
throughout this thesis, and the dichotomies I have used are either based on 
conventional reporting in large trials (e.g. for mRs) or based on opinions of 
stroke professionals working in the hospital where recruitment took place. I 
acknowledge that different people would have different judgements on ‘good’ 
and ‘poor’ outcomes; for example, for some people, survival at all costs 
would be a ‘good’ outcome, whereas for some, any problem with a specific 
ability (e.g. to walk) may be a ‘poor’ outcome. Furthermore, for some specific 
abilities, different measures/ scales may be used to define the same 
outcome. For example, for ‘to walk’, specific question on walking from smRsq 
(‘Can you able to walk from one room to another without help from another 
person?’), single item measure from BI (mobility on a level surface) or single 
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To walk smRsq Yes No 
To walk BI With the help of 
another person over 
50 yards 
Independent over 50 
yards 
Wheelchair 
independent over 50 
yards 
Immobile or less 
than 50 yards 

















































To live without 
severe pain 




Extreme pain or 
Dead 
To live without  
major anxiety 
or depression 















6CIT No/mild CI 
Moderate CI 
 
Severe CI  
Or Dead 










*Specific question: options given and dichotomised to ‘good’ or ‘poor’ 
outcome 
Note: I decided to report urinary and bowel continence separately as some 
individuals may regard a problem with one to have a worse impact on their 
quality of life than the other. 
2.7 Data management 
I designed a Microsoft Access 2013 database to facilitate data entry, storage 
and to coordinate follow up. I created individual tables and forms for each 
   
40 
 
category of assessments. I linked variables to a unique identifier code and 
exported this into the statistical software package (Stata 15) for analysis.  
I labelled each table and form separately to show what data the form had 
(e.g. social history, smRsq etc.) and at which time point. (i.e. baseline, early 
follow up, six months) 
The database was stored on the central server in the Division of Clinical 
neurosciences and access was granted only to me and my primary 
supervisor via password entry. This allowed secure access. This server had 
automatic regular backup to the central server of the University. I consulted 
the data security officer of the University to ensure that all required security 
measures were adhered to. 
2.8 Data checking 
I employed a number of methods to ensure data consistency: 
  I piloted the data collection forms with several patients on the stroke unit 
and made modifications. This ensured that the form was easy to use 
when I started recruitment.  
  I designed my Microsoft Access database to be similar to the data 
collection form and for data items to be verified on entry. This was to 
reduce transcription errors and alert me to any data that were not in 
range and hence needed to be checked.  
 Where possible, I used categorical answers to force yes/no decisions for 
each variable. 
 Where possible, I used scales (e.g. smRsq, BI) where a numerical value 
could be calculated. This ensured consistency when making comparisons 
over time. 
 I entered data into the database immediately after collecting it. This 
ensured that I was able to check for any missing data immediately and 
could collect these when the patient/ family and/or their medical records 
were still available.  
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 At several points of recruitment (e.g. patient number 100, 200, 300, 400), 
I checked the whole dataset for missing and incomplete records. If any 
were found, I went back to the medical notes to obtain this information.  
 I performed a number of internal consistency checks using Stata 15 
(statistical software) prior to analysis. This was to ensure that there were 
no obvious errors in my data- e.g. I would not anticipate a patient with 
mRs score of 5 to have a high BI, or a patient being recorded as having 
no capacity to have performed the 6CIT.  
2.9 Sample size 
I based my sample size on the NHS Lothian audit data for the Royal Infirmary 
of Edinburgh (RIE) in the year 2015 (the year prior to which I applied for 
funding for this study). This audit collected SSVs at patient admission. In this 
year, 620 (out of 861) admitted stroke patients had two of the following: prior 
dependency (i.e. not independent pre-stroke), immobility (unable to walk after 
stroke) and had an abnormal verbal GCS score response (i.e. unable to 
communicate normally) after stroke. Of these patients, 472 out of 861 
patients survived to six months.  
I aimed to recruit as many patients as possible as a larger cohort would mean 
a tighter 95% confidence interval around any estimates made of the proportion 
of patients with specific characteristics at the specified time points. I expected 
personally to be able to recruit 270 patients during the working week per year. 
Over 1.5 years of recruitment, about 400 patients might therefore be recruited 
into the study.  
2.10 Analysis 
2.10.1 Categorisation of variables 
For the following variables, having collected the total score, I categorised the 
scores either to allow comparisons to be made between two scales (e.g. BI 
and mRs) or for reporting to be consistent with what is used in clinical 
practice (e.g. 6CIT). I detail this below:  
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 To compare mRs and BI:   
The optimum cut offs for BI to make a comparison with mRs levels are 
varied. (12,13,144,145) Based on review of available literature, I categorised 
patients’ BI score to reflect levels of disability (Mild 75-100, moderate 50-70, 
severe 0-45). (145) As I anticipated many of my patients to be at the 
functionally dependent (i.e. severely disabled) end of the BI spectrum, I 
further subcategorised 0-45 into 0-20 (severe) and 25-45 (moderately 
severe). I anticipated that having this extra category would provide a more 
detailed picture of our cohort of patients. I compared the numbers of patients 
in each category of disability as defined by BI and mRs; i.e. Comparing BI 
75-100 with mRs 0-2, BI 50-70 with mRs 3, BI 25-45 with mRs 4 and BI 0-20 
with mRs 5.  
 6CIT: as described above, scores ranged from 0 to 28. I categorised the 
scores based on how they are used in clinical practice (i.e. 0-7= no or 
mild cognitive impairment (CI), 8-9= moderate CI and 10-28= severe CI). 
(146) 
2.10.2 Statistical methods 
I carried out all statistical analysis using Stata 15 (Timberlake Consultants, 
2017). I used descriptive statistics to summarise data and reported 95% 
confidence intervals for proportions. I performed cross tabulations to 
compare baseline and six month outcomes where appropriate. I took P<0.05 
to be statistically significant. I derived utilities from EQ5D dimensions using 
the crosswalk calculator published on the EuroQol website.(147) This 
allowed me to compare individuals in our cohort’s health states to those of 
healthy individuals in the UK population.  
2.11 Results 
I recruited 403 patients between 10th May 2017 and 25th May 2018. Of these 
patients, 386/403 (95.8%) completed early follow up (17/ 403, 4.2% had died) 
and 291/402 (72.2%) completed six month follow up (111/402, 27.5% had 
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died). I was unable to contact one patient for follow up at six months. This 
patient had moved abroad and was uncontactable. (Figure 2.3) 
 
Figure 2.3 Flow diagram of recruitment and follow up of cohort of patients with major 
stroke 
 
2.11.1 Recruitment details 
Most patients were recruited from the acute stroke unit (384/403, 95.3%) and 
248/403, 61.5% of these patients had mental capacity to be able to provide 








Early follow up 
(n=386)
Six month follow 
up (n=291)
Not recruited (n=204)
- Recovered quickly (n=74)
- Other diagnosis (n=53)
- Too severe/unwell (n=28)
- Unable to contact proxy (n=40)
- Declined to participate (n=9)
Death (n=17)
-Death (n=111)
- Unable to contact (n=1)
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Table 2.3 Place of recruitment and consent details of recruited patients with major 
stroke 
Details  N=403 % 
Recruitment 
place 
Acute stroke unit 
















2.11.2 Timings from stroke to baseline assessment and 
follow-up 
The intervals from stroke to baseline assessment are shown in Figure 2.4. 
The mean time from stroke to baseline assessment was 2.73 (SD 2.38) days.  
Two patients were recruited out with the stated period (one on day 11 and 
one on day 32). These patients had provided verbal consent within the 
recruitment window (days 0-10 after stroke) but due to medical illness, they 
were unable to complete certain assessments till later. I gained permission 
from the patient and retrospectively reviewed the patient’s notes to ensure 
that certain parts of the data (e.g. physical function) were collected from the 
early period after stroke. 
Mean time to early follow up was 8.2 (SD 2.63) days [range 4-32] and to final 
follow up, 184.4 (SD 14.17) [range: 164- 291] (Table 2.4) 
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Figure 2.4 Number of patients recruited versus days from stroke to recruitment into 
study 
 
Table 2.4 Timing between stroke and assessments 
Timing n= Mean (SD), days Range, days 
Baseline 403 2.85 (2.54) 0 to 32 
Early follow up 386 8.2 (2.63) 4 to 32 
6 month follow up 291 184.4 (14.17) 164 to 291 
2.11.3 Baseline characteristics of recruited patients 
2.11.3.1 Demographics 
The mean age of the cohort was 77.5 years, standard deviation (SD) 11.8, 
range 36-101. Over a third of recruited patients were between the ages of 80 
and 89. (150/403, 37.2%)  
I recruited 179 males and 224 females into the study. The mean age of 
males was 74.5 (12.5) [36-101]. The mean age of females was 79.9 (10.6) 
[36-97]. (Table 2.5) 




Table 2.5 Distribution of recruited patients by age group and gender 
Age group Male Female Total Total 
 n n n % 
30-39 1 1 2 0.5 
40-49 3 2 5 1.2 
50-59 22 9 31 7.7 
60-69 38 21 59 14.6 
70-79 40 57 97 24.1 
80-89 57 93 150 37.2 
90-99 17 41 58 14.4 
100-109 1 0 1 0.3 
Totals 179 224 403 100 
 
2.11.3.2 Ethnicity 
Most patients were White Scottish (343/403, 85.1%). (Table 2.6) 
Table 2.6 Ethnicity of recruited patients 
  N=403 % 
Ethnicity White other British  
White Scottish 
White Irish  
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2.11.3.3 Social circumstances 
 Table 2.7 summarises the social circumstances of the cohort of patients.   
Table 2.7 Social circumstances of cohort of patients admitted with major stroke 




Own home- alone  
Own home- with family  
Own home- with carers  
Sheltered home  











































































Smoking status Current  
Never  
Ex >12 months  























Pet ownership Never  
Current  
Yes in the last 12 









2.11.3.4 Medical history 
Some patients (23/403, 5.7%) had severe comorbidities before their hospital 
admission with major stroke as defined by the Charlson comorbidity index 
score. Around a third, (123/403, 30.5%) had a previous stroke or transient 
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Table 2.8 Medical characteristics 






































Past history of 








2.11.3.5 Stroke related characteristics 
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Table 2.9 Stroke related characteristics 
Variable  Total n =403 % 
Stroke Subtype Haemorrhagic 63 15.6 























2.11.3.6 Six simple variables (SSV) (91) 
Around three quarters of patients (308/403, 76.4%) in the cohort were 
independent before stroke. Few (28/403, 6.9%) were able to walk after their 
stroke (i.e. at baseline assessment). (Table 2.10)  
Table 2.10 Six Simple Variables at baseline 




Living alone before 
stroke 
158 39.2 
Able to walk after stroke 28 6.9 
Able to lift arms after 
stroke 
152 37.8 
Orientated speech after 
stroke 
248 61.5 
Age (mean, years (SD)) 77.5 (11.8)  
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2.11.3.7 Baseline mRs measured using smRsq  
Over half of the patients I recruited had a mRs of 5 (209/403, 51.9%). Few 
(6/403, 1.5%) had a mRs of 1 or 2 at time of recruitment, but as per my 
inclusion criteria, these patients had two or more specific abilities affected as 
a result of their stroke and were therefore eligible. Of the patients with mRs 1 
and 2 (six in total), all had been thrombolysed. Five of these patients had 
problems with their ability to talk and to eat normally at baseline. The two 
patients with mRs 1 had high level difficulties in their ability to talk and mild 
impairment in their ability to eat normally. Hence although they had 
symptoms, they were able to perform all their usual activities. Four patients 
with mRs 2 had problems with their ability to talk and eat normally and 
required assistance from nursing staff but they were able to walk and self-
care independently. One patient (with mRs 2) had problems with talking and 
continence (urinary only). Though he/she was able to manage daily activities, 
he/she was unable to perform all previous activities e.g. reading. (Table 2.11) 
Table 2.11 Baseline mRs of cohort of patients with major stroke 
mRs n % 
0 0 0 
1 2 0.5 
2 4 1 
3 17 4.2 
4 171 42.4 
5 209 51.9 
6 0 0 
Missing 0 0 
Total 403 100 
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2.11.3.8 Baseline BI (score 0 to a maximum of 100) 
The distribution of BI scores at baseline is shown in Figure 2.5. BI scores at 
baseline were normally distributed (mean 31.6, SD 25.6). Median score was 
30, (5-50) [95%CI]. 
Figure 2.5 Distribution of BI at baseline 
 
When I categorised BI (as described above), most patients were severely 
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Table 2.12 Categorised BI score at baseline 
BI n % 
0-20 176 43.7 
25-45 106 26.3 
50-70 96 23.8 
75-100 25 6.2 
Dead 0 0 
Missing 0 0 
Totals 403 100 
 
Each individual component (single item) of the BI provided more detailed 
information on the ability of the patients. For example,  
2.11.3.8.1 Mobility from BI 
At baseline, 17/403 (4.2%) were classed as being independent over 50 
yards, 83/403 (20.7%) were able to mobilise with the help of another person 
over 50 yards and 303/403 (75.2%) of patients were either immobile, or 
mobile less than 50 yards.  
2.11.3.8.2 Continence from BI 
At baseline, specific to urinary continence, 165/403 (40.8%) were continent of 
urine, 43/403 (10.7%) had ‘occasional accidents’ and 195/403 (48.5%) were 
incontinent or had a urethral catheter. 
Specific to bowel continence, 250/403 (62.0%) were continent, 9/403 (2.2%) 
had occasional accidents and 144/403 (35.7%) were incontinent. 
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2.11.3.9 Talking (language assessments only)  
At baseline, 273/403, 67.7% of patients had a problem with their ability to 
talk.  
2.11.3.10  Eating  
At baseline, 175/403, 43.4% of patients had a problem with being able to eat 
(i.e. they had a problem with their swallow).  
2.11.3.11 HRQoL (EQ5D-5L and VAS) 
A comparison between patients and proxies was not possible as proxies only 
completed these assessments when patients were unable to do so. In the 
absence of an alternative way of obtaining patients responses, I assumed 
proxies were completing the assessments based on what the patient may 
have answered.   
Of the total number of assessments, 245/403 (60.8%) were completed by 
patients and 158/403 (39.2%) were completed by proxies at baseline. Three 
patients who were able to consent (Table 2.3) delegated the completion of 
EQ5D to their proxy due to fatigue (n=2) and did not have their reading 
glasses (n=1).  
I assessed if the mRs of the patient had any bearing on who completed the 
HRQoL assessments. (Table 2.13) I found that proxies completed most of 
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Table 2.13 Completion of HRQoL assessments based on patient mRs at baseline 
 mRs at baseline Totals 
Completed 
by 
0 1 2 3 4 5  
Patient 0 2 4 14 143 82 245 
Proxy 0 0 0 3 28 127 158 
Totals 0 2 4 17 171 209 403 
 
Eight participants (4 patients and 4 proxies) (2.0%) did not complete the VAS 
at baseline.  
The distribution of VAS scores (n=395), by patient (n=241) versus proxy 
(n=154) is shown in Figure 2.6. Patients tended to report a wider range of 
scores on the VAS, with most reporting a score of 50. Proxies tended to 
indicate lower scores. This is likely because proxies completed the HRQoL 
assessment where the patient had had a more severe stroke (as categorised 
by mRs and shown in Table 2.13). It is also possible that proxies may be 
more pessimistic of the patient’s abilities.  
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Figure 2.6 VAS at baseline, patient and proxy 
 
However, as I reported above, a direct comparison of patient versus proxy is 
not possible. Therefore, unless specified, for the rest of my analysis, I 
combined EQ5D-5L and VAS responses provided by patients and proxies 
(i.e. participants).  
Figure 2.7 shows the distribution of all completed VAS at baseline (n=395) 
with corresponding summary statistics. The distribution of VAS at baseline 
was normally distributed: Mean 32.8 SD 23.6. Median was 30 (10-50) 
[95%CI]. 
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Figure 2.7 Distribution of VAS (all) at baseline, n=395 
 
Table 2.14 shows the responses of participants in all five dimensions.  When 
looking at each individual level within each dimension, the highest number of 
participants had indicated ‘unable to perform’ for the first three dimensions 
(i.e. mobility, self-care and usual activities) and ‘none’ for pain and 
anxiety/depression.   
Table 2.14 Responses to each EQ5D-5L dimension at baseline 
Dimension Levels n % 
Mobility No problems 27 6.7 
 
Slight problems 58 14.4 
 
Moderate problems 63 15.6 
 
Severe problems 64 15.9 
 
Unable to perform 190 47.2 




Missing 1 0.3 
Self-care No problems 43 10.7 
 
Slight problems 72 17.9 
 
Moderate problems 80 19.9 
 
Severe problems 43 10.7 
 
Unable 164 40.7 
 
Missing 1 0.3 
Usual activities No problems 13 3.2 
 
Slight problems 41 10.2 
 
Moderate problems 54 13.4 
 
Severe problems 28 7.0 
 
Unable 267 66.3 
 
Missing 0 0.0 
Pain None 257 63.8 
 
Slight 69 17.1 
 
Moderate 52 12.9 
 
Severe 20 5.0 
 
Extreme 3 0.7 
 
Missing 2 0.5 
Anxiety/depression None 133 33.0 
 
Slight 111 27.5 
 
Moderate 99 24.6 
 
Severe 52 12.9 
 
Extreme 7 1.7 
 
Missing 1 0.3 
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The mean utility of patients at baseline was 0.23, SD 0.36.  
2.11.3.12 Cognition at baseline 
The distribution of cognitive scores of patients who were able to participate at 
baseline (232/403, 57.6%) was skewed. The median score was 6 (2-12) 
[95%CI]. Mean 7.2, SD 6.2. (Figure 2.8) 
Figure 2.8 Cognitive scores at baseline, n=232 
 
 Table 2.15 shows the 6CIT scores of our cohort at baseline, categorised as 
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Table 2.15 6CIT scores at baseline, categorised 
Scores Definition           n                %                                   
0 to 7 No or mild CI  129 32.0 
8 to 9 Moderate CI 23 5.7 
10 to 28 Severe CI 80 19.9 





2.11.4 Progression of cohort of patients with major 
stroke over time 
In this section, I describe how the cohort of patients progressed over time 
(from baseline, to early follow up and final follow up). I report: 
 Complications and treatments by early follow up 
 mRs over time 
 BI over time 
 HRQoL over  time 
 Specific abilities (either based on single items from measures/scales or by 
asking specific questions on their abilities) at baseline and at six months 
At early follow-up, 386/403, 95.8% were alive, and at six months, 291/402, 
72.4% were alive.  
2.11.4.1 Complications and treatments by early follow up 
Table 2.16 shows the complications incurred and treatments received by the 
cohort of patients by early follow up.  
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Table 2.16 Complications and treatments by early follow up 
Variable n=403 % 
Complications   
Infection 132 32.8 
Recurrent stroke 12 3 
Treatments   




Antibiotics 129 32 
Urethral Catheterisation 112 27.8 
Enteral tube feeding 78 19.4 
Escalation above ward level 3 0.7 
Neurosurgery 0 0 
 
By day 10 of stroke, 89/403 (23.2%) had a DNAR form instated in hospital. 
Another few, 33/403 (8.6%) had a DNAR form from the community. 
2.11.4.2 mRs measured by smRsq 
A small proportion of patients, 37/403 (9.3%) had an mRs 0-2 at early follow 
up. Few more, 60/402 (13.1%) had mRs 0-2 by six months. However, a 
proportion, 82/402 (20.3%) remained significantly disabled (mRs 4-5) at six 
months. There was a high proportion of patients with mRs of 3 at six months. 
(Table 2.17) The figure below shows the number of patients in each mRs 
level over time. (Figure 2.9) 
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Table 2.17 mRs of the cohort of patients with major stroke over time 




n % n % n % 
0 0 0 1 0.3 8 2 
1 2 0.5 24 6 45 11.2 
2 4 1 12 3 7 1.7 
3 17 4.2 60 14.9 149 37 
4 171 42.4 114 28.3 46 11.4 
5 209 51.9 175 43.4 36 8.9 
6 0 0 17 4.2 111 27.5 
Missing 0 0 0 0 1 0.3 
All 403 100 403 100 403 100 
 
Figure 2.9 mRs of cohort of patients with major stroke over time 
 
While the above represents grouped data, the progress of each individual 
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of each patient over the three time periods (baseline, early follow up, six 
months) in a sample of 200 (50%) out of the 403 patients. This diagram 
provides a pictorial representation of how individual patients may vary in their 
progress over time rather than being intended as a full representation of my 
data. There were overlaps of lines as some patients took the same mRs 
pathway over time. It was not possible to draw a line plot for all 403 patients 
due to restrictions on the number of values that the programme used to draw 
this line plot could handle. 
Figure 2.10 Individual patient data, n=200: mRs pathway taken by each patient over 
















Timings of follow up
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2.11.4.3 BI over time 
At early follow up, BI scores were normally distributed for surviving patients 
(n=386) [Mean 44.0, SD 33.0]. Median score was 40 (10-70) [95%CI]. 
(Figure 2.11)  
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At six months, the distribution of BI of surviving patients (n=291) was 
skewed. Median 75 (50-90) [95%CI]. Mean 67.5, SD 29.3. (Figure 2.12)  
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Figure 2.13 shows the distribution of BI, categorised, over time. While 
154/402 (38.3%) of patients were considered to ‘be independent’ at six 
months (BI 75-100), a proportion: 38/402 (9.5%) of the cohort were 
functionally severely dependent (BI 0-20) at six months. 
Figure 2.13 Number of patients in each category of BI over three time points 
 
The line plot (Figure 2.14) shows the pathway 200 patients (50% of the 
cohort) took with respect to their BI scores at the three follow up times.  This 
figure is indicated as a pictorial representation of how individual patients 
progressed, rather than a full representation of my data. 
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Figure 2.14 Individual patient data, n=200: pathway taken by each patient with respect 
to their BI over three time periods (baseline, early follow up and six months) 
 
 
2.11.4.4 Comparison of two disability scales: mRs and BI 
As described in Section 2.10.1, to compare how mRs and BI may vary with 
respect to categorising patients into levels of disability, I chose BI cut-offs 
based on my review of literature to allow a comparison to be made with mRs. 
(12,13,144,145)  
At all follow up times, BI grouped more patients into the no/mild disability 
group when compared to mRs. BI also grouped fewer patients into the 
moderately severe and severe disability groups when compared to mRs. 
(Table 2.18) I describe the ‘’floor ceiling’’ effects of BI in my discussion.   
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Table 2.18 Grouping of patients into disability categories: mRs and BI of surviving 
patients at three follow up times 










Baseline 403 No/mild disability mRs 0-2 /BI 
75-100 
6 25 
  Moderate disability mRs 3/ BI 50-
70 
17 96 
  Moderately severe 
disability 
mRs 4/ BI 25-
45 
171 106 





386 No/mild disability mRs 0-2 /BI 
75-100 
37 96 
  Moderate  
disability 
mRs 3/ BI 50-
70 
60 79 
  Moderately severe 
disability 
mRs 4/ BI 25-
45 
114 74 





291 No/mild disability mRs 0-2 /BI 
75-100 
60 154 
  Moderate disability mRs 3/ BI 50-
70 
149 67 
  Moderately severe 
disability 
mRs 4/ BI 25-
45 
46 32 
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2.11.4.5 HRQoL: EQ5D-5L and VAS 
At early follow up, 255/403 (63.3%) of patients and 131/403 (32.5%) of 
proxies completed HRQoL assessments. Few, 17/402 (4.2%) patients had 
died by early follow up. Proxies completed HRQoL assessments on behalf of 
the patient where the patient had a higher mRs (i.e. 4 or 5). 
Table 2.19 Completion of HRQoL assessments by patients or proxies based on 
patients’ mRs at early follow up 
Completed 
by 
mRs at early follow up Totals 
 0 1 2 3 4 5 6  
Patient 1 24 12 45 90 83 0 255 
Proxy 0 0 0 15 24 92 0 131 
Dead 0 0 0 0 0 0 17 17 
Totals 1 24 12 60 114 175 17 403 
 
At six months, patients completed 193/402 (48.0%) of HRQoL assessments 
and proxies completed 98/402 (24.4%). As reported, 111/402 (27.5%) of 
patients had died by six months. Similar to baseline and at early follow up, 
proxies completed most of the assessments where the patient had a mRs of 
5 (31/402, 7.7%) and only 5/402 (1.2%) of patients who had a mRs of 5 were 
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Table 2.20 Completion of HRQoL assessments by patients or proxies based on 
patients’ mRs at six months 
Completed 
by 
mRs at six months Totals 
 0 1 2 3 4 5 6  
Patient 8 44 6 118 12 5 0 193 
Proxy 0 1 1 31 34 31 0 98 
Dead 0 0 0 0 0 0 111 111 
Totals 8 45 7 149 46 36 111 402 
 
2.11.4.5.1 Visual analogue scale (VAS) 
At early follow up, VAS data were not available from n=24 participants (17 
patients had died, and 7 did not complete). The distribution of available VAS 
(n=379) was normally distributed with a mean VAS of 43.2, SD 27.3. Median 
was 50 (20-65) [95%CI]. (Figure 2.15) 
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At six months, VAS data were available from 288 participants (111 patients 
had died, 1 was lost to follow up and 3 did not complete). The scores were 
normally distributed: mean 55.3, SD 25.0. Median 50 (40-75) [95%CI]. 
(Figure 2.16) 
Figure 2.16 Distribution of VAS at six months, n=288 
 
2.11.4.5.2 Individual EQ5D-5L dimensions 
Table 2.21 summarises the responses provided by participants in each 
EQ5D-5L dimension over the three time points. The proportion of patients 
reporting severe/ extreme problems or ‘unable’ reduced over time. This could 
be explained by the virtue of patients with more severe problems dying.  
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Table 2.21EQ5D-5L dimensions of patients with major stroke over three times (baseline, early follow up and six months), n=403 


















Mobility No problems 27 6.7 48 11.9 60 14.9 
 
Slight problems 58 14.4 60 14.9 69 17.1 
 
Moderate problems 63 15.6 65 16.1 65 16.1 
 
Severe problems 64 15.9 51 12.7 53 13.2 
 
Unable to perform 190 47.2 162 40.2 44 10.9 
 Dead 0 0.0 17 4.2 111 27.5 
 
Missing 1 0.3 0 0.0 1 0.2 
Self-care No problem 43 10.7 82 20.4 104 25.8 
 
Slight problem 72 17.9 65 16.1 49 12.2 
 
Moderate problem 80 19.9 65 16.1 60 14.9 
 
Severe problem 43 10.7 41 10.2 27 6.7 
 
Unable 164 40.7 132 32.8 51 12.7 
 Dead 0 0 17 4.2 111 27.5 




Missing 1 0.3 1 0.3 1 0.2 
Usual activities No problems 13 3.2 25 6.2 33 8.2 
 
Slight problems 41 10.2 72 17.9 85 21.1 
 
Moderate problems 54 13.4 60 14.9 62 15.4 
 
Severe problems 28 7.0 21 5.2 17 4.2 
 
Unable 267 66.3 208 51.6 94 23.3 
 Dead 0 0 17 4.2 111 27.5 
 
Missing 0 0 0 0 1 0.2 
Pain None 257 63.8 252 62.5 199 49.4 
 
Slight 69 17.1 72 17.9 41 10.2 
 
Moderate 52 12.9 38 9.4 35 8.7 
 
Severe 20 5.0 23 5.7 16 4.0 
 
Extreme 3 0.7 0 0.0 0 0.0 
 Dead 0 0 17 4.2 111 27.5 
 
Missing 2 0.5 1 0.3 1 0.2 
Anxiety/depression None 133 33.0 145 36.0 111 27.5 
 
Slight 111 27.5 110 27.3 100 24.8 




Moderate 99 24.6 91 22.6 41 10.2 
 
Severe 52 12.9 38 9.4 36 8.9 
 
Extreme 7 1.7 2 0.5 3 0.7 
 Dead 0 0 17 4.2 111 27.5 
 








2.11.4.5.3 Utilities (derived from EQ5D dimensions) 
I calculated the utility (the desirability of a specific health outcome, where a 
utility of 1 represents excellent health and one that is negative (less than 0) to 
be worse than death) using the crosswalk calculator published in the EuroQol 
website, (147) for each of the patients in our cohort. Missing data (n=1) have 
been excluded from this part of the analysis.  
Table 2.22 shows the mean utilities of our cohort of patients (n=402). I have 
reported two results: one including those patients who had died (and given a 
utility of 0) and one excluding those who had died. The rationale behind 
including those who had died, and giving them a utility value of 0, was to 
account for the people who had died and acknowledge that there may be 
disability states that were better or worse than death for some individuals. 
The rationale for excluding those who had died was that their utility was not 
measured, and therefore, the utility of those who had died was assumed to 
be 0. 










  Mean 
utility 
SD Mean utility SD 
Baseline 0 0.23 0.36 0.23 0.36 
Early 
follow up 
17 0.30 0.40 0.32 0.40 
Six 
months 
111 0.36 0.37 0.50 0.36 
 
Figure 2.17 shows the number of surviving patients within categories of 
utilities at three time points. This shows that 138 participants indicated the 




utility less than, or equal to 0) This was reported by 91 patients and 47 
proxies. 
At six months, 39 participants indicated the patient’s HRQoL to be worse 
than or equal to being dead. This was reported by 8 patients and 31 proxies. 
Of these 8 patients, four had mRs 5, three had mRs 4 and one had mRs 3.  
Figure 2.17 Number of patients within each category of utility at three time points 
 
2.11.4.6 Specific abilities: based on single items from measures/ 
scales or by asking specific questions.  
In this section, I make comparisons between the specific ability of the patient 
at baseline and at six months 
2.11.4.6.1 ‘To walk’ 
As I described in Section 2.6, based on my data, three measures could be 
used to report the ability of patients ‘to walk’. These are smRsq, BI (mobility 
on a level surface) and EQ5D-5L (mobility). Each measure defines ‘to walk’ 




outcomes (as defined in Section 2.6) would be different when different 
measures/scales are used. (Table 2.23, Table 2.24, Table 2.25, Table 2.26) 
 Using specific question from smRsq (‘Can you walk from one room to 
another without the help of another person’?) 
 
Table 2.23 Using specific question from smRsq to report the specific ability 'to walk' at 
baseline and six months 
smRsq   Six months   
Baseline Yes No Dead Totals 
Yes 22 0 0 22 
No 187 82 111 380 
Total 209 82 111 402* 














 Using single item from BI (Mobility on a level surface) 
Table 2.24 Using single item from BI to report the specific ability ‘to walk’ at baseline 
and six months  





































36 9 1 30 7 83 
Immobile or 
less than 50 
yards 
61 32 11 94 104 302 
Total 113 41 12 125 111 402* 







 Using single dimension from EQ5D-5L (Mobility) 
Table 2.25 Using single dimension from EQ5D-5L to report the specific ability ‘to walk’ 




  Six 
months 









Unable Dead Totals 
No 
problems 
14 5 2 2 2 2 27 
Slight 
problems 
15 18 12 5 2 5 57 
Moderate 
problems 
16 16 12 7 4 8 63 
Severe 
problems 
5 15 16 11 6 11 64 
Unable 10 15 22 28 30 85 190 
Missing 0 0 1 0 0 0 1 
Totals 60 69 65 53 44 111 402* 
*n=1 loss to follow up 
Table 2.26 'To walk' defined by three different scales/measures 
‘To walk’ at six 
months 
Good outcome Poor outcome 
Measure/Scale n (%) n (%) 
smRsq 209 (52.0) 193 (48.0) 
BI 154 (38.3) 248 (61.7) 






2.11.4.6.2 ‘To be continent’ 
 Urinary continence 
This is based on a single item from BI (urinary continence). 
Table 2.27 Using single item from BI to report urinary continence at baseline and at 
six months 
Baseline Six months     





Continent 102 32 15 15 164 
Occasional 
accidents 
18 11 8 6 43 
Incontinent/ 
catheterised 
42 25 38 90 195 
Total 162 68 61 111 402 
 
 Bowel continence 
This is based on a single item from BI (bowel continence). 
Table 2.28 Using single item from BI to report bowel continence at baseline and at six 
months 
Baseline Six months     
 Continent Occasional 
accidents 
Incontinent Dead Totals 
Continent 205 5 13 26 249 
Occasional 
accidents 
5 0 1 3 9 
Incontinent 33 11 18 82 144 





2.11.4.6.3 ‘To talk’ 
Using our own specific questions (Section 2.6), I determined the ability of 
patients in the cohort ‘to talk’ at baseline and at six months:  
Table 2.29 Using specific questions to report the ability of the patient ‘to talk’ at six 
months according to whether the patient was able ‘to talk’ at baseline 
Baseline Six 
months 













Mute Dead Total 
Yes 105 60 12 0 96 273 
No 105 8 0 1 15 129 
Total 210 68 12 1 111 402* 
*n=1 loss to follow up 
There were 105/402, 26.1% of patients who had recovered their ability to talk 
(i.e. had no dysphasia) by six months.  
The one patient who did not have a problem with their ability to talk at 
baseline but was mute at six months had been readmitted to hospital with a 
major haemorrhagic stroke, and at time of final follow up, was in hospital on 
an end of life pathway.  
For the eight who did not have a problem with their ability to talk at baseline 
but had mild to moderate dysphasia at six months, I reviewed the patients’ 
notes to find out the reasons for this. For two patients, a problem with their 
ability to talk was not noticed at baseline, but noticed a few days later. It is 
unclear from the documentation whether this may have been related to the 
stroke that precipitated hospital admission, or another stroke within the first 
few days. Three patients had had another stroke between early follow up and 
six months.  The other three had other documented possible causes for a 
problem with their ability to talk e.g. delirium or dementia, and since these 




of looking for alternative placements), this problem had consciously not been 
investigated. 
2.11.4.6.4 ‘To eat normally’  
Using our own specific questions (Section 2.6), I determined the ability of 
patients in the cohort ‘to eat normally’ at baseline and at six months. As 
reported, this is based on swallow assessments only, independent of the 
patient’s physical ability. 
Table 2.30 Using specific questions to report ability ‘to eat normally’ at six months 
according to whether the patient was able to eat at baseline 
At baseline At six months 











Yes 66 20 0 3 86 175 
No 185 15 0 1 25 227 
Total 251 35 0 4 11
1 
401* 
*missing data n=2 (1 unknown at six months, 1 loss to follow up) 
Some, 66/401 (16.5%) had recovered their ability to eat by six months. 
I reviewed the notes of the patients who did not have a problem with their 
ability to eat normally at baseline but either required a modified diet (n=15) or 
were PEG/RIG fed (n=1) at six months.  
The one patient who was PEG/RIG fed was a patient who had become frailer 
in the six months after stroke, had worsening dementia and was awaiting a 
care home placement. There was no clear documentation of a second stroke, 
but anticipatory care planning had taken place not to investigate any such 
diagnosis. With respect to the 15 patients who needed oral modifications of 
their diet, nine had dementia which had deteriorated, and this was 
documented as a reason for their problems with ability to eat normally. For 
the other six, there was no clear recurrence of stroke, or alternative diagnosis 
provided. However, a problem with their ability to eat normally had been 




2.11.4.6.5 To live without major cognitive problems 
At early follow up, 6CIT scores were available from 240 patients (17 had 
died, 146 were not able to complete). Scores ranged from 0 to 28. Data was 
skewed: median 4 (2-10) [95%CI]. Mean 6.3, SD 6.1.  










At six months, 189 patients were able to complete the 6CIT. (111 had died, 
and 103 were unable to). Data was skewed: median 4 (0-8) [95%CI]. Mean 
4.4, SD 4.8. 













Table 2.31 shows the number of patients in each category of 6CIT scores 
over the three time periods.  
Table 2.31 6CIT scores over three time periods, categorised to no or mild CI, Moderate 
CI and severe CI. 




Score Interpretation n % n % n % 
0 to 7 No or mild CI  129 32.0 148 36.7 139 34.7 
8 to 9 Moderate CI 23 5.7 21 5.2 21 5.2 
10 to 
28 
Severe CI 80 19.9 72 17.9 29 7.2 
 
Could not perform 
(e.g. lack of capacity) 
171 42.5 146 36.2 102 25.3 
 
Death 0 0 17 4.2 111 27.5 
 
Missing 0 0 0 0 1 0.2 
 
Totals 403 100 403 100 403 100 
 
Table 2.32 shows the cognition of patients at six months according to their 
cognition at baseline. The majority had no/mild CI at baseline and at six 
months (97 patients). There were 17 patients who had severe CI both at 
baseline and at six months, and few (6) had no or mild CI at baseline but had 
severe CI at six months. On review of the patients notes, the few (5) who had 
severe CI at six months, but no or mild CI at baseline were patients who 
either had a recurrent stroke (n=2), or were in the process of being assessed 






Table 2.32 6CIT scores: cognition of patients at six months according to their 
cognition at baseline 
Cognitive 
impairment 
Six months  
Baseline No/mild Moderate Severe Missing Dead Total 
No/mild (score 0-
7) 
97 11 5 12 4 129 
Moderate (score 
8-9) 
10 0 1 7 5 23 
Severe (score 
10-28) 
22 7 17 22 11 79 
Missing 10 3 6 61 91 171 
Total 139 21 29 102 111 402* 
* n=1 lost to follow up 
2.11.4.6.6 ‘To live at home’  
Using specific questions, (As described in Section 2.6) I recorded patients’ 
place of residence at six months.  
Out of the 384/403 (95.3%) patients who lived at home prior to the stroke 
(either alone, with family or with carers), 209/384 (54.4%) were able to return 
to their own home, with or without carers. However,  at six months, there was 
a rise in patients in care homes (14/403 (3.5%) to 44/402 (10.9%)) and some 
patients 27/402 (6.7%) were in NHS institutions due to ongoing care needs; 
either because their demands on care were being best met in a hospital 








Table 2.33 Patients’ place of residence at six months, according to their place of 
residence prior to hospital admission 















Home 209 8 1 1 38 26 101 384 
Sheltered 0 0 0 0 1 0 1 2 
Care 
home 
0 0 0 0 5 0 9 14 
Prison 1* 0 0 0 0 0 1 2 
Total 210 8 1 1 44 27 111 402** 
*completed prison sentence and was discharged with care package four 
times a day 
**excludes n=1 lost to follow up 
2.11.5 To relate patients’ BI, HRQoL and specific abilities 
to their mRs at six months after major stroke 
In my introduction, I mentioned how patients in the same mRs level may 
differ with respect to their specific abilities. In Table 2.34, I summarise the BI, 
HRQoL and specific abilities of our cohort of patients according to their mRs 
at six months.  
This shows that patients with higher mRs had lower mean/median BI and 
lower utilities. However, the range of utilities within each mRs level varied, 
indicating heterogeneity of HRQoL. Also, patients’ specific abilities varied 
greatly in each mRs level at six months.   
Although patients with a ‘poor’ outcome according to mRs (3-5) also tended 




yellow, there were proportions of patients in mRs ’poor outcome’ category 
who had a ‘good’ outcome with respect to their specific abilities. For example, 
149/402 (37.1%) were able ‘to walk’ based on smRsq, 96/402 (23.9%) had a 
‘good outcome’ with respect ‘to walk’ based on BI, 135/402 (33.6%) indicated 
no, slight or moderate problems with their walking on the EQ5D-5L, 36/402 
(9.0%) were continent of urine or had occasional accidents only, 366/402 
(91.0%) were continent of their bowels or had occasional accidents only, 
218/402 (54.2%) did not have major problems talking, 226/402 (56.2%) were 
able to eat normally, 217/402 (54.0%) were living without severe pain, 
193/402 (48.0%) did not have major anxiety/depression, 102/402 (25.4%) did 







Table 2.34 Specific abilities of patients at six months after major stroke according to their mRs 
mRs 0 1 2 3 4 5 6 All 
n 8 45 7 149 46 36 111 402 
Mean BI (SD) 98.8 (2.3) 96.9(4.2) 92.9(8.1) 76.6(15.0) 40.4(19.0) 15.8(11.1) 0 67.5 
(29.3) 
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100) 






























0.84     
(0.61 to 
0.91) 
0.32        
(-0.01 to 
1) 
0.21         
(-0.26 to 
0.72) 
       




0.35 to 1) 
Specific ability 
(measure) 
        
To walk (smRsq 
question) 




Able 8 45 7 149 0 0 0 209 
Unable 0 0 0 0 46 36 0 82 
Dead 0 0 0 0 0 0 0 111 
To walk (BI)         
Independent over 50 
yards 
8 44 6 55 0 0 0 113 
Able to walk with help 
from another person 
over 50 yards 
0 0 0 41 0 0 0 41 
Wheelchair 
independent over 50 
yards 
0 0 0 0 9 3 0 12 
Immobile or under 50 
yards 
0 1 1 53 37 33 0 125 
Dead 0 0 0 0 0 0 111 111 




No problems 6 23 4 27 0 0 0 60 
Slight problems 2 18 2 45 2 0 0 69 
Moderate problems 0 4 0 52 9 0 0 65 
Severe problems 0 0 1 25 23 4 0 53 
Unable 0 0 0 0 12 32 0 44 
Dead 0 0 0 0 0 0 111 111 
To be continent of 
urine (BI) 
        
Continent 8 43 7 85 17 2 0 162 
Occasional accident 0 2 0 49 12 5 0 68 




Dead 0 0 0 0 0 0 111 111 
To be continent of 
bowels (BI) 
        
Continent 8 45 7 141 348 8 0 243 
Occasional accident 0 0 0 6 4 6 0 16 
Incontinent 0 0 0 2 8 22 0 32 
Dead 0 0 0 0 0 0 111 111 
To talk without major 
problems 
        
No problem 8 39 6 100 34 23 0 210 
Mild/moderate 
dysphasia 
0 6 1 45 9 7 0 68 
Severe dysphasia 0 0 0 4 3 5 0 12 
Mute 0 0 0 0 0 1 0 1 




To eat normally         
Normal 8 45 6 139 34 19 0 251 
Oral modified 0 0 1 10 11 13 0 35 
NG 0 0 0 0 0 0 0 0 
PEG/RIG 0 0 0 0 1 3 0 4 
Unknown 0 0 0 0 0 1 0 1 
Dead 0 0 0 0 0 1 111 111 
To live without 
severe pain (EQ5D-
5L) 
        
No pain 6 33 7 101 35 17 0 199 
Slight pain 1 8 0 24 3 5 0 41 
Moderate pain 1 2 0 18 3 11 0 35 
Severe pain 0 2 0 6 5 3 0 16 




Dead 0 0 0 0 0 0 111 111 




        
No problems 6 25 3 55 15 7 0 111 
Slight problems 2 17 3 51 17 10 0 100 
Moderate problems 0 3 0 28 5 5 0 41 
Severe problems 0 0 1 15 8 12 0 36 
Extreme problems 0 0 0 0 1 2 0 3 
Dead 0 0 0 0 0 0 111 111 
To live without major 
cognitive problems 
        
No/ Mild CI 8 41 6 73 8 3 0 139 




Severe CI 0 0 0 23 4 2 0 29 
Unable 0 1 1 34 34 32 0 102 
Dead 0 0 0 0 0 0 111 111 
To live at home         
Own home 8 43 7 130 17 5 0 210 
Relatives home 0 2 0 6 0 0 0 8 
Sheltered 0 0 0 1 0 0 0 1 
Care home 0 0 0 8 17 19 0 44 
NHS care 0 0 0 3 12 12 0 27 
Other 0 0 0 1 0 0 0 1 







I have recruited a cohort of patients with major stroke (defined as mRs 3-5 or 
0-2 with two specific abilities affected by the stroke). I have reported their 
progress and abilities with respect to global scales (mRs, BI and EQ5D) and 
derived their specific abilities (to be independent, to walk, to be continent, to 
talk, to eat normally, to live without severe pain, to live without major anxiety/ 
depression and to live at home), either based on single items from these 
measures/scales or by asking specific questions. (As described in Section 
2.6) 
I listed my aims in Section 1.3. Here, I summarise my findings based on my 
aims.  
 To describe the baseline characteristics of a cohort of patients 
admitted with major stroke (n=403) 
The mean age of the patients in our cohort was 77.5 SD 11.8, with a large 
proportion of recruited patients in the 80-89 age group. Most (340/403, 
84.4%) had an ischaemic stroke. 
Over half (209/403, 51.9%) had an mRs of 5 at baseline. The mean BI was 
31.6 (SD 25.6) and many (176/403, 43.7%) had a BI score between 0 and 
20. The mean utility at baseline was 0.23 SD 0.36.  
Under half (165/403, 40.8%) were continent of urine, and 250/403, 62.0% 
were continent of their bowels at baseline. A third (130/403, 32.3%) did not 
have a problem ‘to talk’ and over half (228/403, 56.6%) did not have a 
problem ‘to eat normally’ at baseline. The median score of 6CIT of those who 




The majority of patients (384/403, 95.3%) lived at home (rather than in 
supported accommodation e.g. care home or sheltered housing) before 
hospital admission.  
 To describe the progress of patients after major stroke at three 
time points 
By early follow up, a third (132/403, 32.8%) of patients admitted with 
major stroke had had an infection and many had had life-extending 
treatments. For example, 284/403, 70.5% had had at least 24 hours of 
parenteral fluids and 275/403, 68.2% had had IPC.  
A small proportion (60/403, 14.9%) had mRs 0-2 by six months. The 
mean BI score of surviving patients improved over time. At six months, 
the mean BI score was 67.5 (SD 29.3) but 154/403, 38.3% were classified 
as independent according to BI. (Score 75-100) BI grouped more patients 
into the no or mild disability group when compared to mRs. The pathway 
that individual patients took with respect to their mRs or BI varied over the 
three time points.  
The mean utility of surviving patients improved over time: Mean utility 
0.50 SD 0.36 at six months.  
Nearly two thirds (102/164, 62.2%) of patients who were continent of 
urine at baseline were continent of urine at six months. The majority 
(205/249, 82.3%) of patients who were continent of bowels at baseline 
were continent of their bowels at six months.  
Of the patients who were able to complete the 6CIT, median score at 
early follow up and at six months was 4 (IQR 8). 
Over a third (105/273, 38.5%) of patients who had a problem with their 
ability to talk at baseline had recovered their ability to talk and had no 
dysphasia at six months. Over a third (66/175, 37.7%) who had a problem 




six months. Over a half (209/384, 54.4%) of patients who lived at home 
prior to their stroke were able to live at home at six months after major 
stroke.  
 To relate patients’ BI, HRQoL and specific abilities to their mRs at 
six months 
The general trend was that patients with lower mRs had higher BI and higher 
utilities. However, the range of utilities within each mRs level was wide, 
indicating heterogeneity. 
Specific abilities of patients varied greatly within each mRs level; for 
example, two patients in the same mRs level varied with their abilities to talk, 
eat normally, etc.  
Using different measure/ scales to report a specific ability (e.g. ‘to walk’) 
would cause further variation in results.   
2.12.2 Stroke outcome scales such as mRs, BI and EQ5D  
There is no single perfect stroke outcome scale. The mRs and BI have both 
been used to report patient outcomes in clinical trials and are good measures 
of physical dependency. (12)  
The mRs has several strengths: it covers a range of functional outcomes 
from no symptoms to death, its levels are intuitive to clinicians and it has 
been used in clinical trials to assess efficacy of acute stroke therapies.(42) 
Although it has a limited number of levels (i.e. 0 to 6), a single point change 
on the mRs has been reported to be clinically relevant.(148) However, the 
optimal cut-off for ‘good’ and ‘poor’ outcomes  depends upon the anticipated 
distribution of mRs outcomes based on the initial severity of illness, which 
informs the level of the scale at which a treatment effect is most likely to be 
observed. Unfortunately, researchers may not know this distribution when 
planning a trial; and trials have either used 0-2 or 0-3 as ‘good’ outcomes. 
(42) As I acknowledged, ‘good’ and ‘poor’ outcomes may also be judged 




A limitation of the mRs has been the reproducibility of the score by different 
individuals. (148,149) To improve consistency in scoring, various 
interventions have been tried e.g. structured mRs interviews (118,150) and 
staff training (151) but with limited improvements. In order to simplify, 
standardise and increase the reproducibility of the mRs score, the smRsq 
was developed. This simple questionnaire yields similar results to the mRs, 
and is easily performed over the telephone, thereby saving researchers time 
when conducting patient follow up. (133,152) However, I found that a 
significant proportion (149/403, 37.0%) of patients in our cohort were 
categorised to mRs 3 at six months. The ‘Effects of fluoxetine on functional 
outcomes after acute stroke’ (FOCUS) trial also reported similar findings 
when using smRsq to report patient mRs. (153) It is unclear if, or how, this 
grouping had any impact on my overall results.  
The mRs has been reported to be superior to BI for describing extremes of 
disability; (154) the well-known ‘’floor’’ and ‘’ceiling’’ effects of BI makes the 
scale less discriminating in patients with severe or minor strokes. (12,155) 
‘’Floor ceiling’ effects describes the phenomenon by which the BI score does 
not change from minimum or maximum despite clinical change. (156) For 
example, a stroke patient who is discharged from hospital and is independent 
may still have substantial functional problems but will score 100 on the BI, 
and a patient may have made substantial functional gains but still score 0 on 
the BI. As I reported, when compared to the mRs, the BI categorised more 
patients as ‘’no/mildly disabled’’. However, the cut offs for comparing BI 
scores to mRs levels are not standardised (13,145,157,158) and therefore, 
my results would be different if different cut-offs had been used.    
While the mRs and BI provide a general overview of the physical ability of 
patients, individual patients’ progress varied greatly (Figure 2.10 and Figure 
2.14). Therefore, describing prognosis based on grouped data may not be 
accurate.  
More recently, the focus has been on patient-centred outcomes or HRQoL. 




several attempts have been made to assign utility scores to mRs levels. (40–
43) My findings broadly agree with the trend; i.e. decreasing utilities with 
higher mRs. (Table 2.34) However, I have also reported the wide range of 
utilities within each mRs level, indicating heterogeneity of HRQoL. A 
limitation of utilities is that these are derived based on assessments 
completed by healthy (non-disabled) individuals rather than those who are 
disabled.  
The use of VAS in the major stroke setting may be limited. Although the VAS 
has been suggested to be an accurate measure of continuous subjective 
variables such as pain and analgesia, (137,160–162) global well-being (163) 
and functional capacity, (164) older people (165,166) and people with 
aphasia (167) may find the VAS difficult to complete. Price et al also 
demonstrated that patients with any stroke (but especially those with more 
severe stroke subtypes, and those who had cognitive and visuospatial 
impairments) found it challenging to complete the VAS. (168)  
In our study, proxies completed HRQoL (EQ5D-5L and VAS) assessments 
where the patient was unable to do so. The completion of EQ5D by proxies in 
the context of a stroke is valid and widely used. (169) However, there is also 
evidence that agreement between patient and proxy on the VAS is low, (169) 
patients and proxies may  agree better on physically based observable 
attributes rather than psychosocial attributes (170–173) and that  proxies 
tend to report more problems than the patient on the EQ5D dimensions at six 
months for self-care, pain/discomfort and anxiety/depression. (169)  While I 
was unable to make any direct comparisons between patient and proxy 
responses in the EQ5D 5L and VAS in this study, I did find that, a significant 
proportion (31 out of 39) of participants who had indicated the patients quality 
of life to be equal to, or worse than death (i.e. utility less than or equal to 0) at 
six months after major stroke were proxies. This may be unsurprising, as 
most HRQoL assessments completed by proxies at six months were on 
behalf of patients who were significantly physically disabled (mRs 4-5) who 




However, it is also possible that family members may be placing their (more 
pessimistic) judgement on the patient’s HRQoL.   
Only 8 surviving patients reported their HRQoL to be equal to or worse than 
being dead while the majority of those who were ‘dependent’ (mRs 3-5) 
[127/402, 31.6%) had a utility above 0. A possibility for this finding is the 
phenomenon ‘response shift’ (explained in chapter 1) where patients had 
adapted to their new baseline and therefore, report a quality of life that is 
higher than previously anticipated. (67,72,174) It is also possible that these 
patients, though physically disabled, may have retained specific abilities (e.g. 
their ability to eat normally or be continent) which had led them to rate their 
HRQoL as being better than anticipated. 
I acknowledge the limitations of utilities and VAS in my study, but to preserve 
patient autonomy and in the absence of other ways of obtaining answers to 
assessments which the patient was unable to complete, it is difficult to know 
how this may have been improved. Perhaps alternative tools incorporating 
both patient reported outcome measures and patient reported experience 
measures may more accurately present the patient’s perceptions of both the 
process and outcome of their care. However, their validity and reliability in 
stroke and use by proxies would need to be determined. (175) 
2.12.3 Describing prognosis by specific abilities rather 
than based on global scales 
As I have shown, while ‘’poor’’ outcomes tended to group together (Table 
2.34), there were exceptions and patients may differ with respect to their 
specific abilities even though they had the same mRs. It is also possible that 
these different specific abilities, and combinations of abilities may contribute 
to the heterogeneity I found in their HRQoL. Therefore, describing prognosis 
in terms of specific abilities may be more appropriate rather than outcomes 




As I described, different measures/scales may be available to describe one 
specific ability. (Table 2.2) Furthermore, we could have used different 
dichotomies to define the specific abilities. Different measures/scales and 
dichotomies would give us different results. (Table 2.26) It would be useful to 
agree on a standardised approach towards defining specific abilities. It may 
also be appropriate to develop and validate predictive models to give a 
probability of a specific ability to patients/ families six months after major 
stroke. I will describe the development and validation of new models 
predicting some specific abilities in Chapter 7.  
2.13 Limitations  
2.13.1 Recruitment 
The patients I recruited were based on my inclusion criteria. Therefore, there 
is a possibility of selection bias as not all consecutive stroke admissions were 
eligible to be recruited.  
2.13.2 Data collection 
I collected data on specific abilities judged to be useful to patients and their 
family members. This was based on expert opinion of stroke doctors in the 
hospital where recruitment took place, and my own clinical experience. 
Ideally, I would have engaged doctors, patients and family members in focus 
groups and/or performed qualitative interviews with patients/family members 
before the recruitment and follow up of our longitudinal cohort. However, this 
was not possible due to time constraints. Some outcome scales and 
variables that I collected were also determined by those available in our large 
trial datasets- this was to allow external validation of developed prognostic 
models. (Which I describe in Chapter 7) 
2.13.3 Assessments 
While the EQ5D-5L (176) and smRsq (133) are acceptable for use through 
interview in the stroke population, literature describing telephone assessment 
to elicit BI scores is limited. Existing literature indicates that when compared 




identify those who had high BI scores and in some cases, provided optimistic 
scores (indicating less disability) for those with identified moderate to severe 
disabilities in face-to-face assessment. (12,177,178) Therefore, in this study, 
where I performed six month assessments over the telephone, it is possible 
that the ‘’floor’’ and ‘’ceiling’’ effects of BI may have been accentuated.  
The 6CIT has not been tested for use over the telephone in major stroke. 
Therefore, the appropriateness of this test in our study is debatable.  
2.14 Conclusions 
 Major stroke has significant mortality and morbidity 
 Global scales such as mRs, BI and EQ5D provide an overview of 
patient outcome over time. However, individual patients progress 
differently over time 
 Specific abilities and HRQoL of patients in the same disability level 
vary greatly. Therefore, it is likely that different patients would have 
different experiences of major stroke in hospital, views on survival and 
on treatments and needs (i.e. of information and support) 
Therefore,  
 Describing prognosis by specific abilities may be appropriate. We will 
develop predictive models to give patients/ families a probability of 
having a specific ability at six months. This may improve 
communication of prognosis. 
 Understanding each individual’s experiences after major stroke, 
wishes and preferences for information and treatment would give us 
insight into how doctors can support patient needs 
2.15 Next steps 
Since each individual patient varies with respect to their abilities and HRQoL, 
it is likely that each patient would have different experiences in hospital after 
major stroke, and their views and needs (e.g. regarding information, survival 




In my next chapter (Chapter 3), I will report findings from qualitative 
interviews with patients admitted to hospital who retained mental capacity 
after major stroke. Specifically, I will focus on their background prior to 
hospital admission to set the scene and provide context to their description of 
their early experiences in hospital and information and support needs at a 
time when treatment decisions were being made. At six months, I explore 
their reactions to living with significant physical disability and explore their 
retrospective views on information needs in the early period after a major 
stroke.  
I will discuss the development and validation of prognostic models to predict 

























Chapter 3 A longitudinal qualitative study of 
patients’ experiences, views, 
information needs and approaches 
towards making treatment 
decisions. 
3.1 Publication status and acknowledgement of 
contribution 
This chapter has been published in PLoS One. (119) The publication can be 
found in Appendix A. 
I designed the study including topic guides and performed all the interviews. 
My supervisor JL supported data analysis; this was necessary to comply with 
the ‘Consolidated criteria for reporting qualitative research’ (COREC) 
requirements for qualitative data reporting. I wrote this manuscript with 
comments and guidance from JL. All co-authors commented on the final 
manuscript before submission. 
 
3.1.1 Brief summary of this chapter 
In chapter 1, I described how the knowledge of patient preferences and 
communication between doctors and patients are thought to be key aspects 
to effective shared decision-making. I also noted the challenges of 
implementing shared decision-making in the context of a major stroke and 
expressed the need to explore patients’ experiences after major stroke and 
their views regarding treatments, especially where treatments may increase 
the chance that they survive, but be left with significant disability. 
In chapter 2, I then showed how patients varied with respect to their specific 
abilities (e.g. to walk, to talk) and this could relate to the observed 




experiences, views, needs and approaches towards being involved in 
decision-making regarding treatments.   
Therefore, in this chapter, I explore the early experiences, views, needs 
(information and support) and approaches towards  decision-making of 
patients who retained capacity after being admitted with a major stroke (a 
sub-group from our longitudinal cohort of patients I recruited and described in 
Chapter 2). I followed patients up at six months to assess their ongoing 
experiences and retrospective views on how their needs could have been 
better met during their time in hospital. 
Since this chapter is a publication, there is overlap in the material in several 
sections (e.g. introduction, methods) and Chapters 1 and 2. I have made 
minor editorial changes in this chapter to acknowledge this overlap where 
appropriate.  
The flow diagram below (boxes coloured in yellow) indicates the part of my 
study this chapter relates to.  




















In Chapter 1, I described the burden of stroke. Each year approximately 
150,000 people have a stroke in the UK. (14) In the UK, stroke is the leading 
cause of reported severe disability. (179) Almost two-thirds of stroke survivors 
leave hospital with a disability. (4) More than half are left dependent on others 
for everyday activities and may require long-term, institutional care (e.g., in 
hospital or a care home). (4,180) Therefore, suffering a stroke can be life-
changing and stroke patients need to access appropriate treatment during the 
acute phase as well as follow-on rehabilitation. 
In Chapter 1, I also described how different treatments may influence 
patient outcome differently. In the UK, acute treatment of stroke and follow-
on rehabilitation has improved in recent years. (19,181) Relative to 20 years 
ago, patients generally have better access to treatment and care. (20) Yet 
there remain significant challenges with respect to stroke care. Notably, there 
are different options for treatments during the acute phase, which are each 
associated with different outcomes. Some treatments (e.g. thrombolysis 
(182) and mechanical thrombectomy(22)) improve functional outcomes for 
patients who survive the stroke (i.e. it is less likely for patients to be left with 
significant physical disability as a result of these treatments). However, other 
treatments (e.g., intermittent pneumatic compression for prevention of deep 
venous thrombosis, (35) antibiotics for treating infections, (183) parenteral 
fluids (184) and enteral feeding [feeding through a tube placed into the 
stomach through the nose or surgically into the abdomen] (24)) increase the 
likelihood that patients who have suffered a severe stroke and been left with 
significant disability will survive longer. Therefore, the net effect is that more 
patients will survive with significant disability as a result of these latter 
treatments.  
Therefore, a key decision that patients, along with their doctors need 
to make is: should the patient receive treatment that increases the likelihood 
that s/he will survive the stroke but with a significant disability or forego such 




difficult question and there are no easy answers. Making decisions regarding 
stroke treatments typically warrants careful discussion between the patient, 
their family, their doctor and the multidisciplinary team– a “shared decision-
making” process. (30)  Yet, in practice, (particularly, in the early period after 
an acute disabling stroke) implementing effective shared decision-making 
can be challenging. (49) This issue has been under-studied with respect to 
acute stroke. Exploring these challenges goes to the heart of the issues 
considered in this paper. 
I described the challenges associated with involving patients in shared 
decision-making in Chapter 1. These are reiterated below. 
Firstly, acutely unwell patients may be in shock as result of having 
been given a life-changing diagnosis. Literature from critically unwell patients 
(185) including in coronary care (64) have highlighted how a sudden 
deterioration in health may leave patients fearful and distressed; (65) 
especially when they have not considered a situation where they may be left 
disabled. Critically ill patients, such as those who have suffered a severe 
stroke, may lack capacity (that is, lack the ability to understand, process and 
weigh up information to make a decision) [17] and their inability to engage 
with health professionals may make them ineffective partners in a shared 
decision-making process. (65) However, much of the research around this 
issue has focused on the experiences of patients with chronic, progressive 
conditions such as dementia (186) (rather than stroke) and how these 
patients engage with health professionals to make treatment decisions. The 
experiences and reactions to diagnosis of those who have suffered an acute 
disabling stroke are under-reported – we go on to explore this key area in this 
paper.  
Secondly, an important step in shared decision-making is for health 
professionals to provide necessary information to patients. This is intended to 
enable patients to arrive at an appropriate treatment decision having properly 
weighed the outcome-related risks, such as those outlined above. In 




has been shown to help them understand their diagnosis and make decisions 
regarding treatments. (187–189)Decision aids (such as leaflets and 
educational programmes) in stroke have been reported to help patients 
understand their diagnosis. However, most of these aids have been tested 
just before patients are discharged from hospital or in the outpatient setting. 
Moreover, those severely affected by the stroke had been excluded from 
these studies. (190) Hence, the transferability of these interventions to an 
acute setting and to patients severely disabled as a result of their stroke is 
uncertain. While guidelines published by professional bodies such as the 
General Medical council,(44) American Heart Association (191) and Royal 
College of Physicians (192) iterate the need for early, timely and tailored 
information delivery to patients, we need to consider how this 
recommendation may affect those who have had a severe stroke who, like 
many critically unwell patients, may not be able to fully process this 
information. (64) Overall, the information needs of acute disabling stroke 
patients to make decisions about their treatments have not been fully 
considered. This is therefore a key focus of study in this paper.  
Thirdly, literature in stroke, (72) brain injury (193) and older patients 
(194) has reported how patients, who have survived these illnesses and been 
left with a significant disability, when asked several months later, appear to 
have learnt to adapt to their situation (a process termed ‘response shift’) and 
therefore, report higher quality of life than anticipated. (67,174) In contrast 
when individuals who are well are asked about their preference for treatment 
which could leave them significantly disabled, they often report that they do 
not wish to receive such treatment: that is, they do not want to survive if they 
will be left significantly disabled. (195) Therefore, patients’ treatment 
preferences appear to be inconsistent. This so-called ‘disability paradox’ 
adds to the challenges associated with decision-making in acute stroke. 
(196) For doctors to be able to support patients in making treatment 
decisions, they need in-depth insight into each individual’s values, 




In this longitudinal qualitative study, we aimed to address several gaps 
in research involving acute stroke patients. Specifically, we explored how 
decisions were made regarding treatments in the context of an acute severe 
disabling stroke. To better understand this, we explored the early 
experiences of patients with a disabling stroke in hospital, their needs [for 
information] in the early period after a life-changing diagnosis and their views 
about surviving, potentially with significant disability. To gain deeper insight 
into their ongoing wishes and needs, at six months post-diagnosis, we 
explored their feelings about their situation [being significantly disabled] and 
views regarding information that would have been useful to them in the early 
period in hospital after their stroke.   
As acknowledged in Chapter 1, while shared decision-making in acute 
stroke is a team approach, where various members of the multidisciplinary 
team (e.g. doctors, nurses, physiotherapists and dieticians) have input into 
patient management, the focus of our study is on decision-making regarding 
treatments that extended survival of the significantly disabled patient. These 
discussions are primarily conducted between the patient and their hospital 
doctor. Therefore, our recommendations are intended specifically for doctors 
taking care of acute severe stroke patients in hospital.  
3.3 Materials and methods 
3.3.1 Research design and methods 
This study was informed by an epistemological position which 
recognises that illness experiences and, relatedly, treatment decision-making 
are socially and contextually informed. (197) This position informed our 
approach to both data collection and analysis. For instance, we developed 
topic guides (Table 3.1) which allowed us to explore what patients’ lives were 
like before suffering a stroke. We also explored their experiences soon after 
their admission in order to set the context for understanding the treatment 




Initial interviews took place within a week of a patient’s admission to 
the stroke unit. This time point was chosen to capture their early experiences 
after a disabling stroke. Also, we recognised that most treatment decisions 
that we were interested in exploring (such as initiation of enteral feeding) 
should have been taken within a week of admission.  
Where possible, we undertook follow-up interviews at six months 
following first admission to the stroke unit. We chose this time frame because 
we recognised that, by six months, most patients would have plateaued with 
respect to their functional recovery.(23,198,199) Had we interviewed them at 
an earlier point in time (for example, at three months following first admission 
to the stroke unit), their recovery might have still been ongoing. By contrast, 
had we interviewed at a later point in time (for example, at one or two years 
following first admission to the stroke unit), this might have meant that other 
factors (for example, increasing age and frailty, recurrent stroke, declining 
cognition or death) might have adversely affected patients’ ability to be 
interviewed.  
Table 3.1 Guide to the topics covered in patient interviews 
Baseline  
Background  The pre-stroke functional status of the patient: 
how they were managing at home before the 
stroke, any formal or informal care required, 
and their interactions with their family. 
 Reported preferences on surviving with 
significant disability: if they had made any 
advanced statements or had any thoughts of 
what they may want in terms of treatments if 
they had an illness that may result in them 
surviving with potentially significant disability.  
Experiences  Patients’ feelings about their situation post 




how they felt they were coping with the 
situation 
 Patients’ experiences in hospital in the early 
phase after the stroke: their interactions with 
staff  
Needs  Patients’ perception of information in general: 
whether this may help them understand their 
diagnosis, potential prognosis and help them 
make treatment decisions. 
 Their understanding about the goals of 
treatments that were being offered after acute 
stroke and what they would need to make 
decisions about these treatments  
Six month follow up  
Experiences  Patients’ thoughts and feelings having 
survived a physically disabling stroke, how 
they were managing on a day to day basis, 
their thoughts on their recovery process since 
hospital discharge 
 
Needs  Looking back to their time in hospital, their 
thoughts on what (for example, information or 
support) could have been given to them in 
hospital which may have been useful to them.  
 
3.3.2 Recruitment and data collection 
We recruited adult patients who had been admitted to a stroke unit in 
a large teaching hospital in the United Kingdom. These patients were a sub-
group of patients recruited into our longitudinal cohort (described in Chapter 




increased the likelihood that the patient who has been left with significant 
disability as a result of stroke will survive longer; to be eligible to participate, 
the stroke needed to have caused significant physical disability and the 
patient needed to have had decisions made regarding treatments (such as 
enteral feeding, parenteral fluids, antibiotics or intermittent pneumatic 
compression).  Therefore, we recruited patients whose extent of disability 
was at least a modified Rankin scale score of four as a result of the stroke 
(i.e. they were unable to walk or attend to their own bodily needs without 
assistance).  
The medical team (consultants, registrars and other trainee doctors 
who looked after the patients on a daily basis) identified eligible individuals 
who had the capacity to consent to participating in the study (i.e. the patient 
was able to understand and retain information and communicate decisions). 
If the patient’s speech or swallow was affected, the medical team assessed 
them to ensure this did not affect their decision-making capacity and that they 
were able to fully participate in an interview. In each case, before 
approaching the patient regarding in this study, the medical team also 
considered whether participating might cause distress.  
Once the medical team determined that the patient was suitable to 
participate, they asked the patient for permission for the researcher (me) to 
approach them and provide further information about the study. I am a 
clinical doctor specialising in geriatric medicine and had previously worked in 
the stroke unit. However, patients were not informed about my clinical 
background and they were advised that I would not be able to provide any 
treatment advice or medical information specific to their care.  
I then provided information about the study and obtained the patient’s 
formal written consent to participate. We made every effort to recruit patients 
of different ages, genders and ethnic backgrounds. However, we recognised 
that patients with an acute disabling stroke are a group who are hard to 
recruit: many patients are medically unwell and the impact of the diagnosis 




pragmatic decision to interview all eligible individuals who had agreed to take 
part. As the clinical team did not keep a log, it is not possible to report the 
total numbers approached and, of those, how many declined to participate.  
We endeavoured to recruit sufficient participants to address our study 
aims while not creating a dataset which would be too large and unwieldly to 
analyse in-depth. In practice, this meant that we stopped recruitment after 
on-going analysis of the interviews indicated that sufficient data had been 
obtained to address the study aims and that a point had been reached where 
patients were volunteering similar views. Hence we recognised that recruiting 
additional patients would not enhance the quality or diversity of the data 
collected.  
Prior to the start of each interview, I reassessed patients’ capacity to 
participate. This was done because we recognised that patients’ capacity 
might have changed from when they had initially been assessed as suitable 
to take part. Initial interviews were conducted in a private room in the stroke 
unit at a time convenient to the patient. Table 3.1 summarises the main areas 
explored. Where possible, we conducted six month follow-up interviews in 
the patient’s place of residence (i.e., either own home or care home). 
Telephone interviews were considered where the multidisciplinary team felt 
that it would not be safe for me to visit the patient.  Before contacting the 
patient to arrange the interviews, I phoned their general practitioner to check 
the patient still had capacity to participate. This was part of the consent 
process at recruitment. Prior to follow-up interviews, I reassessed the 
patient’s capacity.  
I kept a reflexive diary. This detailed my interactions with the 
participants, including a record of why, based on what patients said in 
interviews, I had decided it would be insensitive or inappropriate to pursue 
certain lines of questioning. For instance, when I explored patients’ feelings 
about potentially living with disability, only physical aspects of disability were 
discussed (for example, immobility and inability to perform activities of daily 




disability only, and exploring irrelevant disabilities (such as cognitive or 
intellectual) may cause the patient unnecessary worry. Also, as we will go 
onto describe, it became apparent to me that, in the early stages post stroke, 
some patients did not appear to understand that the goals of some stroke 
treatments were to extend their life but they will be significantly disabled and 
that decisions needed to be taken regarding these treatments. Making this 
known to them either acutely or six months later could have caused undue 
distress. 
Initial interviews took place between September 2017 and January 
2018 and lasted 25 to 66 minutes.  Six month interviews took place between 
April 2018 and July 2018 and lasted 32 to 56 minutes.  All interviews were 
digitally recorded and transcribed in full with the patient’s consent.  
3.3.3 Data analysis 
I (who received training in qualitative methods, including qualitative data 
analysis) and JL (a very experienced, non-clinical qualitative researcher) 
undertook data analysis. All data were analysed thematically using the 
method of cross-comparison.(200)  This approach entailed repeated read 
through of all interviews to allow familiarization with the data (immersion). 
Interviews were then cross-compared to identify key findings which cut 
across different accounts (themes). Both inductive and deductive approaches 
were used; this allowed unanticipated themes to emerge from data as well as 
identification of material needed to address the study aims. Data were also 
analysed longitudinally to establish whether, and why, peoples’ needs and 
views changed over time. JL and I analysed the data separately and wrote 
separate reports.  We then met to discuss their interpretations, resolve any 
areas of disagreement (which were found to be minimal), and reach 
agreement on the main findings and themes. A coding frame was then 
developed which captured these findings and themes. Coded datasets were 
subjected to further analysis to allow development of more nuanced 




11, a qualitative software package produced by QSR International, was used 
to facilitate data coding and retrieval.  
3.3.4 Ethical approval 
This study was approved by Scotland A Research Ethics Committee (Ref: 
17/SS/0029).  
To safeguard participants’ confidentiality, pseudonyms are used.  
3.4 Results  
Fifteen patients were interviewed within a week of their stroke. None 
were able to mobilise independently or wash and dress themselves without 
help after the stroke. Five also had speech impairment. The medical team 
assessed and confirmed that this did not affect their capacity to participate in 
interviews. Although we tried to include patients of varying backgrounds, 
most were of similar ages (70s) and ethnicities (White British). 
At six months, thirteen patients had survived. Eleven had capacity to 
take part in an interview. All surviving patients had varying degrees of 
physical disability. Of these, two had ongoing speech problems but this did 
not affect their ability to participate in an interview. Eight of the eleven 
patients with capacity were living at home, two in care homes and one in 
hospital. Ten interviews took place in person. One interview took place over 
the phone due to safety concerns raised by the multidisciplinary team in 
hospital and the patient’s general practitioner. 
Table 3.2 summarises the characteristics of our sample. 
Table 3.2 Characteristics of study participants 
Patient characteristics Number of participants (n=15) 
Mean age in years (range) 79 (53-93) 
Female/Male 9/ 6 




Formal care package prior to stroke 4 
Do not Attempt Resuscitation order 
(in the first week) 
3 in hospital, 2 from the 
community, 10 none 
First stroke 15 
Comorbidities (Charlson index: 0, 
1-2, 3-4, >=5) Max score=33 
Score 0(no comorbidities)= 6 
 
Score 1-2(mild comorbidities)=5 
 
Score 3-4 (moderate 
comorbidities)=3 
 
Score 5 and above (severe 
comorbidities) =1 








Modified Rankin score (mRs) 
(Scores 0-6) (149) 
mRs 4a =4   
 
mRs 5b=11 
Speech problem not affecting 
capacity or participation in 
interview 
5 
Fed enterally (Nasogastric or 
gastrostomy) 
5 
At six months 
Survived 13; 11 with capacity 
Modified Rankin score (mRs) 
Scores 0-6 (149) 
mRS 1 c=1 
 









mRs 6 e=2 
Place of residence At home=8 
 
Nursing home=4 (2 did not have 
capacity to be interviewed) 
 
Hospital=1 
Speech problem not affecting 
capacity or participation in 
interview 
2 





a- Moderately severe disability; unable to walk or attend to own bodily needs 
without assistance 
b- Severe disability; bedridden, incontinent and requiring constant nursing care 
and attention 
c- No significant disability despite symptoms; able to carry out all usual 
activities 
d- Moderate disability; requiring some help but able to walk without assistance 
e- Dead 
 
We found that patients’ pre-stroke functional status; specifically, whether 
they were largely independent or dependent on others for their activities of 
daily living (for example, showering and dressing), appeared to influence 
their experiences, views and involvement in making treatment decisions. 
Therefore, where appropriate, we have separated our reporting according to 
these two groups. 
We begin by describing patients’ backgrounds and pre-stroke functional 
status. We then explore patients’ experiences and reactions to their 




how patients’ need for hope appeared to influence their needs [for 
information and support] and views [regarding treatments] in the early period 
after a disabling stroke.  
We then go onto consider how patients’ pre-stroke background and 
functional status appeared to affect their feelings about their situation six 
months later and how, and why, on reflection of their time in hospital, their 
needs [for information] may have changed based on the situation they now 
found themselves in.  
3.4.1 Pre-stroke background and early reactions to diagnosis 
of stroke 
3.4.1.1 Patients who were independent pre-stroke 
The majority of patients reported either living alone or with their family and 
described how they were constantly doing things for others. While this kept 
them busy, these patients also described how being part of a close network 
of family and friends gave them a sense of purpose. For instance, Dorothy, 
who was in her late 70s, described her role as a helper to her disabled friend: 
 ‘I’m always helping other people.  I’ve got…my friend…I usually drive her 
about because she’s in a wheelchair. ‘(Dorothy). 
Likewise, Edith, who was in her early 80s, described how she loved cooking 
and being involved in the lives of her grandchildren:  
“I go away shopping an awful lot. And I make, like, pots of soup and I give it 
to my grandchildren.” 
These patients described how they had never considered a situation where 
they might be left disabled and how the stroke had come as a surprise to them:  
 
‘And life so far, never had any problem.  It’s just come as such a surprise, 
‘cause I'm not a person to give in to anything.’ (Dorothy) 
 
The sudden loss of independence resulting from the stroke was described as 
devastating and as having given rise to a sense of loss, uselessness and 




in their disabled state. This included Colin, a man in his 70s who had lived 
alone and previously worked in healthcare. He described his feelings of 
anguish as he reported how he felt he had lost his dignity:  
‘Not walking, talking. I feel embarrassed when I meet people.  They’ll say to 
me, look at the state of him. Well, there was today a girl came and washed 
me and it was the first time. It’s just that I’m not used to it.  I feel absolutely 
terrible. 
I told her though, I’m so sorry...to see me in such a state, you know, all your 
private parts just hanging out and she’s washing it all….I was just lying there 
and I was shutting my eyes hoping that she wouldn’t be long....’ (Colin) 
 
However, many described how they had quickly transitioned from shock and 
distress to focusing on regaining their pre-stroke functional abilities. This 
included Edith who reported wanting to be able to do her own shopping again, 
‘I don’t want to get restricted from anything’ and Larry, a man in his 50s, who 
reminisced about his independent past where he cared for his wife and 
children, and described wanting ‘the use of my arm and leg again’. 
 
While continuing to focus on regaining their independence, these patients 
also reported that, should the circumstances arise where they were unable to 
independently care for themselves at home, they would accept formal or 
informal care. These patients suggested that they had family and friends to 
live for and, therefore, for them, survival, even with disability, seemed 
acceptable. For instance, Larry expressed his wish to ‘be part of the family 
again so [my] wife don’t have to do everything’. Similarly, Edith, who often 
helped her family by caring for her grandchildren, described how she felt she 
had so much left to live for, and also how she had people in her life who 
would care for her if necessary: 
‘I like to be amongst my family all the time. I can revolve round it (referring to 
disability).  Obviously if I find out I need a lot of help, I can get one of my 





3.4.1.2 Patients who were dependent pre-stroke 
These patients described prior restrictions to their mobility and ability to care 
for themselves, which had meant that they already had a formal care 
package which allowed them to live at home. In contrast to the group above, 
these patients described a general deterioration in their quality of life over the 
preceding years and also lacking a strong family network. In addition to a 
formal care package, some of these patients required help from friends and 
family with shopping and housework. This included Harriet, a woman in her 
late 80s, who was largely housebound. Harriet described how her nephew 
(her next of kin) visited her once a year and dealt with her finances and how 
she was reliant on the kindness of her neighbour who came in and helped 
her on a regular basis: 
 ‘Oh he [nephew] visits, yeh, he does the ‘big stuff’ you know, like me house, 
money and that but [name of neighbour deleted] she’s brilliant, she is. Does 
my shopping and all that, keeps an eye on me’’.  
These patients reported how their pre-stroke illnesses had led to them 
leading very restricted lives. They also described how, while they had not 
been content with this situation, they had adapted to it. For example, Nigel, a 
man in his 70s, described what it was like to have a neurological condition 
which had meant that his life had been dictated by his illness:  
‘I don’t go out nearly as much.  I don’t have as many circle of friends. I used 
to go out every six weeks to a lunch at [Place name removed].  I’ve had to 
curtail that, because my carers clash with the times.’ (Nigel) 
 
Due to their generally poor (and deteriorating) health, these patients reported 
multiple previous hospital admissions, where, on discharge, they had not 
returned to their previous level of functioning. Therefore, they described 
being mentally prepared for, and unsurprised by, a further deterioration in 
their abilities because of the stroke. Consequently, these patients, in contrast 
to those who were independent prior to the stroke, reported having thought 
about a situation where they might be left significantly disabled. In the event 
of this happening, Nigel, like others, described how he would not like his life 




‘I don’t relish that idea to get spoon-fed……on a permanent basis.  I 
hate the idea of being shut up in my own house. No, I would hate to be 
a vegetable.’ (Nigel) 
 
3.4.2 Trying to cope with the diagnosis: generating and sustaining 
hope 
Regardless of their pre-stroke functional status, all patients described looking 
for hope of functional recovery. This included Nigel who described how: ‘I 
am, I can and I bloody well will: where there’s breath, there’s hope’ and 
Graham, a man in his 60s who, prior to the stroke, owned his own business, 
and enjoyed outdoor activities, who described how:  
(Re: recovery) ‘I’ll say [I am at] about 20% now.  I can see the future higher 
up the ladder is there for me to climb up to it.’ (Graham) 
In-keeping with their wish to maintain a positive outlook, patients reported 
using different coping mechanisms to generate hope. Some reported 
comparing their functional state to that of other patients in hospital, and 
described how they thought that others were less fortunate than themselves 
as they had impairments that they felt were more severe. Such patients 
reported how this fuelled their hope that they may return to their pre-stroke 
state: 
‘When I was sitting in bed and watching the others, I kept thinking I’m lucky 
I’ve not got it as bad as they have, you know. I can swallow but I’ve just got to 
watch not to take a big mouthful.’ (Dorothy, a woman in her 70s, who was 
unable to mobilise or independently self-care post stroke) 
 
Others described how they valued speaking to stroke survivors they knew 
who had made full functional recovery and been discharged home. Indeed, 
such patients described seeking out stroke survivors, often with help from 
their family and friends, and welcoming hearing encouraging stories about 
their recovery:  
‘That was what she [friend] went through.  I mean, I know that she’s okay.  




good to understand that, just that there is light at the end of the tunnel, if you 
like.  So that’s a positive experience, positive discussion I’ve had with 
someone who I know and I know she’s not lying to me.  She’s looking good.  
She talks good.  She’s not got any signs of a stroke.’ (Graham)  
 
Most patients also described how they needed information that was framed 
positively in order to help them maintain an optimistic outlook. In keeping with 
their need for hope, patients also described not wanting to engage with 
information that was ‘negative’; that is, which alluded to a lack of recovery or 
the possibility of living with significant disability. Many, like Graham, 
described even being prepared to accept information that was not 
necessarily correct, as long as it gave them hope:  
‘I want to know I’m going to get back to a hundred per cent; that’s what I 
believe inside that I’ll get back to. I think it’s vital to move forward, even if 
it’s…I was going to say even if it’s not completely true, but you’ve got to have 
a positive outlook. But if you come along and say, well you’ve got no chance, 
you’re going to be, you know, wrapped up in a wheelchair for the rest of your 
life, that’s not going to help me.’(Graham)  
Indeed, some described how they might lose trust in health professionals if 
given discouraging information. For example, Olivia, a woman in her early 
80s recalled a situation where potentially dispiriting information would have 
been unhelpful:  
‘Well if somebody had said to my friend who died of the stroke, oh this is a very 
serious condition you’ve got yourself into, I don’t know if we’ll be able to get 
you out of this, well it wouldn’t have done him any good at all would it? I mean, 
where’s the trust that staff are helping?’(Olivia) 
 
3.4.3 Decision-making regarding treatments following 
diagnosis  
It was against the above backdrop, that decisions about treatments such as 
intermittent pneumatic compression, enteral feeding, parenteral fluids and 
antibiotics were made. 
3.4.3.1 Patients who were independent pre-stroke 
Patients in this group generally reported taking all treatments that were on offer 




treatments or even that treatment decisions had needed to be made.  In 
keeping with their need for hope, many described assuming that treatments 
they were given were to help them make a full functional recovery. For 
example, Edith who was bed-bound after the stroke and needed a hoist to 
transfer from bed to chair described how she had been happy to take 
antibiotics for a urine infection because she assumed that these would help 
improve her mobility:  
 
‘Oh, I’ll take anything like that. Well, to get me on my feet.’ (Edith) 
 
Given their understanding of these treatments, some patients, including 
Graham, expressed their surprise that others might refuse them:  
‘I overheard someone very recently saying that if they’re not getting better 
they’d not want to be treated you know, they want to die, not me; I’m a fighter 
to the end, you know’.(Graham)  
 
3.4.3.2 Patients who were dependent pre-stroke 
In contrast, these patients described having recalled the conversations with 
their doctors where treatment plans relevant to their situation had been 
discussed. They reported how they had informed their doctor that they would 
not want to have treatments that might leave them significantly disabled and 
therefore, when offered, they had declined these treatments.  
This included Harriet, who declined enteral feeding as she felt that this might 
impact negatively on her already deteriorating health and quality of life: 
‘Oh gosh, no.  That would be the last straw.  I'd ask the Lord to take me away 
if that [referring to accepting enteral feeding] happened’. (Harriet)  
Similarly, Nigel, described how he had decided he did not want any 
treatments (referring to enteral feeding and intermittent pneumatic 
compression) that would increase the possibility of him being more 




‘I hate the idea of being shut up in my own house, no. I hate not knowing 
what is happening around me’ (Nigel) 
3.4.4 Six month follow-up 
3.4.4.1 Reactions to living with disability 
At six months, none of the surviving patients had returned to their pre-stroke 
functional state and, since hospital discharge, many had experienced a 
further deterioration in their health and functional abilities.  
3.4.4.1.1 Patients who were independent pre-stroke 
Nearly three quarters of patients who were independent prior to the stroke 
required a formal care package to be able to manage at home at six months. 
This was a cause for despair for many such patients who described how, 
when they had left hospital, they had remained hopeful that they were going 
to be independent again. This included Brenda, a woman in her 80s, who 
shared her upset and grief at now needing carers to help her with daily care: 
‘Everyone kept saying, well, it’ll improve, but you don’t really realise how bad 
you’re going to be. I didn’t realise how much of a setback it was going to be. 
When people said they had a stroke, I didn’t realise what they were going 
through, whereas I certainly do now.’ (Brenda) 
Brenda, like many others who had been independent pre-stroke, reported a 
mixture of disbelief and frustration and described feeling unprepared for the 
reality of the situation she was now in:   
‘Very frustrating, because I can’t do what I normally do, like I went onto the 
computer yesterday to put in [husband’s name] prescription as I normally do, 
and I couldn’t press the bracket key, you know, the upper case.’ (Brenda) 
Indeed, it was evident from these patients’ accounts that their inability to do 
things they had previously taken for granted was a source of considerable 
grief. This included Irene, a woman in her 80s, who was previously 
independent and had regularly cared for her grandchildren.  She now shared 
the anguish, embarrassment and distress she felt because of being unable to 
look after herself:   
‘I’m always embarrassed about asking somebody to help me do things that I 




is sore because the way I’ve been lying I was...it’s over and I’ve got to get 
somebody to straighten it out for me. I can’t do that myself which I get quite 
annoyed about.’ (Irene) 
 
Some described how they were struggling to cope on a day-to-day basis and 
expressed their grief with their current situation:  
‘My walking and my balance is terrible. Well sometimes...I’ve fell a couple of 
times and my leg...got bruises on my other...while I was trying to collect 
things. 
I’m just...how can I say...depressed. My words don’t come out right. My 
sentences don’t come out right.’ (Colin) 
Some patients also described having felt abandoned by staff once they were 
discharged from hospital. They noted how all therapy (specifically 
physiotherapy) had stopped following hospital discharge and suggested that if 
this therapy had been continued, they would not have been in the situation 
(disability requiring help from others) they were now in. This included Edith 
who described feeling alone and hopeless as a consequence:  
 
‘Oh, they’re finished with you once you’re out of the hospital.  They don’t 
entertain you at all after that.  To me they should carry it [referring to 
physiotherapy] on.’(Edith) 
 
This feeling of abandonment caused patients considerable upset. Edith, for 
instance, who had previously found meaning and purpose in her life by caring 
for her grandchildren now needed a hoist to transfer in the care home. Like 
others, she shared her feelings of despair and of not having anything left to 
look forward to in her life:  
 
‘I can go out when my sons come up if they’ve got…they take me outside in a 
wheelchair Some days they’re getting me in the car and I lower myself into it 
but I don’t ever get out of the car, nothing like that.  They’ll open the windows 
and take me to the seaside and open the windows and let me look out and 
things like that but I feel it’s like a wasted life.  You’re here for a wee while, 






Despite reporting feeling helpless and upset, some patients also described 
clinging onto hope of some functional recovery. This included Irene who 
recounted how she wished for an improvement in her balance:  
‘The physiotherapists were trying to get my balance sorted but it was 
hopeless. I kept falling back or to the side. So, unless I get that done there’s 
no way I can stand even, you know. I would like to improve on that, you 
know. Even just to stand up and get out of bed, just to move from here to the 
chair without having to use the stand aid, you know.’(Irene)  
 
A similar account was provided by Edith who described how she battled to 
cling onto hope and the possibility of some improvement:   
  
“Well, I can’t imagine myself being like this to the end.  It’s not me. Oh, yes, 
definitely.    They said apparently you can’t get any better but I did.  I can get 
better. My brain’s fine and if I got help, through time I’d get this leg moving 
more because I’d like to be a wee bit more independent when it comes to the 
toilet and that if I can use…get on to one of these things that you push anyway. 
To be able to walk, maybe with a Zimmer. (Edith)  
 
3.4.4.1.2 Patients who were dependent pre-stroke 
These patients, like those who were independent pre-stroke, described 
needing more help than before to be able to carry on with basic daily 
activities (such as showering, dressing and mobilising to the toilet) However, 
in contrast to those who were independent pre-stroke, it was evident from 
their accounts that this group of patients had given up battling for hope of 
further functional recovery. This included Nigel, who, six months previously, 
had already described a situation where he was largely housebound but had 
been able to mobilise independently (though slowly) indoors, was able to 
prepare a simple lunch and had got out (albeit only occasionally) to see his 
friends. Now, he described being fully housebound and needing help from his 
carers to get to the toilet and perform simple kitchen tasks. Despite this 
deterioration, he described, in a very ‘matter-of-fact’ manner how he:  
‘Would like just to have a more active life, If it (his mobility) comes, it comes, 




Likewise, Harriet, described how, against a background of deteriorating 
health, she had previously been able to shower herself and entertain friends 
for afternoon tea but was now needing help to shower and was no longer 
able to invite her friends over. She reported that, while she wished to 
improve, she had accepted her situation:  
‘I have a minder who comes in; my only visitor really... She comes and gives 
me a shower in the morning. I’d like to do that you know…but I'm coping with 
all that. I've got a special seat in my bathroom, where I sit for the shower’. 
(Harriet, a woman in her late 80s) 
 
3.4.4.2 Retrospective views regarding information in the early period 
after the stroke 
When patients were asked to consider what would have been useful 
for to them to have known before they were discharged from hospital,  all 
patients, regardless of their pre-stroke functional status, reported their wish to 
have been given information which would have helped them better 
understand and prepare for the situation they were now in. For instance, 
Irene, in her current state, was in a care home and required hoist for 
transfers and a catheter to manage urinary incontinence. She reported:  
“Well, I think we wanted more information, you know. Excuse me. Just to 
understand why we’re like this, you know.” (Irene) 
Likewise, Brenda who was now needing carers to help her mobilise to the 
toilet and to shower, described how she wished she had been given 
information on what her future may have looked like:  
‘An idea. You can’t precisely say when it’s going to happen, an idea of what 
image of what’s ahead.’ (Brenda) 
However, while these patients described their wish to have had information in 
hospital, they were not specific about the type and timing of this information.  
3.5 Interpretation 
In this study involving patients who had an acute disabling stroke but 




patients prior to their stroke and their need for hope of functional recovery 
appeared to impact on their experiences, views and involvement in decision-
making. First, patients who were functionally independent prior to their stroke 
were emotionally devastated in the early period post stroke and described 
feeling abandoned and struggling to find a sense of purpose six months later. 
They also appeared to be unaware that treatments in the early period post 
stroke might extend their life, but that they might be significantly disabled. 
These patients did not engage in shared decision-making and took all 
treatments in the hope of functional recovery. In contrast, those who were 
dependent prior to the stroke were more stoic, had considered treatment 
implications and were more involved in decision-making. They often chose 
not to have treatments that might prolong their already deteriorating health 
and poor quality of life. While they reported adapting to and accepting their 
increased need for care six months later, they were also saddened by their 
increased disability and social isolation.  
Second, in the early stages post stroke, stroke survivors looked for various 
ways to cultivate and maintain hope that they would recover to their pre-
stroke functional state. This included seeking positive information from 
doctors and other sources. At six months, many of the same patients 
(especially those who had been independent prior to the stroke) continued to 
be hopeful of improvement in their functional abilities. However, they also 
reported wishing they had been given realistic information in the early period 
after their stroke in order to prepare for the situation they were now faced 
with. Therefore, there appeared to be a mismatch between patients’ need to 
maintain hope of functional recovery and their retrospective wish to have had 
realistic information in the early period after their stroke. We refer to this as 
the “hope-information paradox”.  
3.5.1.1 Reactions to diagnosis- and the need for support 
Our study corroborates with existing literature that stroke survivors 
have ongoing unmet needs (physical, psychological and social) after hospital 




recommendations provided by the Stroke Association (4) and Harrison et al 
(202), that stroke survivors may benefit from psychological support on 
discharge from hospital. Psychological support has been shown to be 
beneficial in patients with dementia (203), cancer  (204) and myocardial 
infarction (205) because it reduces rates of depression, improves patients’ 
ability to cope with their situation, better optimises patients’ remaining 
abilities and improves their quality of life. This would be an important 
consideration for stroke patients, who, as we observed, had unmet 
psychological needs which seemed to contribute to a poor or suboptimal 
quality of life.  In addition, our findings suggest that the type and amount of 
support required by patients who had suffered a disabling stroke may depend 
upon their functional status prior to the stroke and may also change over 
time. Therefore, different forms of psychological support (e.g. 
counselling(206), support groups (207), clinical psychology (208) and be-
friending services(209)) may be appropriate for different patients at different 
time points.  For example, those who had been functionally independent prior 
to the stroke may initially benefit from attending clinical psychology services 
and emotional support groups in order to come to terms with their diagnosis 
and loss of independence. Such patients would also benefit from be-friending 
services and peer support in the longer term to address social isolation as 
would patients who were functionally dependent prior to the stroke. A 
stepped care approach to psychological care after a stroke (that is, where 
patients are identified and treated and ‘stepped up’ to more intensive 
treatments based on their clinical need) was proposed by the National 
Institute of Health and Excellence in 2011 (210,211). Although there are 
pathways into psychological services for stroke patients in the U.K, 
(202,212), patients in our study did not seem to have benefited from this. We 
recommend that the multidisciplinary team in hospital, in collaboration with 
specialist neuropsychology services if appropriate, assess the type and 
amount of psychological support each patient needs prior to hospital 
discharge and collaborate with community services to assess ongoing patient 




3.5.1.2 Involving patients in making treatment decisions  
Similar to acutely unwell patients in the intensive care unit (65), we 
also found that it may not be possible to involve some patients in shared 
decision-making in the early period after their stroke. This was especially the 
case for those who had been functionally independent prior to their stroke. As 
we have shown, such patients may not appreciate that, in the early stages 
post stroke, some treatments might extend their life, but with significant 
disability.   They may also struggle to engage with health professionals in 
order to make treatment decisions in the early stages post-stroke. We have 
also highlighted how the emotional impact of a life-changing diagnosis and 
patients’ need for hope may not be conducive to them receiving and 
understanding realistic information, rationally weighing up the pros and cons 
of treatment and/or expressing their preferences for these treatments 
(65,185) – these all being key to effective shared decision-making as 
described early on in this paper. Trying to involve these patients in making 
collaborative decisions may cause unnecessary psychological distress. (213) 
By contrast, patients who were already significantly disabled before the 
stroke, like frail older patients with chronic progressive conditions,  may be 
mentally prepared for further deteriorations in their health, have considered 
consequences of different treatment options and have often decided not to 
have treatments that may prolong an already unsatisfactory quality of life. 
(214–217) Hence these patients may be in a better position to be more 
engaged in the shared decision-making process. We recommend that health 
professionals explore patients’ pre-stroke functional status and consider if 
and whether the emotional impact of diagnosis may prove it challenging to 
involve them in making treatment decisions.  
3.5.1.3 The hope- information paradox 
The need for hope which we have reported in this paper is not exclusive to 
stroke patients: for cancer patients and older patients too, communication of 
hope by health professionals is said to help such patients adjust to their 
diagnosis and improve their welfare and quality of life. (188,218,219)  Striking 




while not providing false hope is challenging. (220) We report two further 
dilemmas for health professionals. First, shortly after their stroke, some 
patients volunteered that if their doctor were to provide them unfavourable 
information regarding the likelihood of their recovery at that point, they would 
lose confidence in their doctor, thereby detrimentally affecting the doctor-
patient relationship. Second, when asked at six months to look back to the 
period shortly after their stroke, patients described wishing that their doctors 
had given them realistic information that could have prepared them better for 
their current (unfavourable) functional status.   
While there are no easy answers with respect to resolving the “hope-
information paradox”, one potential solution is to consider using existing 
cancer communication strategies in the stroke context. Potentially relevant 
cancer communication approaches include ‘Ask-Tell-Ask’ and ‘Hope for the 
Best, Plan for the Worst’ approaches. For example, under the ‘Ask-Tell-Ask’ 
approach, a doctor would communicate poor cancer prognosis, then respond 
to the patient’s emotions and finally transition to talking about next steps. 
Under ‘Hope For The Best, Plan For The Worst’ approach, a doctor would 
join with the patient in embracing their hopes while simultaneously asking 
them to explore a back-up plan based on their prognosis. This could help 
cultivate the patient’s hope by seeking to understand their diagnosis and 
prognosis and thereafter re-orient the patient’s care based on the patient’s 
goals and objectives. (220) Yet there are some challenges to directly 
adapting cancer communication strategies for using in the stroke context: the 
illness trajectories for cancer and stroke are different. (220) Specifically, 
relative to cancer, stroke is an acute medical condition, many treatment 
decisions need to be taken early, and the trajectory of the patient’s condition 
is difficult to predict.(100)  By appreciating that stroke patients too, like other 
patients, may require different types of information at different points in their 
illness trajectory,(187,221) health professionals may consider reassessing 
stroke patients’ need for information at different points during their hospital 




While it is difficult to make concrete conclusions from our small study, we 
recommend doctors consider the following:  
(1) Exploring the social context and early experiences of patients to gain 
an understanding of their views and needs.  
(2) Being aware that patients may need ongoing support, and that this 
best assessed prior to hospital discharge.  
(3) Being aware that, while guidelines exist, they may not apply to acute 
stroke patients: a shared decision-making approach may not always be 
appropriate.  
(4) Adapting strategies used in cancer when communicating hope but 
maintaining realism for patients who have had an acute disabling stroke. 
(5) Assessing the information needs of acute disabling stroke patients at 
various points during their hospital admission.   
 
3.6 Strengths and limitations 
We were successful in engaging and interviewing a group of patients at a 
time when they are often ‘hard to reach’ and therefore excluded from 
research. Following up these patients at six months has given us important 
insight into their ongoing (and changing) needs for information and support. 
However, due to the impact of a disabling stroke on patients’ physical and 
psychological states, it sometimes proved challenging to probe and explore 
some of their experiences and views in-depth. Our sample size was relatively 
small and all participants were recruited from one tertiary teaching hospital. 
This reduced the diversity of our sample and hence, potentially, the 
transferability of the findings to other populations. (222) We considered data 
saturation to have occurred as no new themes were emerging from our 
sample and purposive sampling was not possible; we accept the uncertainty 
of this and therefore, the conclusions drawn. Patients in this study had 





3.7 Recommendations for further research 
Future researchers could consider investigating the views and needs of 
stroke patients from different socio-economic and ethnic minority 
backgrounds who may have different information and support needs. Future 
work may also consider using specific communication tools to involve 
patients with aphasia. Interviewing doctors who look after severe stroke 
patients could give us important insight into how, and why, doctors may have 
made decisions on behalf of the patient or what other factors they may have 
considered in the context of treatment decision-making. 
3.8 Conclusions 
Whilst acknowledging the limitations of this study, we report several findings 
and suggest some recommendations. 
Survivors of an acute disabling stroke have unmet psychological needs which 
may contribute to a poor quality of life post stroke.  These needs must be 
identified and addressed to help patients cope with their situation. A shared 
approach with respect to decision-making regarding treatments may not 
always be possible or appropriate for patients who have had an acute 
disabling stroke, especially when they may be emotionally distressed and 
wishing to maintain a hopeful outlook. Health professionals should therefore 
exercise professional judgement when trying to involve patients in decision-
making in the early period after a disabling stroke.  The mismatch between 
patients’ ongoing need to maintain hope of functional recovery at six months, 
but retrospectively wishing they had been given realistic information in the 
early period after their stroke further adds to challenges of shared decision-
making. In order to achieve a balance between maintaining hope while not 
providing false hope, communication strategies used in cancer may be 
adapted to the acute stroke setting. We also recommend reassessing the 




3.9 Next steps 
As I have shown, it may not be possible to ascertain patient preferences or 
involve them in effective shared decision-making in the early period after 
major stroke. Therefore, doctors may often turn to proxies (usually family 
members) to obtain information about patient preferences and involve them 
in the decision-making process. I explore family members’ experiences, 
needs and involvement in shared decision-making in my next chapter. 













Chapter 4 A longitudinal qualitative study of 
the considerations, experiences and 
needs of family members involved 
in decision-making  
4.1 Publication status and acknowledgement of 
contribution 
I wrote this chapter following comments from my supervisors. This chapter 
contains a paper that has been published in ‘BMC Informatics and Decision-
making’. This paper can be found in Appendix A. I wrote this manuscript with 
comments and guidance from JL. All co-authors commented on the 
manuscript before submission.  
I designed the study including topic guides and performed all the interviews. 
In keeping with COREC guidelines, my supervisor JL supported data 
analysis.  
4.2 Summary of this chapter 
In Chapter 1, I described how some treatment decisions after major stroke 
would need to be made early and proxies (usually family members) may be 
consulted regarding patient preferences where the patient does not have 
capacity to participate in shared decision-making. I also summarised reasons 
why it may be appropriate to involve family members in decision-making but 
also acknowledged the challenges they may face. I will detail this in the 
background section below. 
In Chapter 3, I described the experiences, views and needs of patients, and 
found that in the early period after major stroke, patients were looking for 
hope and often not ready or able to participate in decision-making. However, 
at six months, their preferences and needs had changed; they said they 
wished they had been given realistic information and many were still upset 




Following on from these, in this chapter, I will explore the experiences, views 
and needs of family members involved in decision-making where the patient 
admitted with major stroke did not have capacity. Six months later, I will 
explore their thoughts and feelings on reflection back to their time in hospital.  
These family members are a subgroup of participants who had provided 
consent on behalf of the patient to be included in our longitudinal cohort 
(described in Chapter 2).  
The flow diagram below (boxes coloured in yellow) indicates the part of my 
study this chapter relates to.  
Figure 4.1 Study schematic: Chapter 4 
 
4.3 Background 
As I described in Chapter 1, some treatment decisions need to be made early 
after a major stroke. Treatments such as hemicraniectomy (22) enteral tube 
feeding (24) and IPC (23) increase the likelihood the patient will survive but 
with significant disability. However, declining these treatments may increase 
the likelihood of death. Shared decision-making regarding treatments 
following major stroke is particularly challenging because most patients do 
not have the mental capacity and/or are too medically unwell to understand 
the consequences of treatments. (As described in Chapter 3) To ascertain 
patient preferences in these situations, professional organisations such as 
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the General Medical Council and The American College of Critical Care 
Medicine encourage doctors to involve proxies (often family members) in 
decision-making. (44,223) This recommendation is supported by literature 
which suggests that families know patients’ preferences the best, (79–83) 
and seeking patients’ preferences from others is a way of extending patients’ 
autonomy. (77,78) Furthermore, patients generally want their family members 
to be involved in decision-making (87) and most families want to be involved. 
(84–86) 
In Chapter I, I also acknowledged how being involved in decisions 
concerning life and death may not be easy for families for several reasons. I 
expand on this below. 
Firstly, family members may not know the patient’s preferences and hence 
they may voice preferences based on their own values rather than those of 
the patient. (50,51) They may also find it difficult to be involved in decisions 
that are potentially not life-extending, even if these are consistent with what 
patients may have previously expressed. (52) Patients may also change their 
views regarding the acceptability of treatments and potential outcomes once 
they are faced with a situation of critical illness or significant disability. 
(67,72,224)  
Secondly, families may be in shock and being involved in decision-making 
under these circumstances may be overwhelming. This challenge has been 
reported in various contexts, including in intensive care and severe stroke 
settings. (223,225,226)  
Thirdly, an important step in facilitating decision-making is for doctors to 
provide necessary information to families. (44,227,228) In the early period 
after a major stroke, families may be distressed. Hence, too much 
information may be overwhelming (229) and, families may want information 
that is specific to their situation along with support from doctors. (88–90) 




major stroke is crucial to doctors who may need to tailor their communication 
to facilitate shared decision-making. (49,201,230,231)  
A mixed methods study has acknowledged the need for effective 
communication of prognosis and psychological support for family members in 
the context of dealing with consequences of severe stroke. (73) Literature in 
stroke have also indicated that family members wish for information on 
prognosis. (232,233) However, to our knowledge, there is a lack of research 
exploring how and why certain treatment decisions are made in the early 
period after a major stroke.  
Months, or even years later, family members may feel unprepared for the 
consequences of a major stroke such as patient death or patient survival with 
significant disability. Literature from severe stroke and intensive care 
(73,231) has highlighted the ongoing support needs of family members over 
time. (201,231) For instance, where the patient may have died, family 
members may still be grieving months later and may not have been prepared 
for this outcome. (73)  
The patient who may have survived major stroke may also have ongoing 
emotional and support needs. (Chapter 3) Family members who may have 
taken on a caregiving role for the stroke patient with significant disability may 
feel ill prepared for their role and concerned about their own competence. 
(234–236) Taking on a carer role may also result in physical and emotional 
problems (234,237,238) and cause the carer to feel isolated and their own 
needs neglected.(235) Different family members may require different level of 
psychological support.(239) Some patients and family members may even 
reflect back to the early period after diagnosis and wonder if death would 
have been preferable to survival with disability. (73,193,240) 
Exploring the ongoing thoughts and feelings of family members and their 
perception of the feelings of the patient (who had survived the stroke with 
significant disability) would give insight into how their ongoing needs may be 




may gain insight into how they may have been better prepared for the 
consequences of major stroke during their time in hospital. 
Thus, in this longitudinal qualitative study, we aimed to address gaps in 
research on involvement of family members in shared decision-making 
regarding treatments after major stroke. We only recruited family members of 
patients who lacked capacity after major stroke. Specifically, we explored 
how family members were involved in decisions regarding treatments in the 
early period after a stroke that may increase the likelihood of the patient 
surviving longer, but with significant disability. We explored the factors 
considered by family members when deliberating about treatments, their 
early experiences in hospital when these decisions were made and their 
information and support needs. At around six months after the patient’s 
admission to hospital with major stroke, we explored family members’ 
thoughts and feelings about their and the patient’s situation and asked them 
to reflect on their experiences in hospital six months previously. 
Based on our results, we provide recommendations for doctors 
communicating with family members of patients with major stroke who lacked 
capacity. 
4.4 Methods 
4.4.1 Study design 
We used semi-structured interviews informed by a topic guide to allow 
flexibility for participants to discuss issues and experiences which were 
important to them, including those unforeseen at the study outset and ensure 
the discussion remained relevant to addressing the study aims. (241) Based 
on reviews of the literature and discussion with clinical colleagues, we 
developed a topic guide (Table 4.1) which allowed us to explore, with 
families, what the patients’ lives were like before the stroke and how this may 
have influenced their views. We also explored their experiences soon after 




understanding the treatment decisions which were made. We then explored 
their ongoing thoughts and feelings at six months on reflection of their time in 
hospital six months previously. Data collection and analysis took place 
concurrently, enabling issues identified in early interviews to inform areas 
explored in later ones.(242)  
Initial interviews took place within the first two weeks of the patient’s 
admission to hospital with a major stroke. This time point was longer than the 
time point for patient interviews (a week of admission to hospital with major 
stroke) because as we will go on to describe, some family members needed 
more time to consider what the patient may have wished for.  Therefore, 
early on in the study (After three interviews), we extended our recruitment 
window. We also recognised that most treatments we were interested in 
exploring (i.e. hemicraniectomy, enteral tube feeding, intermittent pneumatic 
compression, antibiotics and parenteral fluids) should have been discussed, 
and decisions made, during this time.  
Follow up interviews took place at around six months after the patient’s 
hospital admission. We chose six months as our follow up time as we 
anticipated that this would be a compromise between giving family members 
enough time to come to terms with their situation but not too long that their 
experiences in hospital became too vivid that they would no longer be able to 
reflect on this.   
 








 How family members saw the patients’ life before the 
stroke; how patients were coping and if they required 
any help for their day to day activities. The patients’ 
















 Whether patients had made any pre-stated wishes about 
treatments in the event of a critical illness and if so, the 
context in which these wishes were stated.  
 The emotional reactions of family members to stroke 
diagnosis and their initial experiences in hospital; if and 
how they reacted to, and came to terms with, the 
diagnosis and potential poor prognosis 
 The factors considered by family members when 
decisions needed to be made on treatments that were 
life-extending, but may leave the patient with potentially 
significant disability; how a decision was made, and why 
 Based on family members’ experiences in hospital, their 
early needs; how and why information or support may 
be useful to them, whether these changed over the first 
two weeks in hospital and if so, how and why. 
 
 How family members were feeling and coping with their 
current situation; where the patient may have died or 
survived with significant disability 
 Where the patient had survived, how they thought the 
patient was feeling or coping with significant disability  
 Their thoughts reflecting back to the early period in 
hospital when the patient was admitted with major stroke 
 Their thoughts on how they may have been better 
prepared for the consequences of major stroke while 
they were in hospital 
 
 
4.4.2 Recruitment and sampling 
We recruited adult family members of patients admitted with major stroke to a 
large teaching hospital in the United Kingdom. To be eligible for the study, 
the patient needed to be significantly disabled as a result of the stroke and 
not have mental capacity to participate in decision-making. This is in contrast 
to our patient interviews (described in Chapter 3) where the patient retained 
capacity after stroke. Treatments (such as hemicraniectomy, enteral tube 
feeding, parenteral fluids, antibiotics or intermittent pneumatic compression) 
also needed to have been discussed and decisions made between the doctor 




The medical team identified eligible patients.  They considered whether the 
family member would be appropriate to approach regarding the study (i.e. 
participation would not be too distressing for them) and, if considered 
suitable, they asked them if they would be interested in taking part. Where 
family members were agreeable to being approached, I then provided them 
with further information and if family members agreed to take part, I then 
obtained informed written consent. As described in Chapter 3, participants 
were not informed about my clinical background.  
Recruitment continued till data saturation was achieved; that is when no new 
findings were identified in new data collected. Initial interviews were 
conducted in a private room in the ward where the patient was admitted at a 
time convenient to the family member. These interviews took place between 
May 2017 and November 2017 and lasted 20 to 55 minutes. Family members 
were given the option of six month follow up interviews in person or over the 
telephone. Six month interviews took place between November 2017 and 
April 2018 and lasted 15 to 60 minutes. All interviews were digitally audio 
recorded and transcribed in full.  
Table 4.1 summarizes the main areas explored in these interviews.  
4.4.3 Data analysis 
Similar to that described in Chapter 3, JL and I analysed the interviews 
thematically using the method of constant comparison.(200) Both inductive 
and deductive approaches were used, which allowed unanticipated themes 
to emerge from data as well as identification of material needed to address 
the study aims. JL and I read the interviews repeatedly and cross compared 
them to identify issues and themes that cut across different individuals’ 
accounts. Upon discussion and agreement, a coding frame was developed 
that captured key themes.  
We further analysed coded datasets to develop more nuanced interpretations 




software package (Nvivo version 11, QSR International Pty Ltd.) to facilitate 
data coding and retrieval. 
4.4.4 Ethics approval 
The study was approved by Scotland A Research Ethics Committee (Ref: 
17/SS/0029).  
To maintain anonymity, pseudonyms are used below. 
4.5 Results 
4.5.1 Initial interviews 
We interviewed 24 family members. Demographic information and relevant 
patient data is presented in Table 4.2. 





Mean age in years 
(range) 
62 (32-75) 
Gender 8 male, 16 female 
Relationship to the 
patient 
3 partners, 19 children, 2 others (cousin, sister) 
Ethnicity All British white 




Mean age in years 
(range) 
85 (55-101) 
Gender 7 male, 17 female 





prior to the stroke 
11 independent, 13 required care (either a 
package of care at home or in a care home) 
First stroke 23 











Based on family members’ interpretation of the patients’ treatment 
preferences, decisions regarding treatments lay on a spectrum. At one 
extreme, family members (the majority) described how they felt that the 
patient would have chosen not to initiate treatments from the outset. In the 
middle of the treatment decision spectrum, were family members who felt 
that the patient would have chosen to continue all treatments initially but 
later, expressed that the patient may no longer find life-extending treatments 
to be appropriate. At the other end of the spectrum, family members 
described feeling that the patient would wish all treatments to continue at all 
costs. 
Below, we will consider the factors determining these different preferences 
and therefore, treatment decisions. We will then explore how this seemed to 
influence family members’ early experiences in hospital, and their 
accompanying information and support needs both in the early period after 
major stroke and at six months. Where possible, we will report our findings 
based on where family members were on the treatment decision spectrum 





4.5.1.1 Reflecting on patients’ health pre-stroke, and preferences for 
life-extending treatments   
4.5.1.1.1 Family members who felt that the patient would have chosen not to 
initiate life-extending treatments 
Family members at one end of the treatment decision spectrum described 
how the patient who had been admitted to hospital, many of whom in their 
eighties or nineties, already had chronic progressive conditions (e.g., 
dementia and arthritis) prior to their stroke. They described how, over the 
years, these conditions had resulted in gradual decline in their health and 
quality of life. Hence, family members noted how these patients had not been 
fully independent prior to stroke and how some had either lived in a care 
home or had been reliant on others for aspects of their care, such as washing 
and dressing. Family members further noted how this dependence on others 
had been a source of frustration and distress to the patient.  
For example, Paul, the son of a woman in her nineties noted how his mother 
had various chronic medical conditions including arthritis and heart disease, 
and although she had lived at home, she had needed carers to come in four 
times a day. He also described how her dependency on others had led to her 
being unhappy with her life and extremely low in mood:  
‘She’s depressed… every time I go up she’ll say to me I don’t want to be 
here, [name removed].    I seem to get it every week In fact...... she had said 
to me I love you but I want you to put the pillow over my head...’ (Paul) 
According to these family members, which included Paul and Imogen (who is 
quoted below), patients’ increasing frailty and dependence on others had 
meant that, in many cases, they had indicated their preference, either to their 
family or their doctor, for not wanting their already poor quality of life to be 
extended:  
‘Well, my mother has been very unwell for the last nine months now.  She 
had caecal carcinoma, so we have been involved with the hospital for a long 
time.  So, we have had all the discussion about, what interventions she would 





Many of these family members also reported how the patient had thought 
ahead to a circumstance where a decision might need to be taken regarding 
resuscitation:  
‘Mum already has a DNR in place.  She’s a very strong woman.. She 
knew...well told us this is what...if it comes to a point where all the numbers 
stack up against her, and she finds herself requiring a DNR, which she 
wants, that would be the line to take.  Do not resuscitate’. (David) 
4.5.1.1.2 Family members who felt that the patient would have chosen to 
withdraw life-extending treatments over time 
Family members who were in the middle of the treatment decision spectrum 
described how, although the patient had generally been quite old (late 
seventies or early eighties), they had been determined and able to maintain 
moderately independent lives. This included Moira who described how her 
husband, in his eighties, had continued to lead a busy and active life right up 
to his stroke: 
‘When we got to 80, and [name removed] said he retired; well, he continued 
to work whenever he got the chance – he couldn’t retire – and what he’s 
done since he was 80 is he’s chopped wood and split logs…and even on 
Sunday, the day before this, he was working splitting logs. So he was very, 
very active and very strong’. (Moira) 
 
Colin, likewise, described how his father had been a very determined man and, 
despite having had multiple health problems and hospital admissions, had only 
needed minimal help to live independently:   
 
‘Well, he’s physically very strong, mentally very strong and he’s had things 
before which he’s come back from, in the hospital, heart attacks and 
quadruple bypass surgery and so on and he’s quite tenacious about life in 
general. We just do some shopping and cleaning for him.’ (Colin)  
 
In keeping with their relative independence, family members noted how they 
felt that the patient had not generally thought about a circumstance where they 
may be left significantly disabled in any meaningful way. Hence, as Martha, 
the daughter of a woman in her eighties noted, any comments the patient had 




necessarily be interpreted as their true preferences, because they felt that 
these individuals had not properly considered a future situation of critical 
illness and/or significant disability:   
 
‘Her friend had a stroke and went into a home…and that allowed me to 
introduce the subject of what would you like to do in the long term if you 
weren't able to live in your own home?  And her response was, oh, I've never 
really thought about it. But well, if I couldn't stay in my own home I'd probably 
want to come and live with you. But I said that won’t be possible as I work full 
time, and she says ‘oh well, I’d go to a home then.’(Martha) 
 
4.5.1.1.3 Family members who felt that the patient would have wished for all 
treatments to continue at all costs 
The minority of family members at the other end of the treatment decision 
spectrum reported how the patient had been relatively young and independent 
prior to their admission. Hence, family members reported that they did not feel 
that these individuals had considered a situation of critical illness and, 
therefore, they were not aware of them having articulated their own wishes for 
treatments in a situation where they might be left significantly disabled. This 
included Jenna the stepdaughter of a man in his 50s:  
 
’Not really something that he would speak about; like, we like to get away 
every now and again, sort of, just we go camping and stuff like this; we’ll walk 
at weekends.  It’s not really something that he…I don’t think he’s thought 
about the, sort of, long term’. (Jenna) 
 
4.5.1.2 Early hospital experiences and accompanying needs  
4.5.1.2.1 Family members who felt that the patient would have chosen not to 
initiate life-extending treatments 
Family members of patients who had already been physically dependent 
before the stroke, described how these patients had had multiple previous 
hospital admissions and therefore, how these previous experiences had 
made it easier for them to understand and accept that the patients’ prognosis 
might be very poor. For instance, Susan, the daughter of a woman in her 




being in hospital and was accepting of the fact that her mother was very 
unwell and might not survive:  
‘I mean, we kind of predicted that this was maybe the way it was going to go 
with this second stroke Mum’s had, the second time she’s been here; so 
there’s a bit of history, so it’s easier for all of us to understand the 
predicament we’re in’. (Susan) 
Given these experiences, and their confidence in knowing what the patient 
would have wanted with respect to life-extending treatments, these family 
members reported how such treatments would not be in the patient’s best 
interests. This included Murray who described how he had considered his 
mother’s preferences and had concluded that the situation his mum was now 
in (significantly disabled and requiring 24 hour care) would not be the kind of 
life she would want to endure:  
 ‘She said she did not want people looking after her and I think the point with 
Mum’s situation is that massive stroke – it’s unlikely she will recover from it.  
If she does recover …she’s going to need full-time care, so that’s…for Mum 
that’s not an option; she wouldn’t want that.’ (Murray) 
 
These family members thus described how, based on what the patient may 
have expressed previously, initiating life-extending treatments would not be 
in line with the patient’s wishes even before the doctor had provided their 
opinion on the patient’s prognosis. Hence, as Linda, the daughter of a 
woman in her eighties, described, a discussion with the doctor on what the 
patient would have wished for was often used to support a treatment 
preference and decision that had already been made by the patient::  
‘So, we've (referring to Linda, her mother and family) been very open about it 
and feel very strongly that no prolonging of life, given the quality of life that 
she has.  So, that was the conversation I had with the consultant and it was 
rather nice and refreshing that he was very open to listening and in total 
agreement with that, and also being quite honest as to the implications of the 




4.5.1.2.2 Family members who felt that the patient would have chosen to 
withdraw life-extending treatments over time 
Family members of patients who had been moderately independent and had 
not formally expressed their preferences for life-extending treatments, 
described having been shocked and distressed by the diagnosis of a major 
stroke with poor prognosis. This included Jack who shared his astonishment 
at how, on the same day as the stroke, his mother had been leading a group 
tour of a historical site: 
‘Especially since she was, you know, completely fit and healthy one day, and, 
well, the same day, just suddenly, wallop. It was completely…changed her, 
you know. So, yeah, it was a bit of a shock to the system’. (Jack) 
 
These family members discussed how, because of their shock and distress, 
and not really knowing what the patient’s preferences were, they had initially 
felt that the patient would wish all treatments that might have given them a 
chance of survival:  
 
‘So after two days of deterioration, so Doctor [name removed], he said, what 
is your position on treatment and antibiotics; and I didn’t really have…I didn’t 
feel that I was in a…couldn’t not doing treatment. So I was trying to think about 
what would [the patient’s name removed] say. She’s really committed to life; 
so I said, well, I think if you felt it was okay I think [name removed] would want,  
she wants to get better, she’s not ready to die’. (Lorna) 
 
Having initially voiced a preference that the patient may wish for all 
treatments, these family members reported how, over the days which 
followed this decision and as they got over their initial shock,  they had 
reassessed the situation the patient was in and gathered evidence to make 
further decisions about (withdrawing) treatments. This included having 
discussions with family and friends about what the patient might have wanted 
with respect to treatments and future quality of life: 
 ‘And…initially my view was that because I didn’t have enough medical 




other medication, we would start to see an improvement.  And, you know, I 
had a hope…whether it was a forlorn hope or not that the treatment would 
have an effect.  But her condition got worse-  I’d spoken to various relatives 
and various friends of hers and explained the situation and all of them said, 
oh she wouldn’t want to carry on living like that.’ (Jack)  
They also described how such discussions had jogged their memory about 
situations where the patient had previously made informal comments about 
life-extending treatments or surviving with disability. They then reported how 
these remarks had led them to conclude that the patient would not have 
wanted to have been kept alive by tube feeding or if they needed full-time 
care. For example, Collete described how her mother had been the main 
carer for her father who had had a stroke, and had, based on her 
interpretation of his preferences, expressed that no life-extending treatments 
be given to him:  
‘I don't think she would be very happy to be constantly fed and kept alive with 
tubes.  My father died with a stroke and she said the same thing, your dad 
wouldn't want this, your dad wouldn't want that, he wouldn't be happy if he 
couldn't do XY and Z.  So she was probably the most calm out of the whole 
family when my father died.’ (Collete) 
Many also described how, when they were visiting the patient in hospital, 
they had observed them making gestures, such as removing oxygen masks 
and feeding tubes, which they interpreted as them wanting to reject these 
treatments:  
‘I think a lot of it was informed by the fact that she kept taking the feeding 
tubes out … And…just other signs.  I mean, as her son, I know her facial 
expressions.  And I just got the impression looking at her that she really 
wasn’t happy in the situation that she was in.  She’d had enough and she 
wanted it come to an end.   She wouldn’t want to be in a care home lying 
there, you know, effectively unable to do anything.  And I think she was 
telling us that by removing the feeding tube and…she’s telling us again by 
removing the oxygen’. (Jack) 
While reflecting on the situation, and realising that the patient might not 
survive the stroke, many of these family members described how they had 
moved away from their initial hope that the patient would recover to a more 




doctor on the patient’s likely (poor) prognosis. They then described how they 
used this information, along with their interpretation of what the patient may 
now wish for, to decide that it would now be appropriate to withdraw various 
life-extending treatments: 
‘Well each time a decision came along, I sat down with either Dr [name 
removed] or Dr [name removed] in the main and the main decision was on 
feeding and whether they should persist with it.  So…yeah, I was given 
information.  I asked them questions. We came to a judgment...’ (Jack) 
Although these family members described how, having reflected on the 
situation, they had felt that withdrawing treatments had been appropriate, 
they also noted how this process of decision-making (and treatment 
withdrawal) had been very upsetting for them. Some expressed how formal 
psychological support from hospital staff might have been helpful to them 
during this distressing time:  
‘You know, this is hard, very tough… some, kind of, counselling service 
available, preferably with people with some medical knowledge’. (Jack)  
 
4.5.1.2.3 Family members who felt that the patient would have wished for all 
treatments to continue at all costs 
The minority of family members, where patients had been young and 
independent before the stroke, described how they had felt shocked, 
overwhelmed and emotionally unprepared for the situation they now found 
themselves in. For example, Andrea, the daughter of a previously independent 
woman in her sixties, described how she and her father had felt helpless and 
extremely distressed seeing her mother in hospital in a physically dependent 
and agitated state:    
‘I saw my mum, my dad was in shock basically. It was quite upsetting to see 
her being sick and she looked like she was not comfortable. It just felt 
yesterday nobody was helping her to try and get this bleed under control and 
trying to get my mum back.  So it’s, kind of, upsetting [sounding upset].’ 
(Andrea) 
 
These family members expressed how, while feeling extremely distressed, 
they had looked for ways to maintain hope that the patient would survive. For 




where her mother, based on her determination to improve, had recovered well 
from minor illnesses. She expressed how she felt that, based on these 
previous situations, the current situation her mother was in would be one from 
which she would be able to pull through:  
 
 ‘I think she would cope with a lot.  My mum can cope with a lot.  She did 
have an operation on her arm and she had to get a plate put in and they did 
say to her that she would only get…likely 45/50 per cent usage.  But she 
pushed on and pushed on and she’s got 90 per cent usage in her arm.  They 
say she would only manage to get her arm to here [lifting arm up from the 
table].  She can actually get her arm to there [extending arm to 60 
degrees].  And, you know, she’s a determined woman.’(Andrea) 
In a related example, Jenna described how she had looked for information 
from the doctor that gave her hope that her step-father would survive:  
‘To have heard from the doctor when he had said to us, you know, some 
people will survive, kind of, gave us a bit of hope; like, well, there is hope.’ 
(Jenna) 
In their situation of extreme anguish, they expressed how they thought that 
the patient would have wished for all treatments and therefore, it would be 
appropriate that all treatments be given to the patient to promote the 
possibility (however small) of them surviving the major stroke:   
‘When it’s a family member like you don’t want them to withdraw treatment, 
you want them to give a 100 per cent and keep going no matter what. If a 
patient needs to be fed through a tube then they need to be fed through a 
tube and I don’t think that’s a decision that should be given to the family.  It 
should just be...it should just happen’. (Jenna) 
These family members also expressed how they felt isolated at this difficult 
time and reported that emotional support would have been helpful:  
‘Dad’s not coping, we were just left, left like that. There’s no one…Some sort 
of support would have been helpful, you know…but there was nothing..’ 
(Andrea) 
4.5.2 At six months 
At six months, 21 patients had died and three had survived. All surviving 




capacity. I interviewed 23 family members by telephone at six months. One 
withdrew consent. We found that their thoughts and feelings appeared to be 
related to their interpretation of the patients’ preferences, how those 
impacted on treatment decisions that had been made, and if the patient had 
died or survived at six months. Therefore, where possible, I have related my 
findings to these.  
 
4.5.2.1 Feelings and thoughts about their (and the patients’) situation 
while reflecting back to their time in hospital  
4.5.2.1.1 Where the patient had died by six months 
Based on their interpretation of the patients’ preferences, family members 
who had felt that the patient would have chosen not to initiate treatments at 
the outset described how they were largely coping with the patient’s death. 
For instance, Sophie, who had, six months previously, expressed her 
mother’s preference on not to initiate treatments described her feelings:  
‘We've been fine, actually.  As a rule, we’re always a very, very busy family so 
there have been many distractions going on, but obviously you have your quiet 
moments when you think about mum, but we've been managing.’ (Sophie) 
 
Many family members who were in the middle of the treatment decision 
spectrum (i.e. where treatments were withdrawn over time) expressed how 
things had been difficult for them after the patient had died. They described 
looking back to their time in hospital, and voiced how distressed they had felt 
then and were still feeling. 
For example, Jack, the son of a previously independent woman in her early 
eighties who had eventually died from the stroke after treatments were 
withdrawn, expressed his ongoing feelings of upset:  
‘It is obviously a difficult time. I think the process of mum dying after treatment 
was withdrawn was quite a long, drawn out and painful process for the family. 




was ended. And so, we could get on and grieve. Yeah. It was a difficult time. 
We’re still grieving’. (Jack) 
 
While grieving their loss, many of these family members also described being 
confused and distressed by certain aspects of the patients’ care in hospital. 
For example, Murray described the confusion he had felt when tube feeding 
had been stopped for his mum, but she had not died immediately after this was 
done:  
 
‘Yeah. I was quite frustrated then for a time, because the way I was looking at 
it was that we’re basically starving her to death. And, you know, just drugging 
her up on morphine to keep her from being distressed through the process. 
There should be a kinder way to allow people to slip away.’ (Murray) 
 
Similarly, David described how he felt puzzled when fluids were withdrawn 
from his mother, but his mother had continued to survive for weeks after this:   
 
‘When they withdrew fluids from my mother.. that went on for nearly two weeks, 
and our mum was still with us. And then they put her back on the fluids, just 
really to make her comfortable. So, that was rather confusing. Because, clearly 
they (referring to doctors) didn´t expect mum to last as long as she did when 
they withdrew fluids, as it were. But she kept, you know, living’. (David) 
 
Such family members described how direct realistic communication would 
have been useful to them to better understand and be prepared for the 
patient’s death:  
‘The knowledge that I had, or we had, of the situation would probably have 
been made clearer to us, look, your mum´s not going to recover. I know, they 
want to be tactful about this, but there´s sometimes you just need to be told. I 
mean you just need to be told so we can come to terms with it, because my 
mum´s there but she´s not alive. So, really, we know she´s going to die. So, it 
was more a case of telling us that… Be more direct’. (David)  
 
Some families also expressed their regret at not being by the patient’s bedside 
when s/he had eventually died. This appeared to be important to them to be 





‘I missed my mum passing by about two or three minutes I think, because we 
had just gone home again.  We had been there a lot in and out, and they said, 
oh, you could just go home and we’ll give you a call when anything is 
happening, and which they did, but that was just too...slightly too late… I’d like 
to have been there to hold her hand’. (Mark) 
 
4.5.2.1.2 Where the patient had survived to six months 
In the very few circumstances (three) where the patient had survived, these 
patients were significantly physically disabled. Two were living in care homes, 
requiring 24 hour care while one patient was still in hospital, being assessed 
for an appropriate discharge destination.   
 
Where the family members had felt that the patient would have chosen not to 
initiate treatments for the patient, but the patient had survived, these family 
members described how they felt that the patient was very upset due to their 
inability to function as they did prior to the stroke. This is similar to my findings 
in Chapter 3. For instance, Lindsay described how her mother’s mood had 
been very low mainly due to her lack of mobility, which had led to consequent 
feelings of loneliness and isolation:  
 
‘Well, she’s not what she was before she had the stroke, but sometimes she’s 
quite depressed and says she’s lonely.  I don't think she will ever have muscle 
power to walk...that’s what upsets her most I think not being able to walk...just 
sitting there in the chair, in the wheelchair day after day.  Anyway, she has not 
got the concentration that she had.  She has got her telly in her room, and she 
watches it, but falls asleep …’ (Lindsay). 
 
These (two) family members seemed quite reluctant to discuss their feelings 
about their current situation. For example, Lindsay dismissed the question:  
 
‘Well, we are where we are, aren’t we? I mean, what can I say…’ (Lindsay) 
 
In the one circumstance where the family member had felt that the patient 
would have wished for all treatments to continue, and the patient had survived 
but with significant disability, the family member described how she thought 





‘I think he feels a bit useless.  And he can’t walk or use his left arm at the 
moment, they’ve had to put him on antidepressants. But, I mean, we were told 
he was going to die and we had prepared...like, you know, we were switching 
off his food and stuff. We just remind him of that and he does know, he does 
know how lucky he is to still be here, and it must be hard because it is...like he 
said it is a completely different life to what he’s used to, but it still is life and 
he’s still here’. (Jenna) 
 
This family member was also reluctant to fully detail her situation but reported 
that her mother (who was the main carer) was not coping with her new role 
as a carer: 
 
‘Mum’s back at work.  She’s just part-time at the moment.  I think she’s 
maybe struggling a bit.  It’s not just [patient’s name removed] life that’s 
changed, it’s mum’s as well.  She’s doesn’t want to be his carer but she is 
going to have to take on that role and it’s just, sort of….different…. but I think 
she has to be very very happy that he’s still with us...’ (Jenna) 
 
4.6 Discussion 
4.6.1 Summary of key results 
This longitudinal qualitative study explored early decision-making regarding 
treatments involving family members of patients who lacked capacity in the 
context of a major stroke and family members’ ongoing thoughts and feelings 
six months later.  
Early decisions regarding treatments after major stroke lay on a spectrum, 
based on the patient’s pre-stroke functional status and prior experiences of 
illnesses, and any views they had expressed about treatment preferences in 
the event of a critical illness which might result in significant disability or 
death. At one extreme of the treatment decision spectrum, there were family 
members who felt that the patient would have chosen not to initiate life-
extending treatments at stroke onset due to the patients’ deteriorating health 
pre-stroke and stated treatment preferences pre-stroke. These family 




preference that had already been expressed by the patient. In the middle of 
this spectrum were family members of patients who were relatively 
independent, who felt that the patient would have chosen to withdraw 
treatments over time, once they got over the initial shock of the diagnosis and 
had time to gather relevant information from family, friends and doctors. At 
the other end of the spectrum were family members of previously 
independent patients whose treatment preferences were unknown.  These 
family members felt that the patient would have wished all treatments to 
continue at all costs and reported the need for hope of patient survival from 
doctors and psychological support.  
At six months, some family members (especially those in the middle of the 
treatment decision spectrum) often appeared to be confused by and 
unprepared for the process of the patient dying after all treatments had been 
withdrawn. Family members also had ongoing emotional needs, either to 
cope with the patient having died or to cope with the patient having survived 
with significant disability, and hence requiring more care.   
Below, we place these findings into context of existing literature, and make 
recommendations for clinical practice. 
4.6.2 The need to explore the patient’s state of health before 
stroke 
Our results agree with sociological literature reporting that the experiences of 
health and illness of individuals and relatedly, decision-making regarding 
treatments, are socially and contextually informed. (197) Our findings also 
corroborate results from studies involving family members of patients 
admitted to intensive care which have reported that, in addition to information 
regarding prognosis from doctors, the majority of family members estimated 
the patient’s prognosis depending on their perceptions of the patient’s 
strength of character, unique story of illness and survival and previous 




Family members who felt that the patient would have chosen not to initiate 
life-extending treatments appeared to have already experienced some 
anticipatory grief (244) and seemed to be prepared for the possibility that the 
patient might not survive.  During the decision-making process, they had 
drawn on their previous experiences with those of the patient (for example, of 
the patient’s multiple hospital admissions, and declining health and quality of 
life), and knowledge of the patient’s treatment preferences. In contrast, where 
family members were unaware of the patient’s preferences, they were 
generally in shock and unprepared for a situation of critical illness (52), and 
therefore, found being involved in decision-making more difficult . (243) Our 
study therefore further reiterates the need for doctors to explore the patient’s 
preferences by gathering information from family members, perhaps through 
a narrative approach, i.e. by developing the patient’s story. (245)  
4.6.3 Providing tailored information 
As we have reported, the type of information that a family member might wish 
for varied depending on the patient’s health state and stated preferences pre-
stroke. Though we accept that family members may not respond in 
predictable ways, our findings provide some insight to doctors to help them 
better prepare for discussions about prognosis with family members. For 
example, before meeting with families of older and dependent patients, 
doctors may be able to prepare themselves by ensuring that they can provide 
realistic information about the patient’s (likely poor) prognosis.  
For families of (relatively) independent patients, several meetings may be 
needed to share sufficient and relevant information, discuss preferences, 
weigh up pros and cons of available treatments and then arrive at decisions. 
(59,230,246)  
In contrast, before meeting with families of young, previously fit and 
independent patients, who may well be very distressed by the situation, 
doctors should be ready to respond to the likely emotional response (e.g. 




prognosis sensitively.  For example, doctors may consider using the 
‘SPIKES’ protocol used in oncology which provides a six step strategy for 
breaking bad news and dealing with emotional responses. (247) Specifically, 
approaches such as active listening, observation of non-verbal 
communication, choosing words that may not be perceived negatively, 
breaking down information into small pieces and offering another meeting at 
an agreed time may help families understand the situation of major stroke 
with poor prognosis better and help them cope with their emotions. (247,248) 
As I described in Chapter 3, doctors should also consider how to balance the 
communication of hope with that of realism (53). This can be complex.(249) 
Some family members may maintain a strong sense of hope that the patient 
may survive and recover despite accepting poor prognosis. (250,251) Others 
may find hope by being overly optimistic about the patient’s prognosis 
(89,250,252) and may not wish to obtain realistic information.(253) In 
contrast, some individuals may find hope when doctors discuss preparations 
for possible death and optimising comfort at end-of-life.(254) This further 
highlights the need for tailored communication, and doctors may consider 
adapting some communication strategies used in intensive care to the major 
stroke setting. For example, the use of the phrase ‘hope for the best and 
prepare for the worst’ can help manage expectations. (255) Using ‘I wish’ 
statements (e.g. I wish things were different) may also acknowledge the limits 
of available options while expressing empathy in a situation which may be 
futile, or where individuals may have unrealistic hopes. (255,256) .  
Where appropriate, doctors should also consider communicating the 
uncertainty of the process of dying i.e. inability to predict duration and the 
possible protracted course even after treatments had been withdrawn. 
Despite recommendations on communication techniques on approaching 
conversations about dying in stroke, (45) e.g. ‘firing a warning shot’ and using 
‘I wish’ statements, doctors do not find it easy to convey uncertainty (53) and 
tend to focus on communicating active treatments including rehabilitation, 
rather than preparing individuals for the possibility of the patient dying. (73) I 




4.6.4 The need for psychological support 
Our results indicate that the shock of stroke diagnosis and being involved in 
decisions not to continue life-extending treatments can be upsetting for family 
members.  (257–259) Therefore, when meeting with family members, doctors 
may consider exploring if they had support from friends and other family 
(260) and if they may wish counselling and emotional support from clinically 
trained staff (e.g. psychologists) to help reduce their distress. (261,262)  
As I have reported, the distress individuals may feel can even linger for 
months. (263) Therefore, similar to patients who had survived a major stroke 
(described in Chapter 3), family members too appear to need ongoing 
emotional support. Although family members who had taken on a carer role 
for the patient who had survived major stroke are inadequately represented 
in this study, in keeping with existing literature, it is apparent that these 
individuals have support needs that do not appear to have been adequately 
met. (235,237,238) 
A stepped approach towards psychological support, where level of 
intervention is ‘stepped up’ according to necessity (211) may be helpful. Grief 
and bereavement services which have been stressed in other carer groups 
such as after head injury and in dementia may also be appropriate. (264,265) 
The Stroke Association (266) provides support and advice to bereaved 
families of stroke patients and therefore, family members could be 
encouraged to contact this organisation.  
 
4.7 Recommendations for clinical practice 
We recommend doctors communicating with family members of patients with 
major stroke to consider the following:  
1. To gather evidence regarding the patient’s functional status pre-stroke 




2. To tailor their communication of information to the individual’s needs:  
i.e. information to confirm poor prognosis and support a treatment 
preference that the patient had already made, that to facilitate shared 
decision-making, information to maintain hope (while being realistic 
and not offering false hope) or to communicate the possibility of dying, 
and the uncertainties of this process. This can be done by exploring 
their understanding of the patient’s condition, eliciting their hopes, 
concerns and expectations, and finding out what they know about any 
wishes or views the patient may have expressed previously. 
3. To be aware that family members may have unmet psychological and 
emotional needs both in the early period after stroke and at six months 
which would need identified and addressed.  Some may require more 
specialist input, e.g. clinical psychology. Others may require 
information on how to access support services e.g. by contacting the 
Stroke Association. 
4.8 Recommendations for further research 
Future research could consider investigating the experiences, views and 
needs of families from different socio-economic and ethnic backgrounds, who 
may have different experiences and views on being involved in treatment 
decisions. Future research may also focus on interviewing family members of 
patients who have retained mental capacity after a major stroke. Qualitative 
interviews with family members in different hospital settings may increase 
generalisability of our results. Staff training on communication strategies in 
major stroke would be helpful, and future research could consider further 
adapting and evaluating these strategies in the context of major stroke. I will 
discuss this further in Chapter 9. 
4.9 Strengths and limitations 
We engaged with a group of family members at a time which can be 
emotionally distressing for them and therefore, we were able to gain novel 




decision-making. Their thoughts and feelings six months later provided us 
with insight into how their information and support needs may have been, or 
could be better supported. However, our sample size was homogenous; all 
participants were of similar ethnicities and were recruited from one tertiary 
teaching hospital. Furthermore, since this study relied on participants ‘opting-
in’, it is possible that individuals who participated were those who were more 
able to voice their experiences.  Therefore, our sample of family members 
may not be representative of all family members of patients admitted with 
major stroke which may reduce the transferability and generalisability of our 
findings to other populations. (222) 
4.10 Conclusions from chapter 
 We identified a spectrum of treatment decisions made for patients who 
lacked capacity after major stroke, defined by the patient’s state of 
health and stated preferences pre-stroke. This influenced information 
and support needs of family members involved in this process both in 
the early period after major stroke and at six months. 
 Family members need tailored information from doctors; in the early 
period after major stroke they may require information to support a 
treatment preference and decision that the patient had already made, 
be involved in the decision-making process or maintain hope that the 
patient may survive. They may also require information and 
preparation for the possibility that the patient may die, and 
uncertainties in prognosis and the dying process.  
 Family members and patients may have early, and ongoing unmet 
emotional needs. These need to be identified and addressed. 
4.11 Next steps 
As I have described, communication between doctors and family members in 
the context of a major stroke where the patient lacked mental capacity 




In my next chapter, I will compare how these family members and doctors 
perceive current communication between them in the context of a major 
stroke, aiming to identify areas where communication may be improved.  
As I described in Chapter 1, the doctor’s view regarding appropriateness of 
treatments for the patient may also affect the way they communicate. 
Therefore, in my next chapter, I will also explore if the doctor’s view of 
appropriateness of specific treatments for the patient admitted with major 
stroke may influence the decisions made about these treatments.  
Furthermore, as I have described in this chapter, for some family members, 
information on prognosis from doctors may be important to facilitate shared 
decision-making regarding treatments.  In Chapter 6, I will explore family 
members’ views regarding prognostic information and their views on how 











Chapter 5 Doctors’ views on appropriateness 
of specific treatments for the patient 
and communication between 
doctors and family members in the 
context of major stroke: an 
evaluation using questionnaires 
 
5.1 Acknowledgement of contribution 
I designed the questionnaires with my supervisors and piloted them before 
their use. I analysed all the questionnaires. I wrote this chapter and made 
changes following comments from my supervisors. 
5.2 Introduction  
In Chapter 1, I reported how doctors and patients may have different 
preferences for treatments. For example, doctors have different thresholds 
for accepting treatment for themselves in conditions such as hypertension 
(267,268) and cancer (269) when compared to patients. Doctors may also 
express different preferences for end of life treatments for 
themselves.(116,270)  It is possible that doctors’ preferences, behaviours 
and styles of communication may influence the decisions that are made. 
(271)  
In Chapter 1, I described how shared decision-making is considered a gold 
standard of care and that communication between doctors and patients/ 
family members was important. (29,30,45) Related to this, I reported how 
patients looked for hope and positive information from doctors (Chapter 3). 
Then in Chapter 4, I found that family members (where the patient with major 
stroke did not have mental capacity) looked for information from doctors. 
In this chapter, using questionnaires, I address five aims related to doctors’ 
views of appropriateness of treatment(s) for the patient admitted with major 




family members* in the context of major stroke. This evaluation is based on a 
single meeting between a doctor and a family member where the patient’s 
diagnosis, prognosis and appropriateness of life-extending treatments were 
discussed for the patient admitted with major stroke and who lacked capacity. 
(Chapter 4) 
*As I reported in Chapter 3, after a major stroke, many patients (who had 
capacity) were overwhelmed and distressed having received, and trying to 
come to terms with their diagnosis. Therefore, while they were able to narrate 
their experiences (reported in Chapter 3), they were not able to engage with 
questionnaires.  
The flow diagram below (boxes coloured in yellow) indicates the part of my 
study this chapter relates to.  





Prior to meeting with the patient’s family member(s): 
Qualitative substudy















a) To ascertain the doctor’s views regarding the appropriateness of 
specific treatment(s) for the patient 
After meeting with the patient’s family member(s): 
b) To ascertain if doctor’s views of the appropriateness of specific 
treatment(s) for the patient influenced the treatment(s) agreed 
(in)appropriate for the patient 
c) To elicit the family member’s perception of the communication that 
had taken place between the doctor and them 
d) To elicit the doctor’s perception of their communication with the 
patient’s family member(s)  
e) To compare family member’s and doctor’s perception of 
communication between them 
 
5.4 Methods 
Each family member (n=24) who took part in qualitative interviews (Chapter 
4) consented to complete a questionnaire evaluating the communication that 
had taken place between them and a doctor. Each senior doctor working on 
the stroke unit (n=9) [6 consultants, 3 registrars] who were involved in 
communicating with these family members completed two questionnaires 
(one prior to meeting with the patient’s family member(s) and one after).  
As described above, the questionnaires were completed based on a single 
meeting between the doctor and family member(s) where the patient’s 
diagnosis, prognosis and appropriateness of life extending treatment(s) were 
discussed. This meeting took place within the first two weeks of the patient’s 
admission to hospital with a major stroke (As described in Chapter 4). I 
handed out the questionnaires to the doctors once they informed me that a 
meeting was scheduled between them and a family member. I handed a 
questionnaire to each family member after their initial qualitative interview. 
(Chapter 4) Questionnaires were returned to me or the ward clerk in person 




The questionnaires were based on Likert type questions (where participants 
indicated their answer [one of five options] from strongly agree to strongly 
disagree). No composite score was calculated from the questionnaires. This 
was because, although the two main focuses of the questionnaires were to 
assess treatment preferences and communication, each question on the 
questionnaire tested different aspects and therefore, it would not have been 
possible to combine them to derive a total score to describe one domain. My 
supervisors and I designed these questionnaires based on what we thought 
would be clinically relevant and on evidence that Likert type questionnaires 
are useful in reporting self-reported outcomes such as quality of life (272), 
mood and fatigue (273) in several neurological conditions including stroke.  
I piloted the questionnaire to be completed by family members on ten family 
members and the questionnaire to be completed by doctors on five doctors 
on the stroke unit before the start of the study. Their feedback had indicated 
that Likert type questionnaires were suitable in this context. The doctors and 
family members who were involved in the questionnaire pilot did not 
participate in our study. 
The questionnaire completed by family members contained questions 
relevant to this chapter and my next chapter. To avoid an excessively long 
chapter, I have split my analysis of this questionnaire between two chapters.   
The statements in the questionnaires relevant to this chapter are as follows: 
To address aims (a) and (b):  
Prior to meeting with the patients’ family, doctors completed a questionnaire. 
For each patient, doctors indicated their views on the appropriateness of 
either introducing or continuing eight possible treatments for the patient: 
fluids, thrombo-prophylaxis (particularly, neurosurgery (particularly, 
hemicraniectomy), intermittent pneumatic compression [IPC]), enteral tube 




resuscitation [CPR], use of antibiotics for treatment of infections and end-of-
life care with prescription of medications to optimise comfort.  
Immediately after the meeting between the doctor and family member(s), I 
reviewed the patient’s notes to find out what was discussed and agreed as 
the most appropriate treatment plan for the patient. 
To address aims (c) to (e): 
Family members completed a questionnaire after the meeting between them 
and the doctor.  
The statements on this questionnaire relevant to this evaluation were: 
i) The explanation of the stroke was difficult to understand 
ii) The predictions of likely outcomes after stroke were clear 
iii) The decisions we made with the clinical team were 
appropriate 
iv) The meeting was very upsetting 
v) The information provided was sufficient 
Doctors completed a questionnaire after discussing patient diagnosis, likely 
prognosis and specific treatments with the patient’s family member(s). 
Statements in this questionnaire were:  
i) They understood the explanation of stroke I gave 
ii) They understood the information on prognosis I gave 
iii) They understood the choices we have about treatment 
iv) We agreed on the most appropriate care plan 
v) The meeting went as well as could be expected 
I then compared the answers provided by family members and doctors.  
Based on the small number of questionnaires, I present my findings 




To assess if there was a link between answers provided by family member(s) 
on these questionnaires and their position on the treatment decision 
spectrum (Explored with qualitative interviews in Chapter 4), I reviewed the 
responses of individual family members to the questionnaires in the context 
of treatment decisions that were made.  
5.5 Results 
Questions relevant to this evaluation were well completed. All 24 family 
members returned the questionnaire. Out of a total possible of 120 
responses (based on 5 questions, each with 5 possible responses), 114 
responses were received. All nine doctors returned the questionnaires they 
completed; i.e. two questionnaires for each meeting based on a total of 24 
meetings. All 48 questionnaires were fully completed. 
Out of the 24 meetings between nine different doctors and 24 different family 
members, 13 were conducted by consultants (A to F) and the other 11 (G to 
I) by registrars. As shown, there was a range of number of meetings 
conducted by each doctor (1 to 5 meetings each with the family member of 
24 different patients). (Table 5.1) 
Table 5.1 Number of family meetings conducted by each doctor, and their grades 
Doctor Grade Number of  family meetings 
A Consultant 3 
B Consultant 5 
C Consultant 2 
D Consultant 1 
E Consultant 1 
F Consultant 1 
G Registrar 4 




I Registrar 3 
 
a) To ascertain the doctor’s views regarding the appropriateness of 
specific treatment(s) for the patient  
(Prior to meeting with the patient’s family member(s)) 
Figure 5.2 Doctor’s view on appropriateness of specific treatments for the patient 
prior to meeting with the patient’s family member(s). 
  
As shown in Figure 5.2, all doctors had strong views on the 
inappropriateness of treatments such as neurosurgery, resuscitation (CPR), 
escalation and intermittent pneumatic compression (IPC) for the patient 
admitted with major stroke who lacked capacity. However, for treatments 
such as enteral tube feeding, fluids and antibiotics, doctors’ views were less 
strong.   
b) To ascertain if doctor’s views of the appropriateness of specific 
treatment(s) for the patient influenced the treatment(s) agreed (in)appropriate 
for the patient 
On review of the patient’s medical notes immediately after the meeting, I 
found that there was only one difference in opinion regarding 
appropriateness of treatment for the patient between a family member and 




inappropriate for the patient, but the family member had expressed that the 
patient would have wished for fluids to be given. In 12 and 17 meetings 
respectively, IPC and neurosurgery were not discussed in this meeting.  
c) To elicit the family member’s perception of communication that had taken 
place between the doctor and them 
Figure 5.3 Family members’ perception of communication between the doctor and 
themselves in the context of major stroke 
 
As shown in Figure 5.3, a few family members (n=3) found the explanation of 
stroke diagnosis difficult to understand. One family member did not think that 
the communication of prediction of likely outcomes after stroke was clear. 
However, nearly all (n=22) thought that information provided was sufficient 
and 23 out of 24 felt that appropriate decisions had been made for the 
patient.  
Ten family members indicated that they found the meeting very upsetting.  









Figure 5.4 shows the doctors’ perception of their communication with family 
member(s) based on the questionnaire they completed. 
Figure 5.4 Doctors’ perception of their communication with family member(s) 
 
Except in three instances, doctors indicated that they thought that family 
members understood the explanation of diagnosis they had given. Doctors 
also indicated that they thought all family members understood the 
information regarding prognosis and treatment choices that they had given 
and that appropriate treatment decisions had been made at the meeting. 
Overall, doctors indicated that communication between them and the family 
member(s) of the patient admitted with a major stroke had gone as well as 
they felt could be expected. 
e) To compare family member’s and doctor’s perception of 
communication between them 
In most instances, doctors and family members seemed to agree that 
communication between them had gone well. Since doctors and family 
members did not complete the same questionnaire, I was not able to make a 
direct comparison between the two.  
Here I have highlighted the few instances where there appeared to be a 
disagreement in perceptions. In brackets, I have indicated which doctor was 




individual doctors’ communication styles, disagreement may have occurred 
with one or two specific doctors.    
There were three instances where family members indicated that they found 
the explanation of stroke diagnosis difficult to understand, (meetings 
conducted by doctors D, G and H) but doctors involved in these discussions 
had thought that the family members had understood their explanation of 
stroke diagnosis. There was one instance where the family member indicated 
that the information about predictions was not clear (meeting conducted by 
doctor A). However, in all instances, doctors had thought that the family 
members had understood the information they had given on predictions of 
outcomes after stroke. One family member did not indicate a response on the 
questionnaire for the statement on appropriate treatment decisions having 
been made. Correspondingly, the doctor (G) conducting this meeting 
indicated a response of ‘neither’ on his/her questionnaire.  
Ten family members had indicated that the meeting was very upsetting for 
them; these meetings were conducted by various doctors; two by doctor A, 
two by doctor G and one each by doctors C, D, E, F, H and I.  
Reviewing responses in the context of family members’ position on the 
treatment decision spectrum (Chapter 4) 
The few (n=3) who indicated that the explanation of stroke diagnosis was 
difficult for them to understand, the one who did not find the communication 
of prediction of outcomes to be clear and those (n=10) who found the 
meeting to be very upsetting were generally family members where a 
decision had been made to withdraw treatments over time or where all 
treatments had been continued. This is not surprising given how these family 
members had described their shock and distress in the early period after the 
patient’s hospital admission with major stroke.  In the one instance where 
there was difference in opinion between the doctor and family member about 




patient may wish for all treatments to continue and was holding onto all hope 
for patient survival.   
5.6 Discussion 
5.6.1 Summary of results 
In these 24 patients who did not have mental capacity after major stroke, 
doctors did not think that treatments such as neurosurgery, escalation, IPC or 
CPR were appropriate for the patient. However, doctors did not have such 
strong views about treatments such as fluids, feeding or antibiotics for these 
patients. Doctors and family members mostly agreed on the (in) 
appropriateness of specific treatments for the patient. 
Based on a single meeting between doctors and family members, responses 
on questionnaires indicated that communication between them was largely 
satisfactory. In the few instances where there was a difference in perception 
or difference in opinion related to treatment, this was more likely associated 
with family members where  treatments were withdrawn over time or where 
all treatments had been continued (Reported in Chapter 4). These family 
members were also more likely to indicate the meeting between them and 
the doctor to be very upsetting. There were no discernible differences 
between meetings conducted by different individual doctors with respect to 
these findings.  
5.6.1.1 Doctor’s views on appropriateness of specific treatment(s) for 
the patient with a major stroke 
In most instances, there was agreement between the doctor’s views on 
appropriateness of treatments for the patient and that which was agreed with 
the patient’s family member at the meeting. This could be due to:  
a) For this group of patients, doctors and family members had similar views 
on (in) appropriateness of life extending treatments. As I reported in Chapter 
4, most family members had, from the outset, already accepted the patient’s 




pre-stroke. Independently, doctors may have also judged these patients to 
have poor prognosis (either with regards to survivability, quality of life, or 
both)   
b) Doctor’s own views regarding preferences of treatment for the patient may 
have affected the way in which they communicated with family members and 
therefore influenced the treatment decisions that were made.   
From my results, it is difficult to speculate which of the above (a) or (b) was 
more likely, if my results are likely to be a combination of both possibilities, or 
due to other possibilities which have not been recognised. 
The ethics of feeding and hydration is complex. (274) Family members have 
previously reported seeing nutrition and hydration as a basic form of 
nurturing for their dying relative (44) and have narrated distressing 
experiences of withdrawal of enteral nutrition and hydration.(275) This 
appears to be reflected in the range of views indicated by different doctors on 
the appropriateness of fluids and feeding for different patients with major 
stroke.  
Despite national guidelines recommending a shared decision-making 
approach when considering the use of IPC post stroke, (47,48) in many 
instances, this was not discussed with family members. This could be related 
to either one or a combination of three possibilities: a) a conscious decision 
by the doctor not to discuss a treatment that they felt to be inappropriate for 
the patient b) not being aware of the guideline; and/or c) a limitation of using 
a questionnaire based on a single meeting.(i.e. it is possible that the 
treatment was discussed at another meeting between the doctor and family 
member).  
5.6.1.2 Communication between doctors and family members in the 
context of major stroke 
Professional bodies such as the General Medical Council (GMC) emphasise 




arrive at appropriate treatment decisions. While I found that communication 
was largely satisfactory between doctors and family members, I also found 
some instances where communication of stroke diagnosis and of predictions 
may be improved. Existing recommendations from the GMC (44) and 
evidence from many other medical and surgical specialties (276–286) 
including stroke (103), indicate that doctors should consider, where 
appropriate, using tools to enhance communication between them and 
patients/families. This includes using visual aids, offering audio recordings 
and written information to those who may find this helpful to their 
understanding of diagnosis, prognosis and treatment options. I will report the 
views of family members regarding these communication aids in my next 
chapter (Chapter 6).  I will also report their views with respect to prognostic 
information in Chapter 6. 
Communicating realistic information with empathy may be helpful to family 
members who found the meeting between them and the doctor to be 
upsetting. (287) I discussed multiple communication strategies which could 
be considered by doctors in Chapter 4 e.g. ‘Hope for the best and prepare for 
the worst’ (255) and ‘I wish’ statements (e.g. I wish things were different). 
(255,256) The use of a ‘warning shot’ by doctors (247) may also help family 
members prepare for news that they may not have been expecting. The 
communication of uncertainty of stroke prognosis is also important. I will 
discuss this further in Chapter 9.  
5.6.1.3 The use of questionnaires to seek opinions of doctors and 
family members in the context of major stroke 
Strengths 
I decided to use questionnaires in this setting based on literature where 
questionnaires have been used to elicit people’s preferences for treatment 
(116,268,269). Likert type questionnaires have also been useful in reporting 
self-reported outcomes such as quality of life (272), mood and fatigue (273) 




questionnaires would be easy and quick to apply and results would be easy 
to present. Questionnaires also asked the same questions from all 
participants.  
Our questionnaires had a good response rate, indicating that family members 
and doctors found this as an acceptable method of providing their opinions 
and also, the areas explored were of potential importance to them.   
Limitations 
A small number of questionnaires were completed by doctors (n=9) and 
family members (n=24) from one hospital. The doctors were colleagues who 
worked in a single stroke service. Therefore, my results would not be 
generalizable to other settings.  
The questionnaires were completed based on one meeting between the 
doctor and family member(s). In reality, the patients’ medical condition may 
change over time and therefore, several discussions of prognosis and 
treatment options usually happen. Therefore, a questionnaire at one time 
point does not fully capture the situation.  
While it appeared that the position family members were on the treatment 
decision spectrum (Chapter 4) had a bearing on their answers in 
questionnaires, questionnaires constrain responses, do not allow clarification 
of responses and therefore, do not capture the reasons behind why certain 
responses were provided. 
In order to elicit useful responses from both family members and doctors, the 
design of the questionnaires were slightly different. This meant that I was not 
able to make any direct comparisons.  
As I described in the beginning of this chapter, I was not able to involve 
patients in this part of my study. Therefore, these results are not transferable 




5.7 Future considerations 
Questionnaires may be applied to a larger number of participants in different 
settings. Repeat questionnaires could be considered at different points during 
the patient’s hospital admission to capture changes in responses and 
treatment decisions.  
We may have gained more insight by observing (and recording) the meeting 
between doctors and family members and interviewing both parties while 
appreciating that different individuals may have different views and 
recollections of what was discussed at the meeting. By audio or video 
recording the meeting, I would be able to revisit the consultation to 
understand what was discussed at the meeting and how decisions were 
made. (288,289) Subsequently, qualitative interviews with doctors would 
allow a better understanding of why they expressed certain views on 
treatments, why they may not have discussed certain treatments and if, and 
how they felt their views regarding treatments and communication may have 
influenced treatments that were agreed for the patient. Qualitative interviews 
with family members, exploring communication between doctors and 
themselves would have given us context to which responses were provided 
in the questionnaires.  
Future studies should also endeavour to involve patients who have capacity 
after major stroke by using effective communication tools and strategies. I will 
discuss this in Chapter 9. 
The evaluation of shared decision-making using validated tools e.g. 
CollaboRATE should also be considered. (290,291)   
5.8 Summary 
Although communication between doctors and family members in this small 
group of participants seemed largely satisfactory, there were certain areas 
(particularly with the communication of diagnosis and predictions of 
outcomes) where communication may be improved. Doctors and family 




major stroke. While questionnaires had several strengths in this setting, their 
results are not generalizable based on their limitations.  
5.9 Next steps 
In my next chapter, I will report the opinions of family members on how 
communication may be improved between the doctor and themselves. I will 
focus on seeking their feedback on several aspects relating to 
communication of prognostic information and also on the use of 
communication aids to enhance communication between the doctor and 























Chapter 6 Presentation of information to 
family members in the early period 
after major stroke 
 
6.1 Acknowledgement of my contribution 
I analysed the relevant questions in the questionnaires I described in Chapter 
5. I performed the feedback exercise reported in this chapter. I wrote this 
chapter and made changes following comments from my supervisors. 
6.2 Introduction 
My findings in Chapter 5 indicate that, in the context of major stroke, certain 
aspects of communication between doctors and family members may be 
improved. In this chapter, I report the opinions of family members of patients 
admitted with major stroke (and who lacked capacity) on how they feel 
communication between the doctor and them may be improved. I obtain their 
opinions on four areas (related to various aspects of being provided with 
prognostic information and on the use of communication aids) using two 
methods: a) A questionnaire (Described in Chapter 5) completed after family 
member initial qualitative interviews. b) A verbal feedback exercise after their 
initial qualitative interviews.  
The flow diagram below (boxes coloured in yellow) indicates the part of my 




Figure 6.1 Study Schematic: Chapter 6 
 
I summarise relevant literature below:   
a) Format of presentation of prognostic information 
In Chapter 1, I noted how prognostic information presented in different 
formats may be useful to facilitate shared decision-making by patients and 
their families. (103–108) However, much of this evidence is reported based 
on patients in the outpatient setting who are less medically unwell when 
compared to major stroke inpatients. In Chapter 4, I reported how family 
members found information regarding the patient’s prognosis from doctors 
useful. Some had also said they wished they had been given information to 
better prepare for the possibility of the patient dying after major stroke. 
Knowledge of the best format in which information may be presented to 
family members could help doctors tailor their communication of information.  
b)  ‘Accuracy’ or ‘correctness’ of prognostic information 
I define prognostic ‘accuracy’ as the probability that, when a statistical model 
is used to make predictions of an outcome, patients predicted to have the 
outcome will truly have that outcome, i.e. the positive predictive value (PPV) 
of a statistical model. In Chapter 1, I described how doctors strive for 
excellent prognostic accuracy to facilitate shared decision-making. (102) 
Qualitative substudy















However, achieving this may not be possible, and an alternative may be to 
communicate prognosis at the ‘accuracy’ or ‘correctness’ patients and 
families wished for.  
c)  Information on specific abilities after major stroke 
In Chapter 1, I described how, in clinical trials, global scales of physical 
disability such as the mRs are used to report patient outcome after stroke. 
This does not take quality of life components into account. (292) In Chapter 
2, I showed how patients varied with respect to their specific abilities and 
HRQoL within the same mRs level. (i.e. two patients with the same mRs may 
differ with respect to their abilities to walk, talk and also rated their quality of 
life differently). Communication of prognosis by specific abilities may be more 
helpful to patients and family members for their understanding and/or to 
facilitate shared decision-making.   
d)  Tools to enhance communication between doctors and family 
members 
As reported in Chapters 1 and 5, the GMC encourages doctors to support 
discussions between them and patients or families by using written materials, 
visual aids and providing a written or audio record of the discussion and any 
decisions that were made. (44) This may be useful in the context of major 
stroke where many patients and families report feeling distressed and 
overwhelmed with the situation. (Chapters 3 and 4) Therefore, it is possible 
that they may not absorb much of the verbal information that is provided to 
them. (Chapters 3 and 4) 
Similar to Chapter 5, this chapter is based on opinions from family members 
only. This is because patients were overwhelmed and distressed having 
received a diagnosis of major stroke. (Chapter 3) Hence, I was unable to 





To obtain the opinions of family members of patients admitted with major 
stroke (and who lacked capacity) on:  
a) The format in which prognostic information should be presented to 
them  
b) How accurate prognostic information should be  
c) Whether information regarding specific abilities after stroke (as 
described in Chapter 2) [e.g. to be independent, to walk, to be 
continent, to live without major anxiety or depression, to live at home] 
would be helpful to them 
d) If additional tools such as visual aids, audio recordings and written 
information may be useful to enhance communication between them 
and the doctor. 
6.4 Methods 
Family members (n=24) who took part in qualitative interviews (Chapter 4) 
and completed a brief questionnaire (Chapter 5) were invited to provide 
verbal feedback on (a) to (d) above. As I described in Chapter 5, I split the 
analysis of this questionnaire between two chapters.  
6.4.1 Questionnaire 
I described the questionnaire completed by family members in Chapter 5. 
The relevant questions/ statements to this chapter are:  
a) Easiest format of presentation of prognostic information to understand  
b) Hardest format of presentation of prognostic information to understand  
c) Predictions are unhelpful in making decisions about treatments  
d) I will be pleased to have an audio recording of the meeting  
e) Written information will be helpful  
Questions relating to the format of presentation of prognostic information (a 
and b) were ‘best of three’, where family members chose one answer from 




on existing literature (Described in my discussion below) and expert opinion 
of stroke doctors in the hospital where recruitment took place. Questions c to 
e were Likert-type questions and participants indicated their response from a 
range of ‘strongly disagree’ to ‘strongly agree’. Since each question 
addressed different domains, a composite score was not calculated. All 
statements except (c) were hypothetical.  
Due to the small number of questionnaires, I report my results descriptively 
and by using tables and figures. 
6.4.2 Verbal feedback 
I asked family members who took part in qualitative interviews and completed 
a questionnaire a series of more structured questions at the end of their initial 
interviews. All questions were hypothetical.  
I detail these questions below:  
a) Format in which prognostic information should be presented  
I showed family members an example of the different formats in which 
prognostic information may be presented (words, pictures and bar chart) 
and asked them which was easiest for them to understand. I pre-warned 
them that some of these formats may be distressing to them and that they 
could refuse to view this information or provide their opinions. I 
specifically iterated that the information presented was not intended to be 




Figure 6.2 Example of formats in which prognostic information may be presented for 
‘able to walk at 6 months’ 
  
 
b) How accurate prognostic information should be  
I asked how correct or accurate (probability that individuals predicted to have 
an outcome will truly end up with that outcome) they thought prognostic 
information should be to inform their understanding and/or facilitate decision-
making. I asked them to offer their answers in percentages. I interpreted their 
answer as the PPV of a statistical model.  
c) Their thoughts on information regarding specific abilities after 
major stroke  
I asked family members what they thought about being given predictions of 
specific abilities (e.g. to walk, to talk, to eat) after a major stroke and if this 
may be helpful to their understanding and/or to facilitate decision-making. 
d)  Their views on additional tools to enhance communication such as 
visual aids, audio recordings and written information  
I explained that the tools I was seeking their opinions about were intended to 
enhance verbal communication between doctors and themselves, rather than 
being used as a substitute. 
I asked family members their opinions about doctors showing them a picture 











opinions on pictures detailing how the stroke could have resulted in specific 
impairments or pictures showing specific abilities (e.g. being able to walk, or 
living at home). I also asked them for their opinion on being provided with an 
audio recording of the communication (of patient diagnosis, prognosis and 
treatment options) between the doctor and themselves. I asked if they would 
listen to this audio recording again, or share it with other people (family 
members or friends). I also asked if providing them with a written record of 
information (e.g. leaflet or printed copy of relevant diagnosis, prognosis and 
treatment options) would be useful to them.  
I present their opinions using relevant quotes. Where possible, I have listed 
the number of family members providing their opinions in each of the 
categories within brackets.  
I also reviewed the responses of individual family members in the 
questionnaires and verbal feedback exercise in the context of their position 
on the treatment decision spectrum (reported in Chapter 4). 
6.5 Results 
6.5.1 Analysis of questionnaires  
As I reported in Chapter 5, all questionnaires (n=24) were returned. For the 
statements relevant to this chapter, 29 responses (out of a total possible of 
120) were obtained. (Table 6.1) 
 











Easiest format of 
presentation of 
prognostic information to 
understand 





Hardest format of 
presentation of 
prognostic information to 
understand 
24 2 One graphs, one 
picture 
Predictions are unhelpful 
in making decisions 
about treatments 
24 20 10 strongly 
disagreed   
7 disagreed   
2 agreed  
1 strongly 
agreed 
I will be pleased to have 
an audio-recording of the 
meeting 
24 2 1 agreed 
1 disagreed 
Written information will be 
helpful 




6.5.2 Verbal feedback 
a) The format in which prognostic information should be presented  
I found that different family members expressed their preference for 
prognostic information to be presented in different formats. About a third 
(n=7) said that they wished this information presented to them in ratios or 
percentages, a further third (n=8) preferred pictorial representation, very few 
liked a bar chart (n=2) and the rest (n= 7) wished prognostic information to be 
communicated to them in ratios or percentages in words, without any visual 
representations.  
i) Wish for information to be presented in different formats 
‘I think you have to make sure that materials are there for people…don’t want 
to be bombarded with too many facts and figures but maybe want to have 
something to look at and like a graph or something like that [pointing to a 
picture], that represents it in a fairly simple way because you maybe got 
enough things going on in your mind.’ 
 
ii) A pictorial representation 
‘Yeah.  It’s really good.  I think it was a bit of a shock, as well, though.. kind 





. ‘I think if I’d shown pictures with little diagrams on it like that I think I’d would 
be treated like an idiot. Just speak to me, you know.’  
 
iii) Information in ratios 
 ‘I think ratios, you know, one in five, one in ten.  Well, I would understand 
it better than looking at the pictures.’ 
 
b) How ‘correct’ prognostic information should be  
More than half of the family members (n=13) reported that they did not think 
prognostic information could be 100% correct. When I asked these family 
members to offer a percentage level of prognostic accuracy, around half of 
them (n=6) reported that predictions that were around 50% correct would be 
sufficient to their understanding of the situation or to facilitate decision-
making: 
‘I think fifty per cent would be fine.  I mean, you can’t say with 100 per cent 
certainty what’s going to happen, so there’s no point in expecting it’.  
 
‘I would think I would like it to be, like, 50 per cent accurate, at least, you know, 
before we can make decisions based on that’.  
 
Another third of family members (n=8) described wishing for predictions that 
were 80% correct and above: 
 ‘I think 80 per cent is a good percentage or upwards.  Anything less is 
basically giving you false hope.  But 80 per cent is… it’s more than half, so 
you know that it’s not going to be totally like that, but you know there’s going 
to be certain aspects that it will be like that, you know. Then you can make 
decisions.’  
In contrast, a quarter of family members (n=6) described their wish for very 
‘correct’ predictions (above 90%) to help their understanding of the situation:  
‘Ninety or a hundred per cent; so we need to be quite certain about what’s 






c) Information regarding specific abilities after stroke  
Some family members (n=7) reported that the prediction of specific abilities 
would be useful to their understanding of the situation, and might even guide 
decision-making.  
 ‘Well, I think there are one or two things that are really most prominent in the 
decisions for me; incontinent and can’t swallow, those are the two main 
things.  I think she (referring to her mother) could put up with being immobile 
and maybe needing help with that but not even being able to enjoy food 
or…you know, that would be no use at all; it’s not a quality of life, I wouldn’t 
have thought, that she would want to endure’.  
 
d) If additional tools such as visual aids, audio recordings and written 
information may be useful to enhance communication between 
them and the doctor. 
 
i) Visual aids  
Many (n=19) family members reported that the doctor had shown them 
the brain scan of their family member (the patient) who was admitted with 
major stroke. Of these family members, over 80% of families (n=17) found 
viewing brain scans of the patient useful to understand the diagnosis and 
likely prognosis and reported that this assisted them in decision-making 
regarding treatments. Another five (who were not shown the brain scan of 
the patient) said that they would find viewing the brain scan useful to their 
understanding of the situation of likely poor prognosis. 
‘At first I felt as though …I wasn’t pressing hard enough for treatment.  But in 
actual fact when the young man showed me the scan and spoke about the 
likelihood of anything, it was clear there was really nothing more to be done.  
So I did feel as though I got a proper understanding of the prognosis.’  
 
‘ Looking at the scan on the computer. That was dead helpful.  It let me 
understand where the massive bleed has happened. Let me understand now 




deep it is.  …you know, when they’re saying ‘massive bleed’, you don’t know 
where.  But seeing it actually on the computer like that, it did help me…’  
 
Nearly two thirds of family members (n=15) described that they would find 
the use of pictures to explain how the stroke had resulted in specific 
impairments (e.g. inability to walk) helpful to understand the situation.  
‘The thing is, as well, none of our family have ever had a stroke.  My mother’s 
the first that’s had a stroke.  So we’ve got no idea about strokes at all. Rather 
than trying to explain something.  You show them a picture, it’s easier for you 
to……look at a picture and say, well, I can see that.  Because where you are 
just now, you’re not in a nice place.  So your mind’s not working right.  But if 
somebody was showing you a picture, you would be able to easier relate…’  
In contrast, few (n=2) family members suggested that viewing pictures might 
be too upsetting for them, especially at a time when they may be feeling 
overwhelmed with the situation.   
‘No; I think that would be quite frightening; wouldn’t need to see that.  … 
couldn’t be bothered to look at that.’ 
ii) Audio recording 
Roughly two thirds (n=14) of family members reported that they might find an 
audio recording of the consultation between the doctor and them useful. Most 
of these family members (n=12) said that they would listen to this again; 
mainly to clarify and ponder the information but also to consider questions 
they may not have raised at the time when they may have been feeling upset 
and overwhelmed: 
‘I think that would be an excellent idea because I was probably overly 
anxious about what had happened and how much I absorbed... I can’t fully 
remember everything said.  I had far too much else running through my mind.  
it would be good to go back over something.  And also, my sister, we share 
the care of my mum, but she lives in [place deleted], so, you know, for me to 
try and repeat everything that Dr [name deleted] had said would be 
impossible’.  
 
However, around a third of family members (n=8) felt that an audio recording 




rather speak to the doctor if they wished for clarifications: 
 
‘No, I wouldn’t listen back to it.  I think once I’d heard what I’d heard and ask 
what I’d wanted to ask; just an understanding, kindly face at a time when 
you’re just looking at somebody in a bed who is going to die is probably much 
better than anything external, like audio’.  
 
iii) Written information 
Around a third (n=7) reported they might find written information useful, as it 
would be a record of what was said at the consultation with the doctor at a 
time when they may not have fully considered all of the information as they 
were in shock from having received the diagnosis:  
 
‘It’s extremely useful because it’s enough of a shock to find that someone’s 
had a stroke to then remember everything that the doctor has been saying to 
you.  So to have written information with diagram of things like the brain and 
where the stroke has been and what parts of the brain affect which bits of the 
body I think is very useful.’ 
 
In contrast, around a half of family members (n=13) said they did not think 
written information would be of any help to them.  
 
‘I’m not in a state, I’m actually too tired to think straight, I think that reading 
stuff – won’t take it in.  Sitting down and reading something I would find quite 
daunting.’   
6.5.2.1 Reviewing feedback provided by family members with respect 
to treatment decisions made 
Family members’ responses in the questionnaire and feedback that they 
provided seemed to be related to their position on the treatment decision 
spectrum (Chapter 4) 
Responses in questionnaire 
Those who strongly disagreed or disagreed with the statement on predictions 
being unhelpful were mostly family members who had felt that the patient 






Many family members, who had felt that the patient would have chosen not to 
initiate life-extending treatments from the outset reported that predictions that 
were around 50% correct would be sufficient and they did not seem to have 
strong views on receiving information on specific abilities or using tools to 
enhance communication.  
The family members who were in the middle of the treatment decision 
spectrum (i.e. who felt that the patient would have chosen to withdraw 
treatments over time), asked for predictions which were at least 80% correct 
to guide their understanding and/or facilitate decision-making. They reported 
that prediction of specific abilities would be helpful to their understanding of 
prognosis and/or to guide decision-making, and that tools such as audio 
recordings and written information would be useful to their understanding of 
diagnosis and prognosis. 
Those family members at the other end of the treatment decision spectrum 
(i.e. who felt that the patient would have wished for all treatments to continue) 
did not express strong views on prognostic information or on tools to 
enhance communication.  
Regardless of their position on the treatment decision spectrum, different 
family members reported preferring prognostic information to be presented in 
different formats. Viewing brain scans seemed to have a beneficial impact on 
peoples’ understanding and in many cases, this allowed them to come to 
terms with poor prognosis and acceptance that life-extending treatments may 
not be appropriate for the patient.  
6.6 Discussion 
My results indicate that information would need to be tailored to suit different 




Format of presenting prognostic information 
In-keeping with existing literature which I described in Chapter 1, 
(109,110,112,114) I also found that different formats of presenting prognostic 
information may be appealing to different individuals.  For instance, graphs 
and pictures, including bar charts, icon arrays and using people images, may 
be helpful to the understanding of some individuals. (110,293–295)However, 
others may find this distressing. Therefore, my results further support 
guidelines recommending information to be personalised depending on 
individual preferences. (29) 
Information on specific abilities after major stroke given at different 
accuracies 
Prediction of specific abilities after major stroke may be useful to some family 
members (specifically those in the middle of the treatment decision 
spectrum). . Predictions that are at least 80% accurate has been suggested 
by these family members to be useful to them to guide their understanding, 
and/or to facilitate decision-making.  
However, the majority of family members who felt that the patient would have 
chosen not to initiate treatments from the outset (Chapter 4) reported that 
predictions which were 50% accurate may be enough for them to confirm 
their understanding of poor prognosis and support a treatment preference 
that had previously been expressed by the patient. Others wished for higher 
predictive accuracies to facilitate decision-making (i.e. 90% and above). 
A statistical model which can provide predictions of specific abilities after 
major stroke at different accuracies may be useful for the communication of 
prognosis. I will describe the development and validation of new statistical 
models predicting various specific abilities after major stroke at PPVs chosen 





Tools to enhance communication 
In stroke, several visual aids (computerised and written) have been 
developed. (190) However, many of these have been tested in the outpatient 
setting, rather than in the early period after a major stroke.(294,296,297)  
The difficulty of using tools to complement verbal communication in the early 
period after stroke is that decision-making is challenged by time limitations. 
The need to engage patients (if appropriate) and families and convey 
knowledge in the context of the shock and effects of stroke is challenging. 
(293)  One tool that has been successfully used in the acute stroke setting is 
a computerised decision aid for stroke thrombolysis (COMPASS) tool. This 
contains visual representations of information and has been shown to 
improve the understanding of families and patients of the risks and benefits 
of thrombolysis. (293) My findings also indicate that visual representations of 
information (especially viewing brain scans) may be appealing to many family 
members. Therefore, a communication tool incorporating pictorial 
representations of information could be useful to some. I will describe this 
further in Chapter 9.  
There is also a wide range of evidence supporting the use of other tools to 
enhance doctor-patient communication. As I reported in Chapters 1 and 5, 
the GMC encourages health professionals to support discussions between 
them and patients or families by using written materials, visual aids and also 
giving a written or audio record of the discussion and any decisions that were 
made. (44) There is a wide range of published literature in intensive care 
(276), paediatrics (277) and stroke (103) on the benefits of providing written 
information to people. The use of audio recordings to aid understanding and 
information recall has also been reported in many medical specialties 
including oncology, (279,280) paediatrics (281–283), cardiac 
surgery,(284,285) orthopaedic surgery (286) and primary care.(278) My 
findings indicate that some family members may find these tools useful.    




I found that statements relating to prognosis and communication aids were 
poorly completed in our questionnaire. This is in contrast to statements 
relevant to communication which were well completed (Chapter 5). This poor 
response rate could be due to a variety of reasons:  
i) Since most family members had already accepted the likely poor 
prognosis of the patient (Chapter 4), the most plausible explanation 
would be that the questions were not seen as relevant by family 
members.  
ii) Forcing an answer for statements that were either irrelevant, or 
required some thought, may have been unacceptable to family 
members  
iii) Most statements were hypothetical; therefore, family members may 
have found it more difficult to provide answers to statements that 
had not been provided to them in ‘real time’ by the doctor 
6.6.1 Limitations  
The questionnaire and verbal feedback exercise did not capture the context 
in which the opinions were provided. No concrete conclusions can be drawn 
from the evaluation of (the very few) responses provided on the relevant 
statements in the questionnaire.  
Most opinions (excluding viewing brain scans) were based on hypothetical 
scenarios. I may have obtained more considered and thoughtful responses if 
doctors had presented ‘real time’ information using visual aids, had used 
different formats of prognostic information to communicate prognosis, offered 
audio recordings or given written information to family members.  
I had not anticipated that there may be a link between the position of family 
members on the treatment decision spectrum and the opinions on 
information presentation that they provided. In hindsight, qualitative 




We did not use a validated measure of evaluating shared decision-making 
between family members and doctors e.g. using CollaboRATE. (290) 
As I described in Chapter 5, patients were not involved in this part of my 
study and therefore, my results are not transferable to patients who had 
capacity after major stroke. 
6.7 Summary 
Information would need to be tailored to each individual’s preferences. The 
communication of specific abilities after major stroke may be useful to some 
family members to understand the consequences of major stroke and/or to 
facilitate shared decision-making. Tools to enhance communication (e.g. 
visual aids, audio recordings and written information) may be useful to some.   
6.8 Next steps 
In Chapter 2, I showed that patients admitted with major stroke varied with 
respect to their specific abilities. In this chapter, I reported that some family 
members found communication of specific abilities helpful to their 
understanding and/or to facilitate decision-making. I also reported that 
different individuals wished for prognostic information at different accuracies 
(which we defined as PPVs). Based on my findings, in my next chapter, I will 
describe the development and validation of new statistical models to predict 















Chapter 7 Predicting specific abilities after 
major stroke: development and 
validation of prognostic models 
7.1 Publication status  
I wrote this chapter following comments from my supervisors. I edited the 
chapter (in length and layout) to submit for publication. A paper from this 
chapter is under consideration with ‘The International Journal of Stroke.’ 
7.2 Acknowledgement of my contribution 
I developed the concept of model development and validation with my 
supervisors. We then involved our statistician to help develop statistical 
models to predict several specific abilities after major stroke.  
I was involved in looking at trial datasets, deciding which datasets were 
appropriate for development of the models, then reviewing potential predictor 
variables and outcomes of interest, in deciding how and why to select 
patients from the trials to be included in our development cohort, in 
discussions on how predictor variables could be standardised when defined 
differently in different trials, in discussions on which predictor variables 
should be included in our models, and why and how models may be 
improved.  
I then externally validated the developed models in our cohort of patients with 
major stroke (Described in chapter 2).  
7.3 Introduction 
In Chapter 2, I found that patients with major stroke varied with respect to 
their specific abilities. Therefore, I reported that describing prognosis by 
specific abilities may be appropriate. Qualitative interviews (Chapter 4) 
suggested that communication of prognosis was important to family members 
and in some cases, to facilitate shared decision-making. In Chapter 6, I 
reported that some family members would find information on specific 




(50%, 80% and 90%) helpful. Based on these findings, in this chapter, I 
describe the development and validation of new models predicting some 
specific abilities after major stroke. I report the performance of the models at 
PPVs (50%, 80% and 90%) chosen by family members (Chapter 6).  
We chose to develop and validate prognostic models for the following six 
specific abilities at six months after major stroke: i.e. to a) be independent, b) 
walk, c) talk without major problems, d) eat normally e) live without major 
anxiety or depression and f) live at home. We were not able to develop 
models to predict three other abilities we judged to be of importance to 
patients and family members (to be continent, to live without major cognitive 
problems and to live without severe pain) (Chapter 2). This was because the 
former two outcomes were not available in the development datasets we 
used. Due to time constraints, we were unable to develop and validate a 
model to predict the latter (to live without severe pain). 
We chose to predict abilities rather than disabilities based on my findings 
(Chapter 3) which indicated that majority of patients looked for hope and 
positive information from doctors after major stroke. (119)  
I reported in chapter 2 that different measures could be used to report the 
same specific ability (e.g. smRsq, BI and EQ5D to report ‘to walk’). However, 
in our development dataset (which I will describe below), the choice of using 
different measures was not available and therefore, we were restricted to the 
measures we had available to us. We dichotomised outcomes based on 
opinion of stroke professionals in the hospital where recruitment of our 
longitudinal cohort (chapter 2) took place. To agree a standardised approach 
towards defining specific abilities, we would ideally have conducted an online 






7.4.1 Model development 
7.4.1.1 Description of the development dataset 
We built a development dataset comprising selected patients who had 
participated in large randomised controlled trials (FOOD 1, 2 and 3, CLOTS 
1, 2 and 3 and IST3) coordinated from our department in Edinburgh. 
(34,36,298) 
We chose these trials because, between them, we knew they had 
baseline variables which are likely to be of predictive value (described below) 
and had the outcome variables of the specific abilities we were interested in 
predicting. The population, which were trial-based cohorts, had data collected 
prospectively, and therefore, of high quality. Furthermore, we had easy 
access to this data which was stored on the University of Edinburgh servers.   
FOOD (Feed Or Ordinary Diet) was a multicentre international 
randomised trial evaluating feeding policies in patients admitted to hospital 
with a recent stroke. (36) A total of 5033 patients were enrolled in the three 
trials which evaluated different feeding policies between November 1996 and 
July 2003. While FOOD 1 recruited patients who could swallow, FOOD 2 and 
3 recruited dysphagic patients within 7 days and 30 days after hospital 
admission respectively. Patients could be recruited into more than one FOOD 
trial. 
CLOTS (Clots in Legs Or sTockings after Stroke) tested external 
compression devices (e.g. graduated compression stockings and intermittent 
pneumatic compression) for prevention of deep venous thrombosis in acute 
stroke patients. (34) A total of 8228 patients were recruited into three trials 
examining the effect of different compression devices versus standard care 
between March 2001 and September 2012. All eligible patients were 




IST3 (The third International Stroke Trial) assessed the benefits and 
harms of intravenous thrombolysis with recombinant tissue plasminogen 
activator within six hours of acute ischaemic stroke.(298) 3035 patients with 
ischaemic stroke were randomly allocated within six hours to intravenous 
alteplase plus standard care or standard care alone. Patients were recruited 
between May 2000 and July 2011. 
The inclusion criteria and outcome measurements from each of these 





Table 7.1 Inclusion criteria and outcome measurements of each trial included in our development dataset 
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Within 7 days Within 30 
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All the trials had different permissible timings to recruitment. We excluded predictive 
variables that were collected after 3 days as the resulting models might not be 
relevant to our aim of making early predictions when there are opportunities to 
influence decisions regarding life-extending treatments. (Described in Chapter 1) 
Therefore, we decided to include patients who were recruited between days 0 and 3 
(inclusive) of hospital admission after stroke.  
The proportions of patients from each trial (FOOD, CLOTS, IST3) who were 
recruited within 0-3, 4-7 and > 7 days of admission are shown in Table 7.2. There 
was a total of 16576 patients recruited into these trials. We included 13117 (79.1%) 
patients recruited into these trials in our development dataset (i.e. those recruited 
within days 0-3). Although patients may be recruited to more than one FOOD trial, 
patients who contributed to more than one FOOD trial were only included once within 
our development dataset. 
Table 7.2 Proportions of patients in each trial based on timing from admission to recruitment 
  0-3 Days 4-7 Days >7 Days Missing Total 
n % n % n % n 
FOOD 1854 36.8 1744 34.7 1434 28.5 1 5033 
CLOTS 8228 96.7 275 3.2 5 0.1 1 8508 
IST 3035 100.0 0 0.0 0 0.0 0 3035 
ALL 13117 79.1 2019 12.2 1439 8.7 2 16576 
 
7.4.1.2 Definition of outcomes 
As described in Chapter 1, outcomes to be predicted should be clinically important 
and collected with good interrater reliability. (299–302) I chose to predict the 
probability of six specific abilities important for stroke patients, their family members 
and the providers of their health care: to be independent, to walk, to talk without 
major problems, to eat normally, to live without major anxiety or depression and to 
live at home. We had data on four of these specific abilities (to be independent, to 
walk, to live without major anxiety or depression and to live at home) from all of the 
trials. For predicting the ability to talk without major problems, data were only 




the FOOD trials. Table 7.3 shows the data available for model development for each 
specific ability. 
Table 7.3 Data available, and used for developing models for each specific ability 
Specific abilities 
at six months 
Total number (n) n excluded 
(Missing values)  





13117 244 12873 (98.1) 
To walk 13117 460 12657 (96.5) 
To talk without 
major problems 
(IST3 only) 
3035 414 2621 (86.4) 
To eat normally 
(FOOD only) 
1854 10 1844 (99.5) 
To live without 
major anxiety or 
depression 
13117 485 12632 (96.3) 
To live at home 13117 415 12702 (96.8) 
 
Outcomes can be predicted at fixed and clinically relevant points in time. (301) We 
predicted specific abilities at six months because all the major trials making up our 
development cohort consistently reported outcomes at six months.  
We dichotomised our outcomes at six months based on judgement of stroke 
professionals in the hospital where recruitment of our validation cohort took place 
(Chapter 2). As described in Chapter 2, we report ‘good’ and ‘poor’ outcomes as a 
shorthand. 
Table 7.4 shows the measures or scales used to measure specific abilities at six 
months, and the dichotomies we used. As described above, (and unlike in our 
longitudinal cohort which I described in Chapter 2, where several measures could 
have been used to define a specific ability), there was only one scale/measure that 




Table 7.4  The measures/ scales used to report specific abilities at six months, and 
dichotomies used to define ‘good’ and ‘poor’ outcomes: development cohort 
Specific abilities 
at 6 months 
Measure/ Scale Good outcome Poor outcome 
To be 
independent 
OHS 0-2  3-6 
To walk EQ5D 3L No problems 
Some Problems 
Confined to bed 
Dead 








To eat normally Specific question* 
(FOOD only) 
Normal Nose tube 
Side tube 
Dead 
To live without 
major anxiety or 
depression  
















*options given and dichotomised as shown 
7.4.1.3 Selection of predictor variables 
Predictor variables entered into prognostic models must be easy to collect with good 
inter-rater reliability. (300–302) The number of variables used must be carefully 
controlled.(303) For example, too few variables may mean that important predictors 
are excluded (underfitting), whilst too many variables can result in overfitting (i.e. 
inclusion of apparently important predictors which are not actually independent 
predictors; equivalent to a Type 1 error) and paradoxical fitting (where, a variable 




in the model e.g. older age might be found to increase the probability of survival 
whereas in reality, it might decrease it).  
The risk of overfitting, underfitting and paradoxical fitting decreases as the Events 
Per Variable (EPV) increases, especially with EPVs over 10. (302,304–306) The 
EPV is the ratio of the number of outcome events in the dataset per variable entered. 
For a dichotomous variable, the EPV is based on the event with the smaller number 
of outcomes. For example, if we wish to find predictors of ‘being independent’ using 
a sample in which there are 60 patients who are independent and 100 who are 
dependent, we can study no more than 6 (=60/10) predictor variables. However, this 
rule has been questioned. (307) 
There are multiple ways by which variables may be added: (i) A ‘forward step-wise’ 
approach (299,308) where the predictor variable that has the strongest (most 
statistically significant) association with outcome is identified and entered first, with 
then the variables not included in this one variable model re-analysed and entering 
the next variable which explains the largest amount of remaining variability. This 
process continues until none of the variables that have been left out of the model are 
associated with the outcome at some predefined level of statistical significance 
(usually probability of less than 0.05). At each step after a new variable has been 
added to the model, the variables already in the model are re-examined to establish 
whether they still have a significant association with the outcome (defined by a Wald 
statistic with a probability of less than 0.1). If the significance of the Wald statistic is 
greater than or equal to 0.1, then that variable is removed from the model. This 
process continues until all variables in the model are significant. (ii) A ‘backward’ 
approach where all the identified variables are initially introduced and then variables 
are withdrawn one by one, till the overall prediction does not deteriorate. (309) In a 
stable model (i) and (ii) should give the same results. If the results obtained are 
different, then there may be an inter-relationship between some variables and the 
model would be considered unstable. (iii) Variables are forced into the model 
because they have been shown to be good predictors of certain outcomes in other 
contexts.  
We identified nine potential predictive variables that were common to all the trials 




[age, pre-stroke functional status, living alone pre-stroke, being able to walk unaided 
post stroke, lift both arms off the bed post stroke and have a normal verbal Glasgow 
Coma Score post stroke], gender, being diabetic and being overweight*. As I 
reported in Chapter 1, SSVs have been widely studied. I will describe this in detail 
below. We tested the addition of extra variables (gender, being diabetic and being 
overweight) to the SSVs using a ‘backward’ approach. We found that the addition of 
extra variables to SSV did not change the AUCs (Area under the receiver operating 
curve) of our models.   
*(Note: The question: ‘Is overweight?’ was asked in different ways in the different 
trials, so to make a comparison, we combined their responses. (In CLOTS, ‘Is 
overweight’ was a yes/no answer. In FOOD, ‘Is obese’ was a yes/no answer. In 
IST3, Male>90kg or female >80kg were considered overweight). 
SSV  
The SSV models were developed from a community based cohort of stroke patients 
(Oxford Community Stroke Project) who presented up to 30 days post stroke. (91) 
The three models predict survival at 30 days, independent survival at 6 and 12 
months following stroke, and ability to live at home at 6 and 12 months after stroke. 
Each of these models have incorporated the SSVs but have different coefficients as 
they predict different outcomes. The model predicting independent survival at six 
months has been validated in those presenting within 2 days of stroke (100) and in 
the hyper-acute stroke phase (101) for stratification in randomised trials. (24) SSVs 
have also been used to adjust for case mix when comparing the quality of hospital 
based stroke services (310) and in data collection for national audit purposes. (98) 
While five of the six simple variables are strong predictors of independent survival 
(100), the variable ‘living alone pre-stroke’ was originally incorporated in the models 
to predict whether someone would be alive and living at home at six months and a 
year after stroke (311) and has been shown in studies to not be predictive of death 
(311) or of independent survival. (312) The SSV model has been shown to have 
similar discrimination to more complex models including the 11 item NIHSS and age 





We used SSVs only as the predictor variables in our models. This was because, a) 
As reported above, the discrimination of the models with or without the addition of 
extra variables to the SSV were the same b) we were interested in predicting specific 
abilities after stroke which relied on the patient surviving and the SSVs have been 
shown to be a good predictor for survival (91)  c) The SSV model includes three 
variables (living alone pre-stroke, ability to walk after stroke and normal verbal 
response on GCS score after stroke) which are closely related to three of the specific 
abilities we wished to predict at six months (to live at home, to walk and to talk 
without major problems) d) As reported above, the SSV has been validated for use 
(in clinical trials) in the acute and hyper-acute stroke settings and we wished to make 
early predictions after stroke (101) d) the variables are clinically relevant and easily 
collected (93) and e) these variables were common to all trials making up our 
development cohort and our validation cohort (described below). 
7.4.1.4 Data quality 
Analysis was conducted on the final versions of the trial datasets, following any 
cleaning determined necessary by the trial teams. Missing values were recorded. We 
checked six month outcomes for consistency e.g. If a patient or proxy had indicated 
‘confined to bed’ in response to the EQ5D-3L dimension on mobility, then they 
should not have OHS 0-2. We excluded any misclassifications. 
7.4.1.5 Statistical techniques 
We used multivariate logistic regression to develop all our models using SSV. We 
used SAS 9.4 (a statistical package developed by the SAS institute, 2013).  
7.4.1.6 Checking our models 
We examined what happened to the models when we made assumptions based on 
baseline variables e.g. If a patient could walk at baseline, then we assumed he/she 
would still be able to walk at six months. We found this to have no effect on the 
AUCs of our models.  
7.4.2 Validation 
Validation is the process of evaluating the performance of a model.(299) Two 




In internal validation, part or all of the dataset on which the model was developed is 
used to test model performance. However, testing a model on the dataset that it was 
developed from usually produces an optimistic view of the model’s performance. 
This is because biases in patient selection or data collection are not accounted 
for.(300) 
External validation is required before a model may be assessed fit for use in clinical 
practice.(304) External validation means assessing the performance of a model 
when applied to an independent dataset. This independent dataset is one that 
should ideally be collected by different investigators in a different location at a 
different time to the development dataset.  
The two aspects of looking at a model’s performance are discrimination and 
calibration. Discrimination is the ability of the model to separate individuals who 
develop the outcome of interest from those who do not. (303,314) It is quantified by 
calculating the area under the receiver operating characteristic curve (AUC) of 
sensitivity versus 1 minus specificity.(100) An area of 1 implies a test with perfect 
discrimination whilst an area of 0.5 implies that the model’s predictions are no better 
than chance. I report the 95% confidence intervals of the AUCs.  
I assessed the calibration of the model. This is an assessment of whether predicted 
probabilities in groups of patients having an outcome were the same, higher or lower 
than those observed. (303,314) I plotted calibration curves of the proportion of 
patients in our validation cohort who actually had a good outcome against the 
proportion predicted by the model (in tenths of predicted probability of a good 
outcome). A model is well calibrated if the points on the graph follow a 45 degree line 
from the origin (i.e. the predicted and observed probabilities are the same). The 
vertical distance between the points and the diagonal indicates how optimistic or 
pessimistic the predictions are.  
Based on my results from Chapter 6, I also performed cross tabulations of predicted 
versus actual outcomes for each outcome at varying PPVs (50%, 80%,90%). This 
allowed me to estimate the proportion of the patients who could be given a prediction 




We assessed internal validation by reporting discrimination of our models in the 
whole development dataset. I externally validated our models in an independent 
cohort of patients with major stroke. (Described in chapter 2)  I used Stata 15 
(Timberlake, 2017) for external validation.  
7.4.2.1 Dataset for external validation 
I described the recruitment and follow-up of our longitudinal cohort of patients with 
major stroke (n=403) in detail in Chapter 2. Briefly, I recruited patients from a tertiary 
teaching hospital in the United Kingdom between 10th May 2017 and 25th May 2018 
between days 0 and 10 after stroke. I followed up patients to around six months to 
assess their specific abilities. Only one patient was lost to follow up.  
The measures/scales and dichotomies that I used to allow comparisons to be made 
between our development and validation cohorts is shown in Table 7.5. There were 
some differences in measures/scales used between our development and validation 
cohort. For example, while the trials in our development cohort all used OHS to 
report functional outcome (to be independent), I used mRs measured by the smRsq. 
However, these scales (OHS and mRs) are very similar and therefore, we 






Table 7.5 Measures/scales and dichotomies to define specific abilities, comparing development and validation cohorts. 
 Development 
cohort 




abilities at 6 
months 




Measure/Scale Good outcome Poor outcome 
To be 
independent 
OHS  0-2  3-6 mRs (via 
smRsq) 
0-2 3-6 










Unable or  
Dead 
To talk 








































without  major 
anxiety or 
depression 















































The characteristics and specific abilities at six months of all 13117 patients in our 
development cohort on whom models were developed and 403 patients in our 
validation cohort on whom the models were externally validated are given in Table 
7.6.  
The mean age of patients in our validation cohort was around 3 years older than our 
development cohort (77.5 and 74.7 respectively). Fewer patients in our validation 
cohort were independent before stroke (76.4% versus 92.6%). At six months, fewer 
in our validation cohort were independent (14.9% versus 29.0%), able to walk 
(48.1% versus 59.1%) and able to live at home (54.1% versus 59.3%). (Table 7.6) 
Note: all percentages are rounded to 1 decimal place and the number who died have 










Table 7.6 Baseline characteristics and specific abilities at six months of patients in each trial (FOOD, CLOTS, IST3) and in combination to form our 
development cohort and our validation cohort. 













Six simple variables 
(91) 
     
Age; mean (standard 
deviation) 
72.7 (12.5) 77.3 (12.2) 74.2 (12.1) 74.7 (12.3) 77.5 (11.8) 
Independent before 
stroke, n (%) 
1663 (89.7) 3018 (99.4) 7468 (90.8) 12149 (92.6) 308 (76.4) 
Living alone before 
stroke 
518 (27.9) 1129 (37.2) 2809 (34.1) 4456 (34.0) 158 (39.2) 
Lift arms after stroke 847 (45.6) 1351  (44.5) 3247 (39.5) 5445 (41.5) 152 (37.8) 
 
Able to walk after 
stroke 





Normal verbal score of 
Glasgow Coma Scale 
1199 (64.7) 1615 (53.2) 5455 (66.3) 8269 (63.0) 248 (61.5) 
Other characteristics      
Gender      
     Male 970 (52.3) 1465 (48.3) 4031 (49.0) 6466 (49.3) 179 (44.4) 
     Female 884 (47.7) 1570 (51.7) 4197 (51.0) 6651 (50.7) 224 (55.6) 
Specific abilities at six 
months (measure/ 
scale) 
     
Disability 
(OHS or mRs) 
     
      0 158(8.5) 254(8.4) 280(3.4) 692 (5.3) 8 (2.0) 
      1 268(14.5) 429(14.1) 626(7.6) 1323 (10.1) 45 (11.2) 
      2 283(15.3) 405(13.3) 1104(13.4) 1792 (13.7) 7(1.7) 
      3 339(18.3) 428(14.1) 1716(20.9) 2483 (18.9) 149 (37.0) 
      4 189(10.2) 255(8.4) 950(11.5) 1394 (10.6) 46 (11.4) 
      5 224(12.1) 449(14.8) 1417(17.2) 2090 (15.9) 36 (8.9) 





     Missing 9 (0.5) 0(0.0) 235(2.9) 244 (1.9) 1 (0.3) 
To be independent 
(mRs/OHS) 
     
     mRs/ OHS 0-2 709 (38.2) 1088 (35.8) 2010 (24.4) 3807 (29.0) 60 (14.9) 
     mRs/ OHS 3-6 1136 (61.3) 1947 (64.2) 5983 (72.7) 9066 (69.1) 342 (84.9) 
     Missing 9 (0.5) 0 (0.0) 235 (2.9) 244 (1.9) 1 (0.2) 
To walk (EQ5D)      
No problems/ some 
(slight/ moderate) 
problems 
1274 (68.7) 1797(59.2) 4684(56.9) 7755 (59.1)  194 (48.1) 
Severe problems/ 
unable 
187 (10.1) 286 (9.4) 1330 (16.2) 1803 (13.7) 97 (24.1) 
Dead 384 (20.7) 815 (26.9) 1900 (23.1) 3099 (23.6) 111 (27.5) 
Missing 9 (0.5) 137 (4.5) 314 (3.8) 460 (3.5) 1 (0.3) 




  N=3035 (IST3 
ONLY) 
 
No major problems 
(No dysphasia/ mild to 
moderate dysphasia) 








NA 474 (15.6) NA 474 (15.6) 13 (3.3) 
Dead NA 815 (26.9) NA 815 (26.9) 111 (27.5) 
Missing NA 414 (13.6) NA 414 (13.6) 1 (0.3) 
To eat normally    N=1854 (FOOD 
ONLY) 
 
Normal/ oral modified 1409 (76.0) NA NA 1409 (76.0) 286 (71.0) 
Tube (side/ nose/ 
percutaneous) 
51 (2.8) NA NA 51 (2.8) 4 (1.0) 
Dead 384 (20.7) NA NA 384 (20.7) 111 (27.5) 
Missing 10 (0.5) NA NA 10 (0.5) 2 (0.6) 
To live without major 
anxiety or depression 
(EQ5D) 
   N=13117 (ALL)  
None/ some (slight/ 
moderate) 
1312 (70.8) 1869 (61.6) 5499 (66.8) 8680 (66.2) 252(62.5) 





Dead 384 (20.7) 815 (26.9) 1900 (23.1) 3099 (23.6) 111 (27.5) 
Missing 14 (0.8) 161 (5.3) 310 (3.8) 485 (3.7) 1 (0.3) 
 To be able to live at 
home  
     
 Own home/ relatives 
home 
1222 (65.9) 1757 (57.9) 4798 (58.3) 7777 (59.3) 218 (54.1) 
Hospital/ care home/ 
residential 
239 (12.9) 366 (12.1) 1221 (14.8) 1826 (13.9) 72 (17.9) 
Dead 384 (20.7) 815 (26.9) 1900 (23.1) 3099 (23.6) 111 (27.5) 
Unknown/ other 
uncategorised* 
0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.3) 
Missing 9 (0.5) 97 (3.2) 309 (3.8) 415 (3.2) 1 (0.3) 









7.5.1 Developed models 
The parameter coefficients, odds ratios (OR) and corresponding 95% 
confidence intervals (CI) for each predictor variable are shown in Table 7.7. 
The OR gives the strength of the relationship between the predictor variable 
and outcome of interest. For example, for the model predicting ‘to be 
independent’, a patient who was able to walk after their stroke had a 4.13x 
increased odds of being independent at six months when compared to a 
patient who was not able to walk after their stroke.  Age has been modelled 
as a continuous variable: the odds ratios presented are the odds per one 
year increase in age. The 95% CI indicates whether the relationship between 
the predictor variable and outcome of interest is statistically significant. If the 
CI does not cross or include 1.0, then the relationship is significant. For 
example, for the variable ‘able to walk after stroke’ in the model predicting ‘to 
be independent’, 95% CI does not cross 1.0, indicating that the relationship 
between ‘able to walk after stroke’ and independence is statistically 
significant.  
Positive parameter coefficients imply that patients are more likely to have a 
‘good’ outcome and a negative parameter implies that patients are less likely 
to have a ‘good’ outcome. For predicting independence, all predictor 
variables excluding age had a positive parameter coefficient. So, younger 
patients were more likely to be independent.   
Table 7.7 Coefficients, odds ratios and 95% CI for each predictor variable predicting 
specific abilities at six months. 
Logistic regression 
model for : 
Parameter 
coefficient (SE) 
Odds ratio (95% CI) 
To be independent   
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Living alone 0.10(0.05) 1.10(1.00-1.21) 
Normal Glasgow Coma 
Scale verbal score 
0.80(0.05) 2.22(2.00-2.46) 
Able to lift arms 1.41(0.05) 4.11(3.75-4.50) 
Able to walk 1.42(0.09) 4.13(3.47-4.91) 
Age -0.04(0.002) 0.97(0.96-0.97) 
 
To walk   
Constant 3.61 (0.19)  
Independent before 
stroke 
0.77 (0.08) 2.17 (1.85-2.55) 
Living alone -0.07 (0.05) 0.93 (0.85-1.02) 
Normal Glasgow Coma 
Scale verbal score 
0.93 (0.04) 2.53 (2.32-2.76) 
Able to lift arms 1.43 (0.05) 4.19 (3.81- 4.60) 
Able to walk 1.12 (0.14) 3.06 (2.34-4.00) 
Age -0.07 (0.002) 0.94 (0.93-0.94) 
To talk without major 
problems 
  





Living alone 0.02(0.09) 1.02(0.85-1.23) 
Normal Glasgow Coma 
Scale verbal score 
1.43(0.09) 4.16(3.48-4.98) 
Able to lift arms 0.98(0.09) 2.66(2.19-3.22) 
Able to walk 0.64(0.15) 1.90(1.42-2.53) 
Age -0.03(0.004) 0.97(0.96-0.98) 
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To eat normally   




Living alone -0.05(0.14) 0.95(0.72-1.26) 
Normal Glasgow Coma 
Scale verbal score 
1.18(0.13) 3.25(2.52-4.19) 
Able to lift arms 0.92(0.15) 2.52(1.88-3.37) 
Able to walk 0.95(0.27) 2.58(1.53-4.34) 
Age -0.06(0.01) 0.95(0.93-0.96) 
To live without major 
anxiety or depression 
  




Living alone -0.03(0.04) 0.97(0.89-1.06) 
Normal Glasgow Coma 
Scale verbal score 
0.76(0.04) 2.14(1.96-2.32) 
Able to lift arms 0.76(0.05) 2.14(1.95-2.34) 
Able to walk 0.65(0.12) 1.92(1.53-2.41) 
Age -0.04(0.00) 0.96(0.96-0.97) 
To live at home   




Living alone -0.50(0.04) 0.61(0.56-0.67) 
Normal Glasgow Coma 
Scale verbal score 
0.89(0.04) 2.43(2.23-2.65) 
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Able to lift arms 1.02(0.05) 2.78(2.53-3.04) 
Able to walk 1.04(0.12) 2.83(2.22-3.60) 
Age -0.071(0.002) 0.93(0.93-0.94) 
 
7.5.2 Internal validation 
The AUCs for the models were good. (AUCs 0.72 -0.81) (Table 7.8) 
Table 7.8 Internal validation: Area under the curve (AUCs) of models in development 
dataset 
Model for specific ability AUC* (95% CI) 
To be independent 0.79 (0.78-0.80) 
To walk 0.81 (0.80-0.81) 
To talk without major problems 0.79 (0.77-0.81) 
To eat normally 0.81 (0.78-0.83) 
To live without major anxiety or 
depression 
0.72 (0.71-0.73) 
To live at home 0.80 (0.79- 0.81) 
*Area under the curve 
7.5.3 External validation 
7.5.3.1 Discrimination 
The Area under the curves (AUCs) of our models are shown in Table 7.9. 
Our models had AUCs 0.78 to 0.84. However, the 95% CI were wide.  Figure 









Table 7.9 Area under the curves (AUCs) of externally validated models 
Specific abilities  Area under the curve (AUC) 
(95%CI) 
To be independent 0.84  (0.79 to 0.89) 
 
To walk 0.80 (0.76 to 0.84) 
To talk without major problems 0.80 (0.76 to 0.85) 
To eat normally 0.83 (0.79 to 0.87) 
To live without major anxiety or 
depression 
0.78 (0.73 to 0.83) 
 To live at home 0.82 (0.78 to 0.86) 
 




Figure 7.1 ROC curves for specific abilities at six months (external validation): (A) To 
be independent (B) To walk (C) To talk without major problems (D) To eat normally( E) 
To live without major anxiety or depression (F) To live at home 
 
7.5.3.2 Calibration 
The calibration curves for each specific ability are shown in Figure 7.2  
Four out of our six models for specific abilities (to walk (B), to eat normally 
(D), to live without major anxiety or depression (E) and to live at home (F)) 
were well calibrated. The model for ‘to be independent’ (A) was optimistic in 
predicting the outcome, but especially so in the middle of the range of 
predicted probabilities of good outcome (i.e. 0.3 to 0.6).The model for ‘to talk 
without major problems’ was pessimistic, especially in the lower predicted 
probabilities of a good outcome. Although it looks as though the first two 
tenths have the same predicted probability of a good outcome (but different 
observed outcomes), the predicted probabilities of the first two tenths are 
different. (Table 7.10)  




Figure 7.2 Calibration curves for specific abilities (A) to be independent (B)  to walk (C)  to talk without major problems (D)  to eat normally 
(E) to live without major anxiety or depression (F)  to live at home (Red lines represent each patient with (1) or without (0) the outcome 
 
















Table 7.10 Predicted probability of a good outcome for first two tenths for the model 
‘to talk without major problems’. 
Specific ability Tenth Predicted 








To talk without 
major problems 
1st  3.42x10-7 (5.72x10-8) 3.21x10-7 
(2.72x10-7 to 
4.54x10-7) 




7.5.4 Performance of models at PPVs 50%, 80% and 90% 
Based on my findings in Chapter 6, here, I report the performance of our 
developed and validated models at varying PPVs (50%, 80%, 90%). (Table 
7.11)  






50% 80% 90% 
To be Independent  Cut-point  0.307  0.51  0.72  
 Sensitivity  53.3 40.0 15.0 
 Specificity 90.9 98.5 99.7 
 NPV 91.7 90.4 87.0 
 Correctly 
classified 
85.3 89.8 87.1 
To walk Cut-point 0.12  0.745  0.80 
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 Sensitivity 99.5 41.2 27.3 
 Specificity 6.7 90.4 97.1 
 NPV 93.3 62.3 58.9 
 Correctly 
classified 
51.5 66.7 63.4 
To talk without major 
problems 
Cut point* NA 0.545 0.73 
 Sensitivity 100 80.2 72.3 
 Specificity 0 56.5 82.3 
 NPV 0 56.0 57.0 
 Correctly 
classified 
69.2 72.9 75.4 
To eat normally Cut point** NA 0.425 0.79 
 Sensitivity 100 92.0 70.3 
 Specificity 0 44.0 81.0 
 NPV 0 68.9 52.5 
 Correctly 
classified 
71.1 78.1 73.4 
 To live without major anxiety 
or depression 
Cut point*** NA 0.57 0.884 
 Sensitivity 100 81.0 15.9 
 Specificity 0 66.0 97.3 
 NPV 0 67.4 40.8 
 Correctly 
classified 
62.7 75.4 46.3 
To live at home Cut-point NA  0.65 0.824 
 Sensitivity 100 60.6 38.5 
 Specificity 0.0 82.1 95.1 
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 NPV NA 63.7 56.6 
 Correctly 
classified 
54.2 70.4 64.4 
*worse PPV possible is 69.2% **Worse PPV possible is 71.1% ***worse PPV 
possible is 62.7% 
The numbers and percentages of patients who could be given a prediction of 
a good outcome at six months after major stroke (i.e. having a specific ability) 
at these PPVs are in Table 7.12 to Table 7.29.   
For example, at PPV 50% for predicting independence (Table 7.12), in our 
validation cohort, we could inform 63/402 (15.7%) patients that they had a 
50:50 chance of being independent at six months. This model had a 
specificity of 90.9% but a sensitivity of 53.3%. (Table 7.11) At PPV 80% for 
predicting independence (Table 7.13), we could inform 29/402 (7.2%) 
patients that they had an 80% chance of being independent at six months. 
This model had a specificity of 98.5% but a sensitivity of 40.0%. At PPV 90% 
for predicting independence (Table 7.14), we could inform 10/402 (2.5%) 
patients that they had a 90% chance of being independent at six months. 
This model had a specificity of 99.7% but a sensitivity of 15.0%.  
Table 7.30 summarises the numbers and percentages of patients/families 
who could be given a prediction of a good outcome of a specific ability at 
varying PPVs.  
For each specific ability, the proportion of patients and their families in our 
validation cohort who could be given a prediction at a PPV varied. For 
example, at 80% PPV, 29/402 (7.2%) patients/families could be informed that 
they had an 80% chance of being independent but 327/402 (81.5%) 
patients/families could be informed that they had an 80% chance of being 
able to eat normally. Also, fewer patients/families could be given a prediction 
of a specific ability at higher PPVs. For example, for predicting the ‘ability to 
walk’, at 90% PPV, 59/402 (14.7%) patients/families could be informed that 
they had a 90% chance of being able to walk at six months. However, at 50% 
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PPV, 387/402 (96.3%) patients/families could be informed that they had a 
50% chance of being able to walk at six months. 
For some specific abilities (to talk without major problems, to eat normally, to 
live without major anxiety/depression and to live at home), I could not report 
the models performances at 50% PPV. The lowest PPV possible (where 
sensitivity of the model is 100% and specificity is 0%) is shown in Table 7.11. 
Table 7.12 Number of patients/families who could be given a prediction of ‘to be 






Predicted Good Poor Total 
Good 32 31 63 
Poor 28 311 339 
Total 60 342 402 
 
Table 7.13 Number of patients/families who could be given a prediction of ‘to be 






Predicted Good Poor Total 
Good 24 5 29 
Poor 36 337 373 
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Table 7.14 Number of patients/families who could be given a prediction of ‘to be 






Predicted Good Poor Total 
Good 9 1 10 
Poor 51 341 392 
Total 60 342 402 
 
Table 7.15 Number of patients/families who could be given a prediction of ‘to walk’ at 
six months at positive predictive value of 50% 
To walk  Actual   
Predicted Good Poor Total 
Good 193 194 387 
Poor 1 14 15 
Total 194 208 402 
 
Table 7.16 Number of patients/families who could be given a prediction of ‘to walk’ at 
six months at positive predictive value of 80% 
To walk  Actual   
Predicted Good Poor Total 
Good 80 20 100 
Poor 114 188 302 
Total 194 208 402 
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Table 7.17 Number of patients/families who could be given a prediction of ‘to walk’ at 
six months at positive predictive value of 90%  
To walk  Actual   
Predicted Good Poor Total 
Good 53 6 59 
Poor 141 202 343 
Total 194 208 402 
 
Table 7.18 Number of patients/families who could be given a prediction of ‘to talk 








Predicted Good Poor Total 
Good 278 124 402 
Poor 0 0 0 
Total 278 124 402 
 
Table 7.19 Number of patients/families who could be given a prediction of ‘to talk 







Predicted Good Poor Total 
Good 223 54 277 
Poor 55 70 125 
Total 278 124 402 
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Table 7.20 Number of patients/families who could be given a prediction of ‘to talk 







Predicted Good Poor Total 
Good 201 22 223 
Poor 77 102 179 
Total 278 124 402 
 
Table 7.21 Number of patients/families who could be given a prediction of ‘to eat 






Predicted Good Poor Total 
Good 286 115 401 
Poor 0 0 0 
Total 286 115 401 
 
Table 7.22 Number of patients/families who could be given a prediction of ‘to eat 







Predicted Good Poor Total 
Good 263 64 327 
Poor 23 51 74 
Total 286 115 401 
 




Table 7.23 Number of patients/families who could be given a prediction of ‘to eat 







Predicted Good Poor Total 
Good 201 21 222 
Poor 85 94 179 
Total 286 115 401 
 
Table 7.24 Number of patients/families who could be given a prediction of ‘to live 
without major anxiety/depression’ at six months at positive predictive value of 62.7% 
(lowest possible PPV) 





Predicted Good Poor Total 
Good 252 150 402 
Poor 0 0 0 
Total 252 150 402 
 
Table 7.25 Number of patients/families who could be given a prediction of ‘to live 
without major anxiety/depression’ at six months at positive predictive value of 80% 





Predicted Good Poor Total 
Good 204 51 255 
Poor 48 99 147 
Total 252 150 402 
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Table 7.26 Number of patients/families who could be given a prediction of ‘to live 
without major anxiety/depression’ at six months at positive predictive value of 90% 





Predicted Good Poor Total 
Good 40 4 44 
Poor 212 146 358 
Total 252 150 402 
 
Table 7.27 Number of patients/families who could be given a prediction of ‘to live at 
home’ at six months at positive predictive value of 50% (closest possible is 54.2%) 
To live at 
home  
Actual   
Predicted Good Poor Total 
Good 218 184 402 
Poor 0 0 0 
Total 218 184 402 
 
Table 7.28 Number of patients/families who could be given a prediction of ‘to live at 
home’ at six months at positive predictive value of 80% 
To live  at 
home  
Actual   
Predicted Good Poor Total 
Good 132 33 165 
Poor 86 151 237 
Total 218 184 402 
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Table 7.29 Number of patients/families who could be given a prediction of ‘to live at 
home’ at six months at positive predictive value of 90%  
To live at 
home  
Actual   
Predicted Good Poor Total 
Good 84 9 93 
Poor 134 175 309 
Total 218 184 402 
 
Table 7.30 Summary of the number and percentages of patients who could be given a 
prediction of having a specific ability at six months at different PPVs. 
N=402 except *n=401 PPV      
 50%  80%  90%  
Specific ability at six months N % N % N % 
To be independent 63 15.7 29 7.2 10 2.5 
To walk 387 96.3 100 24.9 59 14.7 
To talk without major problems 402 100 277 68.9 223 55.5 
To eat normally* 401 100 327 81.5 222 55.4 
To live without major 
anxiety/depression 
402 100 255 63.4 44 10.9 
To live at home 402 100 165 41.0 93 23.1 
7.6 Discussion  
7.6.1 Summary of main results 
We have developed and externally validated statistical models to predict six 
specific abilities after major stroke and reported their performance at PPVs 
chosen by family members of patients with major stroke. In an independent 
cohort of patients with major stroke, all six models had good discrimination, 
and four out of six models calibrated well (models predicting ‘to walk’, to eat 
normally’, ‘to live without major anxiety or depression’ and ‘to live at home’). 
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There is a trade-off between being able to provide patients and families with 
predictions which have a high probability of being correct and the number of 
patients/ families able to receive these predictions. 
7.6.2 Strengths 
The models were developed based on variables (SSV) that are easy to 
collect with good inter-rater reliability (93,100) and most are good predictors 
of survival.(100) The development cohort had patients with a wide range of 
characteristics (based on individual inclusion criteria for the different trials), of 
varying stroke severities and very large numbers of patients (n=13117). 
Since our development cohort was obtained from patients in large trials, data 
collection had a standardized approach, was collected by many persons over 
time with minimal losses to follow up.(23,36,298,315) There was no overlap 
of investigators or patients between the development and validation cohorts. 
Models developed using patients recruited into trials between days 0-3 
performed well in an independent cohort where patients were recruited 
between days 0-10, suggesting that the models are flexible. 
7.6.3 Limitations 
Our development cohort was not designed for the purpose of predicting 
specific abilities after stroke. Therefore, certain baseline variables which may 
have been better predictors of certain specific abilities (e.g. previous history 
of anxiety or depression as a predictor for anxiety or depression at six 
months) were not available. 
The relatively poor discriminatory power (compared to our other models) of 
the model predicting anxiety and depression may be because these two 
different diagnoses have different predictors and hence predicting them in 
combination is difficult. Anxiety may be more evident in younger patients 
(316) and those with milder strokes (317), whereas depression may be more 
likely in  older patients (318,319) and those with greater functional 
dependence as a result of a major stroke.(319–321) Therefore, predicting 
anxiety and depression separately using different predictive variables may be 
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more likely to correctly identify those who would not have major problems 
with either at six months. We were unable to do this as this outcome in our 
development cohort was reported based on the EQ5D where anxiety and 
depression are considered as one entity. 
Relative to our development dataset, our validation cohort of 403 patients 
was small, hence the estimates of AUC and their 95% CI were wide. Ideally, I 
would have recruited a larger cohort of patients with major stroke in order to 
achieve tighter CI around the estimates. However, I was limited by the length 
of my fellowship. The validation cohort was also recruited from a single site.  
Different measures/scales were used to measure specific abilities at six 
months in the development and validation cohorts. As I described, for 
example, while the trials used the Oxford Handicap Scale (OHS) to report 
patient functional status, I used the modified Rankin scale (mRs) measured 
by the simplified modified Rankin questionnaire (smRsq) in my validation 
cohort. Ideally, I would have used the same measures/scales to report 
outcomes in our validation cohort as that used in our development cohort. 
As I described in Chapter 2, using different measures/ scales to report an 
outcome would give us different results. I showed in Chapter 2 how using 
smRsq, BI and EQ5D-5L to report ‘to walk’ at six months gave us slightly 
different results. Ideally, we would have used a measure/scale that reports 
outcomes more consistently (e.g. smRsq rather than BI or EQ5D to report ‘to 
walk’). However, in our development dataset, we did not have this choice and 
were restricted to using assessments that were consistently reported by the 
trials (EQ5D to report ‘to walk’ in this case).  
The cut-offs we chose for dichotomising ‘good’ and ‘poor’ outcomes were 
based on judgements of stroke professionals and we acknowledge that 
different individuals would have different perceptions of ‘good’ and ‘poor’ 
outcomes. Using different cut-offs would give us different results.  
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The different casemix of patients within our development cohort and between 
our development and validation cohorts could account for the modest 
performance of our models. Our development cohort consisted of patients 
with very different inclusion and exclusion criteria being recruited into the 
three different groups of trials (FOOD, CLOTS and IST3). Our validation 
cohort was an observational cohort of patients with major stroke, who, in 
comparison to patients in our development cohort (where patients with less 
major strokes were not excluded), generally had poorer outcomes with 
respect to some abilities (e.g. being independent) at six months.  
These differences could account for our model predicting ‘to be independent’ 
being optimistic. However, the reason for the predictions being optimistic in 
the middle of the range of predicted probabilities of a good outcome is 
unclear.  
Although the model predicting ‘able to talk without major problems’ had 
reasonable discrimination (AUC 0.80), the confidence intervals were wide 
(0.76-0.85). The predictions from this model were particularly pessimistic in 
the lower range of predicted probability of good outcome. This could be 
related to the differences in characteristics between patients recruited into 
IST3 and our validation cohort. Of note, the first two tenths of predicted 
probabilities of a good outcome were both close to zero, though the groups 
had different observed outcomes. A plausible explanation for this could be 
related to the coefficient and confidence interval for the predictor variable 
‘Independent before stroke’. As shown in Table 7.7, the coefficient for this 
predictor variable was large (13.3) and confidence interval was very wide. 
This indicates that being independent before stroke had a large weighting on 
speech outcome, with those dependent before stroke having a very low 
likelihood of having a good outcome for speech after stroke. 99.4% of 
patients in our development cohort (participants in IST3 trial) were 
independent before stroke compared with 76.4% in our validation cohort. 
Therefore, 95 patients (23.6%) were dependent before stroke in our 
validation cohort. According to our model, these patients have a very low 
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likelihood of a good outcome with respect to their speech. However, in-
keeping with my findings in Chapter 2 where I reported that patients in the 
same mRs level could have different specific abilities, this model shows that 
patients who were ‘dependent’ may still have different observed specific 
abilities (‘to talk without major problems’ in this case).  
Although the models predicting ‘able to eat normally’ and ‘to live without 
major anxiety/ depression’ both discriminated and calibrated well in the 
validation cohort, it is possible that much of this may be attributable to the 
models’ abilities to predict survival rather than these specific abilities. As 
shown in Table 7.6, there was a relatively larger proportion of patients who 
had died when compared to having major problems with eating normally or 
living with major anxiety/ depression. I will explore this in Chapter 8.  
7.6.4 Predictions at different PPVs   
There is a trade-off between the PPV and the proportion of patients who can 
be given a prediction at that PPV. There is uncertainty about how well the 
family members who suggested these ‘accuracies’ understood the question 
in the feedback exercise. (Chapter 6) Once some of our models have been 
further evaluated (particularly those which calibrated well in our cohort of 
major stroke patients), it is possible that predictions from these models may 
be used to improve understanding of prognosis and facilitate shared 
decision-making regarding treatments. As I reported in Chapter 6, predictions 
at a PPV of 50% may be sufficient for family members who had already 
accepted poor patient prognosis and where the patient’s treatment 
preference on not initiating life-extending treatments was known.  Predictions 
at 80% and 90% PPVs may be useful for family members where patient 
preferences were not clear at the outset. Since patients and some family 
members looked for hope and positive information (Chapters 3 and 4), it is 
also possible that, when predictions are given at a time when these 
individuals may be receptive to such information, the knowledge that the 
patient may have a 50%, 80% or 90% probability of having a specific ability 
(i.e. a ‘good’ outcome) at six months may offer them the hope they were 
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looking for and even help them prepare for the consequences of major 
stroke. As I described in Chapter 2, there is variation within each mRs level 
of patient’s specific abilities; and therefore, the possibility of having a specific 
ability at six months (e.g. being able to speak) may be enough for some 
patients and families to consider patient preferences for life-extending 
treatments. 
Our models are able to provide predictions at accuracies that are quantifiable 
(i.e. 50%, 80% or 90%). Therefore, they would be able to provide more 
consistent predictions between different doctors. If predictions from our 
models are found to be at least as good as a senior stroke physician’s 
professional judgement, doctors (especially those more junior) may be able 
to use these models as a ‘sense check’ of their judgement of the patient’s 
prognosis before approaching patients or family members to discuss 
prognosis. This requires our models to be evaluated further. 
7.7 Conclusions 
We have developed and externally validated six prognostic models to predict 
specific abilities six months after major stroke. All the models had good 
discrimination in an independent cohort of patients with major stroke and four 
out of six models calibrated well. At PPVs chosen by family members, there 
is a trade-off between the PPV and the proportion of patients/families who 
can be given a prediction at that PPV. Further evaluation of models which 
calibrated well (i.e. models predicting specific abilities to walk, to eat 
normally, to live without major anxiety or depression and to live at home) is 
required before they may be used to provide prognostic information to family 
members in the context of a major stroke. This may include further external 
validation in larger independent cohorts of patients with major stroke and 
assessing if predictions from the models are at least as good as those of 
experienced stroke physicians. 
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7.8 Implications for future work 
There is also potential to evaluate, and perhaps enhance, the performance of 
these models. For example we could:   
a)  Examine how much of the models discriminatory power is derived 
from their prediction of survival versus the prediction of the patient’s specific 
ability. All our models have been developed to predict survival and a specific 
ability (e.g. survival and to talk without major problems). In order to assess 
how much of the model’s discrimination is attributable to its ability to predict 
survival versus the specific ability, we would need to examine the 
performance of models developed and validated in cohorts where only 
surviving patients are included.  
b)  Explore if adding some additional baseline variables and data on 
progress (e.g. patient treatment and complications in the early period after 
stroke, change in functional abilities) may improve predictions.                        
I will explore these possibilities in Chapter 8.   
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Chapter 8 Exploring how predictions of 
specific abilities after major stroke 
may be improved 
8.1 Acknowledgement of contributions 
I performed all the analysis contained in this chapter. I wrote this chapter and 
made changes following comments from my supervisors. 
8.2 Introduction 
Following on from my findings in Chapter 7, in this chapter, I will:   
a) Examine the ability of our models (Described in Chapter 7) to predict 
specific abilities at six months after major stroke in cohorts of survivors 
to establish how much our models are predicting a specific ability as 
distinct from survival.   
b) Explore in models developed from our longitudinal cohort (described in 
Chapter 2) if the addition of some variables to SSV may improve 
predictions of some specific abilities at six months.  
For example, the addition of the following baseline variables 
(described in Chapter 2) to predict the following specific abilities:  
i) Charlson comorbidity index and independence  
ii) Marital status and ‘to live without major anxiety/ depression’  
iii) Current pet ownership and ‘ to live without major 
anxiety/depression’  
iv) Gender and ‘to live without major anxiety/depression’ 
v) Urinary continence and ‘to live at home’. 
The addition of variables on patient progress to predict independence 
at six months. For example, 
vi) Patient complications and treatments by early follow up 
vii) Change in BI between baseline and early follow up, reflecting 
change in patient functional status 
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I will describe my reasoning, methodology, analysis and results within 
each section below.  
8.2.1 The ability of our models (Described in Chapter 7) to 
predict specific abilities as distinct to survival    
8.2.1.1 Reasoning:  
As I described in Chapter 7, it is possible that, for some models, much of the 
discrimination of our models were attributable to the model’s ability to predict 
survival rather than the specific ability. Therefore, to assess this, I will 
describe how we developed and validated models predicting specific abilities 
including only surviving patients (at six months) in both our development and 
validation cohorts.  
8.2.1.2 Method: 
We tried to remove all patients who had died by six months from both our 
development and validation cohorts. However, for some specific abilities (to 
be independent, to walk, to live at home), in our development cohort, 
between 70 and 75 patients had completed their follow up assessments 
before their six month follow up date but had died by six months. These 
patients were not excluded. For ease of reporting, I describe our 
development cohort in this chapter as that containing surviving patients only 
at six months (n=10018). We anticipate that the inclusion of 70-75 extra 
patients may not greatly affect our results. 
We then repeated the process described in Chapter 7 of developing and 
validating models; i.e. we used SSV to develop models from large trial data 
(FOOD, CLOTS, IST3) to predict six specific abilities at six months after 
major stroke using multivariable logistic regression. I externally validated the 
models in our cohort of patients with major stroke who had survived to six 
months (n=291). (Described in Chapter 2) 




I will report the parameter coefficients, odds ratios and 95% CI of each 
predictor variable in these models. I will report the discrimination and 
calibration of these models.  
Table 8.1 summarises the data available for developing models for each 
specific ability in survivors, compared to that for all patients.   
 
Table 8.1 Data available, and used for developing models for each specific ability from 
























13117 10018 244 12873 9846*  

















13117 10018 485 12554  9533 
To live at 
home 
13117 10018 415 12702 9677*** 
*72 extra patients **71 extra observations***74 extra observations 
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The measures/scales and dichotomies that I will use to allow comparisons to 
be made between our development and validation cohorts are shown in 
Table 8.2. I reported this in Chapter 7. The difference here is that those 
patients who had died by six months in both our development and validation 
cohorts have been excluded from our dichotomy of ‘poor’ outcome. (With the 
exception of 70-75 patients for some specific abilities as described above) 
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Table 8.2 Measures/scales and dichotomies; comparing development and validation cohorts of surviving patients at six months only 
 Development 
cohort 









Measure/Scale Good outcome Poor outcome 
To be 
independent 
OHS 0-2  3-5  smRsq 0-2 3-5 
To be able 
to walk 


































































































*Question asked, options given and dichotomised to good and poor outcome




8.2.1.4 Results:  
The specific abilities of surviving patients in our development (n=10018) and 
validation cohorts (n=291) are shown in Table 8.3. As shown, once patients 
who had died by six months were excluded from our development and 
validation datasets, for some specific abilities, the number of outcome events 
was very low. For example, only 51 (3.5%) were tube fed (based on surviving 
patients from FOOD trials). 
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Table 8.3 Specific abilities at six months of surviving patients in development and validation cohorts. 
Specific abilities at six months (scale/ 
measure) 
Development cohort  
n= 10018 (100%) 
 
Validation cohort 
n= 291 (100%) 
Disability 
(OHS or mRs) 
  
      0 692 (6.9) 8 (2.7) 
      1 1323 (13.2) 45 (15.5) 
      2 1792 (17.9) 7 (2.4) 
      3 2483 (24.8) 149 (51.2) 
      4 1394 (13.9) 46 (15.8) 
      5 2090 (20.9) 36 (12.4) 
     Missing 244 (2.4) 1 (0.3) 
Being independent (mRs/OHS)   
     mRs/ OHS 0-2 3807 (38.0) 60 (20.6) 
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     mRs/ OHS 3-5 5967 (59.6) 231 (79.4) 
     Missing 244 (2.4) 1 (0.3) 
Able to walk (EQ5D)   
    No problems/ some (slight/  
    moderate) problems 
7755 ( 77.4) 194 (66.7) 
   Severe problems/ unable 1803 (18.0) 97 (33.3) 
   Missing 460 (4.6) 1 (0.3) 
To talk without major problems  N=2220 (survivors from IST3 
only) 
 
   No major problems (No 
   dysphasia/ mild to moderate 
   dysphasia) 
1332 (60.0) 278 (95.5) 
   Major problems (Severe  
   dysphasia, Mute) 
474 (21.4) 13 (4.5) 
   Missing 414 (18.6) 1 (0.3) 
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To eat normally  N=1470 (survivors from FOOD 
only) 
 
   Normal/ oral modified 1409 (95.9) 286 (98.2) 
   Tube (side/ nose/ percutaneous) 51 (3.5) 4 (1.4) 
   Missing 10 (0.7) 2 (0.7) 
To live without major anxiety or depression 
(EQ5D) 
N=10018 (All survivors)  
   None/ some (slight/ moderate) 8680 (86.6) 252(86.6) 
   Severe/ extreme 853 (8.5) 39(13.4) 
  Missing 485 (4.8) 1 (0.3) 
To live at home    
  Own home/ relatives home 7777 (77.6) 218 (74.9) 
  Hospital/ care home/ residential 1826 (18.2) 72 (24.7) 
  Unknown/ other uncategorised* 0 (0.0) 1 (0.3) 
  Missing 415 (4.1) 1 (0.3) 
*discharged to prison
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The models developed from our cohort of surviving patients are described in 
Table 8.4. I have also listed the parameter coefficients and ORs of the 
models we developed including all patients (reported in Chapter 7). For some 
models, certain predictor variables had higher ORs when only surviving 
patients were included in model development. For example,  for the model 
predicting ‘to walk’, the ORs for the predictor variables ‘able to lift arms’ and 
‘able to walk after stroke’ were higher than the corresponding ORs for these 

























Table 8.4 Coefficients and odds ratios (95% CI): models predicting specific abilities at six months, comparing models developed using all 





Odds ratio (95% CI) Parameter 
coefficient (SE) 
Odds ratio (95% CI) 
 All patients (Chapter 
7) 
 Surviving patients   
To be independent     
Constant -0.82(0.19)  -1.05(0.20)  
Independent before 
stroke 
1.28(0.12) 3.61(2.83-4.60) 1.22(0.13) 3.39(2.64-4.36) 
Living alone 0.10(0.05) 1.10(1.00-1.21) 0.14(0.05) 1.15(1.04-1.26) 
Normal Glasgow Coma 
Scale verbal score 
0.80(0.05) 2.22(2.00-2.46) 0.61(0.05) 1.85(1.66-2.06) 
Able to lift arms 1.41(0.05) 4.11(3.75-4.50) 1.33(0.05) 3.78(3.44-4.15) 
Able to walk 1.42(0.09) 4.13(3.47-4.91) 1.41(0.10) 4.10(3.40-4.95) 
Age -0.04(0.002) 0.97(0.96-0.97) -0.03(0.00) 0.98(0.97-0.98) 
 
 




To walk     
Constant 3.61 (0.19)  3.59 (0.25)  
Independent before 
stroke 
0.77 (0.08) 2.17 (1.85-2.55) 0.81(0.11) 2.25(1.83-2.77) 
Living alone -0.07 (0.05) 0.93 (0.85-1.02) -0.07(0.06) 0.93(0.82-1.05) 
Normal Glasgow Coma 
Scale verbal score 
0.93 (0.04) 2.53 (2.32-2.76) 0.71(0.06) 2.04(1.82-2.29) 
Able to lift arms 1.43 (0.05) 4.19 (3.81- 4.60) 1.82(0.07) 6.20(5.38-7.14) 
Able to walk 1.12 (0.14) 3.06 (2.34-4.00) 1.44(0.25) 4.22(2.57-6.96) 
Age -0.07 (0.002) 0.94 (0.93-0.94) -0.05(0.00) 0.95(0.94-0.95) 
To talk without major 
problems 
    





11.59 (378.6) >999.99 (<0.001-
>999.99) 
Living alone 0.02(0.09) 1.02(0.85-1.23) 0.05(0.13) 1.06(0.82-1.35) 




Normal Glasgow Coma 
Scale verbal score 
1.43(0.09) 4.16(3.48-4.98) 1.82(0.12) 6.16(4.84-7.84) 
Able to lift arms 0.98(0.09) 2.66(2.19-3.22) 0.53(0.13) 1.69(1.31-2.18) 
Able to walk 0.64(0.15) 1.90(1.42-2.53) 0.42(0.18) 1.53(1.07-2.18) 
Age -0.03(0.004) 0.97(0.96-0.98) -0.00(0.00) 1.00(0.99-1.01) 
To eat normally     
Constant 3.97(0.54)  4.25(1.23)  
Independent before 
stroke 
0.39(0.18) 1.48(1.04-2.12) 0.46(0.38) 1.58(0.75-3.36) 
Living alone -0.05(0.14) 0.95(0.72-1.26) 0.56(0.40) 1.75(0.80-3.81) 
Normal Glasgow Coma 
Scale verbal score 
1.18(0.13) 3.25(2.52-4.19) 2.14(0.40) 8.51(3.88-18.68) 
Able to lift arms 0.92(0.15) 2.52(1.88-3.37) 1.57(0.50) 4.80(1.81-12.76) 
Able to walk 0.95(0.27) 2.58(1.53-4.34) 1.38(1.05) 3.98(0.51-31.19) 
Age -0.06(0.01) 0.95(0.93-0.96) -0.04(0.01) 0.96(0.93-0.99) 




To live without major 
anxiety or depression 
    
Constant 2.51(0.18)  0.94(0.27)  
Independent before 
stroke 
0.45(0.07) 1.58(1.36-1.82) 0.27(0.15) 1.31(0.98-1.74) 
Living alone -0.03(0.04) 0.97(0.89-1.06) 0.016(0.08) 1.02(0.87-1.19) 
Normal Glasgow Coma 
Scale verbal score 
0.76(0.04) 2.14(1.96-2.32) 0.177(0.08) 1.19(1.02-1.39) 
Able to lift arms 0.76(0.05) 2.14(1.95-2.34) 0.47(0.08) 1.60(1.37-1.87) 
Able to walk 0.65(0.12) 1.92(1.53-2.41) 0.29(0.16) 1.34(0.97-1.84) 
Age -0.04(0.00) 0.96(0.96-0.97) 0.01(0.003) 1.01(1.01-1.02) 
To live at home     
Constant 4.35 (0.19)  4.98 (0.26)  
Independent before 
stroke 
0.80(0.08) 2.22(1.90-2.60) 0.81 (0.10) 2.24(1.84-2.73) 
Living alone -0.50(0.04) 0.61(0.56-0.67) -0.78(0.06) 0.46(0.41-0.51) 




Normal Glasgow Coma 
Scale verbal score 
0.89(0.04) 2.43(2.23-2.65) 0.62(0.06) 1.87(1.67-2.10) 
Able to lift arms 1.02(0.05) 2.78(2.53-3.04) 0.99(0.06) 2.70(2.39-3.05) 
Able to walk 1.04(0.12) 2.83(2.22-3.60) 1.05(0.18) 2.86(2.02-4.04) 
Age -0.071(0.002) 0.93(0.93-0.94) -0.06(0.00) 0.94(0.93-0.94) 
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8.2.1.4.1 Internal validation 
The Area under the Curves (AUCs) for our developed models are shown. 
(Table 8.5) The AUCs of the models were slightly lower when only surviving 
patients were included in model development when compared to all patients 
being included (Reported in Chapter 7). The exception was the model 
predicting ‘to eat normally’ though the CI was wide.  
Table 8.5 Internal validation: Area under the Curves (AUCs) of models in development 
dataset (surviving patients only) 
Model predicting 
specific ability: 
Area under the Curve (AUC) (95% CI) 
 All patients (Chapter 7) Surviving patients 
To be independent 0.79 (0.78-0.80) 0.76 (0.75-0.76) 
To walk 0.81 (0.80-0.81) 0.80 (0.79-0.81) 
To talk without major 
problems 
0.79 (0.77-0.81) 0.76(0.73-0.79) 
To eat normally 0.81 (0.78-0.83) 0.88 (0.83-0.92) 
To live without major 
anxiety or depression 
0.72 (0.71-0.73) 0.59 (0.57-0.61) 
To live at home 0.80 (0.79- 0.81) 0.78 (0.77-0.79) 
 
8.2.1.4.2 External validation 
8.2.1.4.2.1 Discrimination 
The AUCs of the models are shown in Table 8.6. All six models had poorer 
discriminative ability when compared to the models (which included all 
patients) I described in Chapter 7. Figure 8.1 shows the ROC curves of the 
models developed and validated using surviving patients at six months. 
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Table 8.6 Area under the Curve (AUCs) of externally validated models, surviving 
patients at six months 
Specific abilities at 6 
months 
Area under the Curve (AUC) (95%CI) 
 All patients (Chapter 7) Surviving patients 
To be independent 0.84  (0.79 to 0.89) 
 
0.79 (0.72-0.86) 
To walk 0.80 (0.76 to 0.84) 0.73 (0.68-0.79) 
To talk without major 
problems 
0.80 (0.76 to 0.85) 0.75 (0.63-0.86) 
To eat normally 0.83 (0.78 to 0.87) 0.72(0.34-1.0) 
To live without major 
anxiety or depression 
0.78 (0.73 to 0.83) 0.66 (0.57-0.75) 
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Figure 8.1 Receiver Operating Curves (ROC) curves for specific abilities at six months 
where only surviving patients were included from the development and validation 
cohorts: (A) to be independent (B) to walk (C) to talk without major problems (D) to eat 
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8.2.1.4.2.2 Calibration 
The calibration curves of our validated models predicting each specific ability 
are shown in Figure 8.2. 
Apart from the model predicting ‘to live at home’ at six months, the rest of the 
models calibrated poorly. The model for ‘being independent’ (A) was 
optimistic in predicting the outcome, but especially so in the middle of the 
range of predicted probabilities of good outcome. The model for ‘to walk’ (B) 
was slightly optimistic, especially so at the higher predicted probabilities of a 
good outcome. The model for ‘to talk without major problems’ was 
pessimistic, especially in the lower predicted probabilities of a good outcome. 
Both the models for ‘eat normally ’ and ‘living without major anxiety or 
depression’ were optimistic, predicting all surviving patients in our validation 
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Figure 8.2 External validation: calibration curves for (A) To be independent (B) To 
walk (C) To talk without major problems (D) To eat normally (E) To live without major 
anxiety or depression (F) To live at home; where only surviving patients were included 
in both development and validation cohorts 
 
*The red lines represent each individual patient with (1) or without (0) the 
outcome 
Based on the poor calibration of these models, I will not report their 
performance at PPVs chosen by family members (Chapter 6) as these 
models are unlikely to be of any use in clinical practice due to their poor 
performance.  
8.2.1.5 Summary of results 
When only surviving patients from our development and validation cohorts 
were included in model development and validation, all our models 
discriminated and calibrated less well than our models developed and 
validated including all patients. 
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8.2.2 Addition of variables to improve predictions of specific 
abilities at six months   
8.2.2.1 Reasoning:  
Some baseline variables that I collected (listed in Chapter 2) have been 
shown in existing literature (not restricted to stroke) to be potential predictors 
of specific abilities. I described these in Chapter 2 and have summarised 
below. Therefore, these might be included to improve prognostic models.  
For instance,  
i) Higher Charlson score is associated with poorer functional 
outcome at six months after stroke. (127) 
ii) Being married is associated with lower odds of depression after 
stroke. (123,124) 
iii) Pet ownership is associated with better psychological outcomes. 
(125,126) 
iv) Being male is associated with increased odds of depression after 
stroke, while being female is associated with increased odds of 
anxiety after stroke. (122) 
v) Urinary incontinence is associated with higher rate of 
institutionalisation two years after stroke. (132) 
Furthermore, complications and treatments in the early period after a major 
stroke may also affect patient outcome: patients who have had a major 
stroke can be very unwell in the early period and therefore mortality can be 
high and treatments used in the early period after a major stroke (e.g. enteral 
tube feeding and intermittent pneumatic compression) may prolong patient 
survival, but with significant disability (As described in Chapter 1).  Therefore, 
including extra variables in my prognostic model (of complications and 
treatments, and change in patient functional status in the early period after 
major stroke) may improve the prediction of ‘being independent’ at six 
months. 
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Although literature may have found associations between baseline variables 
and outcome at longer time periods (e.g. two years after stroke), since we 
only had data available at six months after stroke, we were only able to test if 
these variables may improve predictions at six months after stroke. 
8.2.2.2 Our hypotheses (for outcomes at six months after major 
stroke): 
(I) Lower Charlson score may be associated with better functional 
outcomes (i.e. ‘being independent’)  
(II) Being married may be associated with lower odds of 
anxiety/depression  
(III) Pet ownership before stroke may be associated with lower odds of 
anxiety/depression  
(IV) Being female may be associated with lower odds of 
anxiety/depression  
(V) Being continent of urine at baseline may be associated with being 
able to live at home  
(VI) Adding data on patient progress (complications and treatments) 
may improve prediction of ‘to be independent’. 
(VII) Adding data on change in patient functional status in the early 
period after stroke may improve prediction of ‘to be independent’. 
8.2.2.3 Method: 
Using our longitudinal cohort of patients with major stroke (n=402 (one loss 
to follow up at six months), described in chapter 2), I will develop models to 
predict three specific abilities listed above (to be independent, to live without 
major anxiety/depression, to live at home) using multivariable logistic 
regression. I will use SSV as my predictor variables. I will assess if the 
addition of any of the variables (listed above) improved my models. I will 
perform the likelihood ratio test (LRT) (the goodness of fit of two competing 
models based on the ratio of their likelihoods). To compare two models using 
the LRT, the base model (or less general model) is nested inside the more 
general model and the base model can be obtained by constraining some of 
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the parameters of the more general model. The base model represents the 
null hypothesis, whereas the more general model represents the alternative 
hypothesis. I will take p<0.05 as the statistical significance level of the test. 
Low values of the likelihood ratio means that the observed result was much 
less likely to occur under the null hypothesis as compared to the alternative, 
and therefore rejects the null hypothesis. High values of the statistic means 
that the observed outcome was nearly as likely to occur under the null 
hypothesis as the alternative, and so the null hypothesis cannot be rejected.  
My null hypothesis is that a model with SSV as predictor variables predicts 
the outcome of interest at six months. My alternative hypothesis is that a 
model with addition of other variables would give better predictions. A 
likelihood ratio, p< 0.05 would reject my null hypothesis. 
I will use Stata SE 15 for all analysis. 
As I reported in Chapter 7, it may be better to predict anxiety and depression 
separately as these two different diagnoses have different predictors. 
However, this is not possible as this outcome in our cohort is based on 
participants completing the EQ5D-5L, where anxiety and depression are 
regarded as one entity. 
In my longitudinal cohort (described in Chapter 2), I collected two variables 
detailing patient complications- i.e. infection and stroke recurrence. For the 
latter, only 12 patients in my cohort had a recurrence of stroke in the early 
period and therefore this variable is not included due to the low EPV rate. I 
also collected several variables detailing treatments received by the patient 
(enteral tube feeding, parenteral fluids, antibiotics, IPC, catheter, escalation 
beyond ward level care and neurosurgery). Of these treatments, only three 
patients in our cohort were escalated beyond ward level care and none had 
neurosurgery. Therefore, I did not include these in the modelling process.  
I also collected BI at baseline and at early follow up (Chapter 2). I took a 
change in BI between these two time points to reflect a change in patient 
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functional status. I excluded those patients who had died by early follow up 
(n=17). 
8.2.2.4 Results:  
My base model with SSV only as predictor variables, predicting ‘to be 
independent’ (mRs 0-2) is shown below. Although some individual variables 
do not reach statistical significance in our cohort, we know from literature 
(reported in Chapter 7) that SSVs are strong predictors of independence and 
survival. Therefore, all SSVs have been included.  












SSV ‘alone’ 1.08 0.38 0.81 0.55-2.15 
SSV 
‘independent’ 
8.89 7.20 0.07 0.89-53.48 
SSV 
‘orientated’ 
7.98 5.35 0.002 2.14-29.74 
SSV ‘lift 
arms’ 
1.29 0.48 0.49 0.63-2.65 
SSV ‘walk’ 15.98 9.28 <0.0001 5.12-49.85 
Age 0.96 0.01 0.002 0.93-0.98 
Constant 0.08 0.14 0.12 0.003-1.94 
*SSV=Six Simple Variables 
i) Addition of Charlson comorbidity index score to SSV to predict 
independence at six months after major stroke 
Adding Charlson comorbidity index score as a continuous variable to SSV 
did not significantly improve predictions. (OR 0.80, 0.62-1.04), LRT 0.09 
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ii) Addition of variables (gender, marital status, pet ownership) to SSV 
to predict ‘to live without major anxiety/ depression’ at six months 
after major stroke.  
In univariate analysis, unadjusted for SSV, gender (p=0.12) and marital 
status (p=0.35) were not significantly associated with the outcome. Pet 
ownership was significantly associated with the outcome. (p=0.03) 
     The model for predicting ‘to live without major anxiety/depression’ with 
SSV as baseline variables is shown below:  
Table 8.8 SSV to predict 'to live without major anxiety/depression' at six months using 
our longitudinal cohort, n=402 
‘To live without 
major 
anxiety/depression 









SSV ‘alone’ 1.17 0.30 0.55 0.70-1.95 
SSV ‘independent’ 1.23 0.38 0.50 0.67-2.24 
SSV ‘orientated’ 4.87 1.26 <0.0001 2.94-8.07 
SSV ‘lift arms’ 2.28 0.66 0.004 1.30-4.02 
SSV ‘walk’ 3.32 2.69 0.14 0.68-16.23 
Age 0.98 0.01 0.12 0.96-1.00 
Constant 1.66 1.66 0.61 0.23-11.83 
*SSV= Six Simple Variables 
The addition of gender (to our base model with SSV only) as a variable did 
not improve predictions. (OR 1.21 (0.74-1.98), LRT 0.45) 
The addition of marital status (to our base model with SSV only) did not 
improve predictions. LRT 0.43.  OR and 95% CI for each level within ‘marital 
status’ with ‘single’ set as the base is shown in Table 8.9.  
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Table 8.9 Marital status and anxiety/depression at six months, adjusted for SSV 




p 95% CI 
Single 1 (base)    
Married 2.45 1.17 0.06 0.96-6.27 
Lives with 
partner 
5.95 5.95 0.07 0.84-42.21 
Widowed 2.01 0.90 0.12 0.83- 4.85 
Separated 2.02 2.11 0.50 0.26-15.64 
Divorced 1.13 0.74 0.86 0.31-4.10 
Unknown 0.89 1.13 0.93 0.07-10.67 
Constant 1.06 1.19 0.96 0.12-9.51 
*SSV= Six Simple Variables 
Although there appeared to be an association in univariate analysis, addition 
of ‘pet ownership’ to our base model did not significantly improve predictions. 
LRT 0.20. The OR and 95% CI are shown in Table 8.10. 
Table 8.10 Pet ownership and to live without major anxiety/depression at six months, 








p 95% CI 
None 1 (base)    





1.02 0.34 0.94 0.54-1.95 
Constant 1.04 1.08 0.97 0.14-7.94 
*SSV= Six Simple Variables 
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iii) Addition of ‘Urinary continence’ as a variable (single item from BI) 
to SSV to predict ’to live at home’ at six months after major stroke 
The model for predicting ‘to live at home’ with SSV as baseline variables 
is shown below:  
‘To live at 









SSV ‘alone’ 0.63 0.17 0.08 0.37-1.06 
SSV 
‘independent’ 
2.17 0.70 0.02 1.15-4.09 
SSV 
‘orientated’ 
4.76 1.27 <0.0001 2.82-8.04 
SSV ‘lift 
arms’ 
3.00 0.83 <0.0001 1.72-5.16 
SSV ‘walk’ 4.39 3.71 0.08 0.84-22.98 
Age 0.96 0.01 0.002 0.94-0.99 
Constant 3.62 3.71 0.210 0.48-27.00 
*SSV= Six Simple Variables 
The addition of urinary continence as a variable to our base model (with SSV 
only) significantly improved prediction of ‘to live at home’ six months after 
major stroke. (OR 1.10 (1.04-1.18), LRT 0.003 
(iv) Addition of data detailing patient treatments and complications by early 
follow up to predict ‘to be independent’ at six months after major stroke 
I described our model predicting ‘to be independent’ at six months after major 
stroke above.  
Addition of complications (i.e. infection) to our base model containing SSV 
only does not significantly improve predictions. (OR 0.62 (0.27-1.44), LRT 
0.26) 
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Addition of treatments (intermittent pneumatic compression, antibiotics, 
fluids, enteral tube feeding and catheter) individually to our model containing 
SSV only also did not significantly improve predictions. (LRT 0.27) Individual 
OR and 95% CI of each treatment is shown below: 









p 95% CI 
IPC 0.71 0.31 0.43 0.30-1.67 
Parenteral 
fluids 
0.84 0.35 0.67 0.37-1.90 
Antibiotics 0.75 0.34 0.52 0.31-1.82 
Enteral tube 
feeding 
0.30 0.25 0.15 0.06-1.53 
Catheter 0.84 0.45 0.75 0.30-2.40 
Constant 0.15 0.25 0.25 0.006-3.77 
*SSV= Six Simple Variables 
iv) Addition of change in functional status to predict ‘to be 
independent’ at six months after major stroke 
I generated a new variable which reflected the change in BI scores 
between baseline and early follow up (i.e. for each individual patient, BI at 
early follow up minus baseline BI; so negative values indicate 
deterioration in patient functional status and positive values indicate 
improvement in patient functional status) (Table 8.12). Our base model 
with SSV only predicting ‘to be independent’ at six months is shown in 
Table 8.13. n=385 was available for model development as 17 patients 
had died by early follow up and therefore, did not have a BI score.  
Addition of a change in early patient functional status (Reflected by 
change in BI) improves prediction of ‘to be independent’ at six months. 
(OR 1.05 (1.03-1.07)) LRT <0.001 
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Table 8.12 Change in Barthel Index (BI) between baseline and early follow up 
excluding those who had died by early follow up, n=385 
Change in Barthel 
Index between 
baseline and early 




-35 3 0.78 
-30 2 0.52 
-20 11 2.86 
-15 6 1.56 
-10 16 4.16 
-5 34 8.83 
0 65 16.88 
5 58 15.06 
10 39 10.13 
15 30 7.79 
20 35 9.09 
25 21 5.45 
30 18 4.68 
35 14 3.64 
40 12 3.12 
45 5 1.30 
50 3 0.78 
55 3 0.78 
60 4 1.04 
65 5 1.30 
70 1 0.26 
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Total 385 100 
 
Table 8.13 SSV to predict 'to be independent' at six months with surviving patients at 












SSV ‘alone’ 1.07 0.37 0.84 0.54-2.12 
SSV 
‘independent’ 
7.05 7.38 0.06 0.91-54.85 
SSV 
‘orientated’ 
7.27 4.92 0.003 1.94-27.36 
SSV ‘lift 
arms’ 
1.27 0.47 0.51 0.62-2.63 
SSV ‘walk’ 15.78 9.13 <0.001 5.08-49.02 
Age 0.96 0.01 0.003 0.93-0.99 
Constant 0.09 0.14 0.13 0.004-2.04 
*SSV= Six Simple Variables 
8.2.2.5 Summary of results 
When adjusted for SSV, the variable ‘urinary continence’ appeared to 
significantly improve prediction of ‘to live at home’ six months after major 
stroke.  Addition of change in patient functional status (calculated by a 
change in BI scores) in the early period after stroke also improved prediction 
of ‘to be independent’ at six months after major stroke.  
8.3 Discussion 
8.3.1.1 Summary of results from this chapter 
Based on models developed from large trial data and validated in our cohort:  
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Models developed and validated in cohorts including surviving patients only 
had poorer discrimination and calibration when compared to models 
developed and validated on all patients. The discriminative ability of some 
models e.g. those predicting ‘to eat normally ‘and to live without major 
anxiety/depression’ maybe related to their ability in predicting survival rather 
than the specific ability.  
Based on models developed from our cohort:                                            
When models developed from our longitudinal cohort (Described in Chapter 
2) were adjusted for SSV, only the addition of the variable ‘Urinary 
continence’ appeared to significantly improve prediction of ‘to live at home’ 
and addition of data on change in patient functional status by BI improved 
prediction of ‘to be independent’ at six months after major stroke.  
Including surviving patients only in development and external validation of 
prognostic models predicting specific abilities at six months after major 
stroke.  
When compared to the models we developed and validated using all patients 
(reported in Chapter 7), the discriminative ability and calibration of models 
developed and validated using cohorts of surviving patients only was poorer. 
These models are unlikely to be of use in clinical practice. This is because it 
would not be possible to predict specific abilities in patients who have not 
survived. Furthermore, once those who had died by six months had been 
excluded, the EPV to predict some specific abilities (e.g. ‘to eat normally’) 
was low.  
As described in Chapter 7, once the models which calibrated well have been 
evaluated further, it is possible that doctors may be able to use these models 
to provide predictions of survival and a specific ability in a one-step process. 
However, with the models I have described in this chapter, a two-step 
process would be required to provide predictions: i.e. survival and specific 
abilities are predicted separately. When we consider doctors communicating 
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prognosis to patients and families, using a one-step process and saying ‘you 
have a x% chance of being able to walk’ is clearer and raises less uncertainty 
than communicating the likelihood of survival and then the likelihood of 
achieving a specific ability (e.g. ‘You have an x% chance of surviving, and if 
you survive, y% chance of being able to walk).   
Variables which may improve predictions 
Despite literature reporting associations between some variables and specific 
abilities after stroke, when adjusted for SSV, only two variables seemed to 
significantly improve prediction of two specific abilities at six months after 
major stroke. These were urinary continence predicting ‘to live at home’ and 
change in functional status predicting ‘to be independent’. 
Therefore, as previously reported (91), SSV appears to predict outcomes as 
well as models with additional baseline variables. However, one may 
consider adding in and testing data on patient functional change to future 
models. This may also mean that predictions made later (days 7-10, rather 
than 0-3 after stroke) could be useful for shared decision-making regarding 
treatments, especially when some patients and family members may not be 
ready to participate in decision-making in the early period after major stroke. 
8.4 Limitations 
 Although some individual variables in SSV were not statistically 
significant in our cohort, we included all SSV based on existing 
literature which has shown that SSVs are good predictors of 
independent survival 
 Models developed from our cohort are based on relatively (relative to 
models we developed in Chapter 7) fewer patients and therefore do 
not have the required power to draw conclusions from. Ideally, 
variables should be tested in larger cohorts 
 We were not able to externally validate these models, hence they do 
not currently have any clinical use- this was simply intended as an 
exploration of variables to improve predictions from future models 
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8.5 Conclusions 
Models developed and validated using cohorts of surviving patients 
performed poorly and are not useful in clinical practice. The simplest models 
using SSV as predictor variables performed as well as models with additional 
variables, though addition of some variables e.g. data on functional progress 
and urinary continence may improve predictions of ‘to be independent’ and 
‘to live at home’ respectively. Future models may consider further evaluating 
the addition of variables in predicting specific abilities. 
8.6 Next steps 
Based on my findings in this thesis so far, I report that we need to optimise 
communication of information to patients and families in a way that is 
individualised, useful to their purposes, easily communicated and 
understood. In my final chapter (Chapter 9), I summarise my findings and 
describe a future intervention to improve communication between doctors, 







   
  295 
Chapter 9  Conclusions 
9.1  Summary of results 
Through mixed methods research, I have explored various aspects relating to 
shared decision-making regarding treatments in major stroke. This includes: 
a) the characteristics and progress of patients admitted with major stroke 
including their specific abilities and HRQoL, b) the experiences, views and 
needs of patients with capacity and family members where patients lacked 
capacity over time, c) communication between doctors and family members 
in the period where treatment decisions were being made, d) opinions of 
family members on various aspects relating to communication of diagnostic 
and prognostic information, e) development and external validation of new 
prognostic models to provide predictions of specific abilities at six months 
after major stroke f) potential ways in which prognostic models may be 
improved.  
I have found that:  
 Many patients are significantly physically disabled at six months after 
major stroke. However, they vary with respect to their specific abilities 
(e.g. to walk, to talk) and HRQoL despite being in the same disability 
level defined by mRs. (Chapter 2) 
 In the early period after major stroke, patients reported feeling in 
shock and in distress and looking for hope from doctors. They were 
not ready to participate in shared decision-making regarding 
treatments. However, at six months, they said they wished they had 
been given realistic information. Many patients had unmet 
psychological and support needs. (Chapter 3) 
 Treatment decisions involving family members where the patient 
lacked capacity appeared to be influenced by the patient’s pre-stroke 
state of health and preferences they may have expressed before their 
stroke. Family members looked for prognostic information from 
doctors for different purposes i.e. to discuss known patient 
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preferences to not initiate treatments, to help facilitate treatment 
decisions, maintain hope that the patient would survive and recover or 
to prepare for the possibility that the patient may die and uncertainties 
of this process. (Chapter 4) 
 There were areas where communication of diagnosis and prognosis 
may be improved between doctors and family members (Chapter 5) 
 Some family members may wish information on specific abilities after 
major stroke to understand impact of stroke and/or facilitate their 
involvement in decision-making. However, different individuals wished 
for information in different formats and predictive accuracies. The use 
of visual aids, especially viewing of brain scans, was helpful to many 
to understand the impact of major stroke and/or be involved in 
decision-making. (Chapter 6) 
 We can formally predict four specific abilities at six months after major 
stroke. The prognostic models we have developed and validated will 
require further evaluation. In the future, we hope that they may be 
used by doctors as a sense check of their judgement of the patient’s 
prognosis and in communicating prognostic information to provide 
patients and families with the hope they may require, to understand 
the situation of major stroke better or even to facilitate shared 
decision-making regarding treatments. (Chapter 7) 
 Using SSV as predictor variables predicts specific abilities as well as 
models with additional variables. However, addition of data on change 
in patient functional status in the early period after major stroke may 
improve prediction of ‘to be independent’ at six months. (Chapters 8) 
In Chapter 1, I outlined several areas relevant to major stroke and shared 
decision-making regarding treatments. I would like to finish my thesis by 
considering how my findings have contributed towards these areas and may 
have clinical implications.  
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9.2 Impact of major stroke 
In Chapter 1, I reported how patients who have had a major stroke face two 
possibilities: death or survival with disability. I also reported how, in the UK, 
stroke is a major cause of mortality and morbidity, with over a third of stroke 
survivors living with severe disability and many dependent on formal or 
informal care for their daily activities. (9,14–16) Data suggests that one-year 
mortality for TACS is around 60-70% with most people being significantly 
disabled at a year. The one year mortality is around 15-23% for PACS and 
POCS and 10-15% for LACS. (322,323) In my longitudinal cohort, (Chapter 
2), I reported how over a quarter (27.5%) of patients I recruited had died and 
20.3% were significantly disabled (mRs 4 and 5) at six months. The 
difference between the mortality and morbidity of my cohort in comparison to 
published data is likely due to our definition of major stroke and follow up of 
outcomes to six months rather than a year. 
9.3 Patient management in keeping with their 
preferences 
While guidelines (30,324) recommend that patients are involved in decision-
making, as I reported in Chapter 3, I found that patients were shocked and 
distressed as a result of their diagnosis and were therefore, not ready or able 
to voice their preferences in the early period after major stroke. This has 
been reported in other medical settings including intensive care and 
cardiology. (65,325)  
While studies have reported higher satisfaction and treatment compliance 
when patients are involved in decision-making, (61,62,326) there is also 
evidence to suggest that in some cases, patients may wish to negotiate how 
much and when they would like to know about their prognosis. (327–329) 
Below I report my four main findings with respect to shared decision-making 
involving patients with capacity after major stroke. 
Timing of shared decision-making 
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Guidelines focus on early information provision to patients to guide patient 
management. But the right timing when patients with major stroke may be 
receptive to information and be involved in decision-making would vary 
between individuals. 
However, in the context of major stroke, as I reported in Chapter 1, some 
treatment decisions need to be taken early. (330) Decisions to withhold 
treatments such as IPC (35) and enteral tube feeding (24) can typically not 
be changed later and may influence patient outcome i.e. either death from 
withholding these treatments or survival with disability and a chronic stage of 
recovery with continuing these treatments. These decisions are often made 
at a time when there is large degree of uncertainty. (331) 
Where patients are not ready to participate in decision-making and treatment 
decisions need to be made, doctors often seek patient preferences from 
family members(as I reported in Chapter 4) and consider the patient’s ‘best 
interests’. One has to consider how these approaches may sit with the notion 
of patient autonomy, especially when we cannot be certain that family 
members are voicing patient preferences rather than their own and doctors 
interpretation of what may be in the patient’s ‘best interests’ may not 
necessarily be what the patient may want. 
Looking for hope 
As I described in Chapter 3, patients looked for hope and positive information 
in the early period after major stroke. For doctors to communicate hope while 
being realistic can be challenging. (53) The need for optimism and hope to be 
sustained in the process of honestly delivering bad news (e.g. a limited life 
expectancy) is an ideal expressed by both patients and doctors. (332–334) 
However, providing realistic information which may cause further distress and 
withholding potentially truthful information which may then give false hope 
raises a conundrum between two ethical principles: non-maleficence and 
autonomy. Therefore, there is a delicate balance between fostering realistic 
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hope and unethically creating unrealistic expectations (e.g. of achieving 
independence). (334,335)  
Furthermore, hope is a broad concept that can hold different meanings for 
different individuals. (333) Existing work especially in oncology, on how 
patients may define hope report that some individuals may find hope by 
knowing that things can go well, others may find hope by knowing that there 
is a good chance that things may go well even if things have gone wrong, 
some may find hope by knowing that they have a good chance, if not better, 
as the next person of having the best outcome and finally, some others may 
find hope by knowing that they can still enjoy a good quality of life even if 
there is uncertainty with regards to their life expectancy. (333,336) 
While there is a lack of research on how doctors communicate hope while 
trying to maintain realism, (336) some communication strategies have been 
studied and reported in literature, especially in oncology (333,337) and 
intensive care (255,256), which may be transferable to the major stroke 
setting. For example, delivering honest medical information sensitively, 
communicating continued support and providing information about choices 
including that of treatments seemed to maintain hope. (337,338) Specific 
behaviours by the doctor such as knowing about the patient’s condition, 
using occasional humour and reassurance that their symptoms may be 
controlled also seemed to maintain hope. (333) 
 
The hope-information paradox 
I reported this phenomenon in Chapter 3. This is where the information 
preferences of patients were not consistent over time and six months later, 
many wished that they had been given realistic information earlier on after 
major stroke to help them prepare for the physical and psychological impact 
of major stroke.   
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This mismatch in information preferences over time has also been reported in 
the palliative care setting. (339)  
While there may not be perfect solutions to addressing this paradox, some 
strategies have been studied. For example, communication strategies which 
maintain hope but deliver honesty (described above and in Chapter 3) may 
be helpful. (333,337) The concept of parallel planning may also be relevant. 
This is where two ‘plans’ run in parallel which allows for the unpredictability in 
the course of the condition; for example, for a patient with major stroke who 
may wish to return home, Plan A may be to return home with a care package 
and Plan B may be to go to a care home. The communication of multiple 
plans maintains hope by acknowledging the patient’s wishes and preferences 
while providing information on alternatives (which may be more realistic) to 
plan for the future. Communicating the ‘best case scenario’ and ‘worse case 
scenario’ and ‘Hope for the best but plan for the worst’ also aim to maintain 
hope but provide an alternative plan for a possible more realistic 
consequence. (220,339) Relatedly, cultivating adaptive coping strategies 
while communicating prognosis may also be useful and could mitigate the 
distress some patients may experience when learning about their potential 
lack of recovery after major stroke. (329) 
In stroke, where prognosis is often uncertain, the communication of 
prognostic uncertainty would be useful to manage patient information needs 
and expectations. I will detail this in Section 9.5. 
Ongoing unmet needs 
I found that many patients described feeling upset and distressed at six 
months and therefore, had ongoing emotional and support needs. My 
findings agree with existing literature in stroke which have shown that even 
years after a stroke, patients describe various physical limitations and 
perhaps relatedly, psychological and support needs which contribute towards 
a suboptimal quality of life. (73,201) My findings re-iterate the need to assess 
and provide support to patients with major stroke, including but not limited to, 
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coming to terms with loss, depression, grief and changes in life participation. 
(73,340–342)  
My work is not intended to find perfect solutions to these challenges. 
However, acknowledging the above areas and related challenges and 
considering recommendations I have provided (above and in individual 
chapters) based on evidence from other settings may allow doctors to 
support patients with major stroke better.   
9.4 Involvement of family members in decision-
making where the patient lacked capacity 
Another area I referred to in Chapter 1 was the involvement of proxies (often 
family members) in decision-making regarding treatments where the patient 
lacked capacity. In my study, this is limited to the appropriateness of life 
extending treatments in patients who were severely ill after major stroke. 
As described in  Chapter 4, my findings confirm existing literature that family 
members consider patient preferences and pre-stroke state of health when 
being involved in shared decision-making  (76,243) and some family 
members may find this process upsetting and challenging. (223,225,226)  
The emotional needs of family members, both in the early period and later 
on, after a major stroke has also been described in another longitudinal 
qualitative study. (73) The grieving process of family members after the loss 
of their loved one is also important to acknowledge and understand to allow 
individuals to be referred for further support.(73,201,231,343) 
As described in Chapter 4, we identified a treatment decision spectrum 
based on the patients’ state of health prior to the stroke and any stated 
preferences which appeared to influence family members’ information and 
support needs. While we accept that people may not respond in predictable 
ways, the knowledge that treatment decisions lie on a spectrum may allow 
doctors to prepare for discussions regarding prognosis with family members. 
I will discuss communication strategies in the section 9.5.    
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9.5 Communication between doctors and family 
members where the patient lacked capacity after 
major stroke 
While feedback on communication between doctors and family members was 
largely positive, I found some instances where this may have been improved 
(Chapter 5).  
Doctors may find it useful to use a framework to guide them through 
decision-making that is both ethical and evidence based. (344) Briefly, the 
recommended four step approach would involve: a) A focus on the condition 
(i.e. stroke): the estimation of prognosis, treatment gains and burdens b) A 
focus on the individual: the values and preferences of the patient c) A focus 
on the healthcare team: situational awareness of what may be appropriate or 
futile for the individual d) A focus on the doctor-patient relationship: the goals 
of care in-keeping with patient values. (344) 
Effective communication would be key in shared decision-making. I have 
described strategies on communicating hope and honesty in Chapter 3 and in 
Section 9.3. Having a structure in communication; for example, using the 
REDMAP (Ready, Expect, Diagnosis, Matters, Actions, Plan) strategy (345), 
serious illness conversation guide (346) or using the DECIDE (Define the 
decision, Explain the situation, Consider available options, Invite views, Decide 
together, Evaluate the decision) model (347) may be helpful for doctors when 
involving patients or family members in shared decision-making. 
Well studied illness trajectories of cancer (short decline), heart failure 
(episodic decline), dementia and frailty (prolonged decline) (348–350) allow 
patients, families and healthcare professionals to understand and prepare for 
how function may decline and advance to death. However, these trajectories 
are not suitable for those who have had a stroke, where patients and families 
are largely unprepared and face a trajectory that often results in early death 
or a more uncertain prognosis that may resemble the chronic disease 
trajectory with prolonged dwindling. (331) Understanding this pattern and 
using strategies to communicate uncertainty and the range of possible 
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outcomes are important. There is evidence from studies in oncology to 
suggest that family members wish to know that it was possible that the 
patient was sick enough to die, communication of uncertainty increases 
satisfaction of care, leaves room for hope, increases trust in doctors and 
allows for preparation that the patient may not survive. (252,335,339,351) 
Similar to the hope-information paradox I described in Section 9.3, family 
members who resist knowing that the patient was sick enough to die have 
also reported a retrospective understanding that they would have benefited 
from prognostic information and that death was a possibility. (339) 
However, doctors may find the communication of uncertainty difficult (53) and 
are often poor at initiating discussions about end of life care. (338,339) Being 
explicit about this uncertainty (338) and using affective sensitive language 
would be helpful.(352) Using strategies (described above) such as 
communicating ‘Best case worse case scenarios’ and ‘Hope for the best but 
plan for the worst’ also increase prognostic awareness while alluding to 
uncertainty. (220) 
I was unable to draw any definite conclusions on the influence of doctors’ 
views or communication on the treatments agreed for the patient. This was 
related to my study design (questionnaires) which did not explore the 
contexts in which answers were provided and small sample size.  
While communication training for doctors may be helpful to familiarise and 
support doctors in various communication strategies,(353) feedback from 
patients and family members are important for continually improving 
communication and professional development. A validated tool such as 
CollaboRATE, a brief patient reported measure, may be useful to evaluate 
shared decision-making. (290,291) 
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9.6 Presentation of prognostic information 
 In Chapter 1, I described how information may be presented to patients and 
families to aid understanding and decision-making. In Chapter 6, I reported 
how the preferences for presentation of information varied between different 
individuals. I also found that many family members found viewing brain scans 
of the patient useful to their understanding of the patient’s poor prognosis 
and therefore, it is likely that the treatment would not be successful. 
The understanding of prognosis and treatment goals is influenced by many 
factors. As I described in Chapter 4, previous experiences, emotions and 
information from other sources (e.g. friends and family) may influence how 
people understand risk of accepting or declining certain treatments. While 
there is evidence advocating the use of pictographs to increase 
understanding, (354) presenting information in natural frequencies rather 
than percentages, and absolute risk reduction rather than relative (355) and 
communicating using quantitative information rather than qualitative, as I 
reported, different individuals asked for different ways for information to be 
presented to them.  
Therefore, doctors are recommended to use balanced framing (to convey 
both loss and gain messages) when explaining benefits and harms to people. 
It may also be helpful to provide the same information in both simple 
frequencies and in percentages and presenting both absolute and relative 
risk reductions of treatment for individuals to make an informed decision. 
Using pictographs and graphs may be useful. (293,356) 
Two main limitations of my work are: 1) my findings were based on 
methodology (questionnaires and verbal feedback) which did not capture the 
contexts in which opinions were provided, and were based on hypothetical 
scenarios rather than real time information. 2) The lack of patient feedback 
on information presentation. This was because patients were too distressed 
and unable to engage in a shared decision-making process in the early 
period after a major stroke (as described in Chapter 3).  
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Future research should focus on obtaining patient feedback at a different 
time point in their post- stroke journey and consider the use of 
communication aids to try and maximise patient involvement. This may 
involve the use of simple aids such as alphabet boards, communication 
charts and books or more complex aids such as the E-Tran Frame (a 
specialised chart) and a communication passport that the person could use 
to communicate their likes and dislikes to others. Electronic aids such as 
Voice Output Communication Aids to play messages aloud, symbol sets e.g. 
talking mats where sets of picture symbols represent a range of vocabulary 
and subject matter and smartphone apps where symbols may be picked and 
text or sound added to them may also be useful for some patients with 
aphasia.(357,358) 
9.7 Prediction of outcomes after major stroke 
As I have described in several areas in my thesis, prognostic information may 
be useful to patients and families to aid their understanding of the impact of 
major stroke or be involved in shared decision-making. (91)  
To communicate the range of possible outcomes after a major stroke, and 
the uncertainty associated with this, doctors need to have an idea of the 
possible trajectory and be able to make predictions based on individual 
patient characteristics. Guidelines recommend the use of prediction models 
to complement clinical judgement when making prognostic estimates. (26)  
Further to what I have described above, I describe two main areas from my 
work relevant to prognostic information after major stroke.  
Describing prognosis by specific abilities 
As I reported in Chapter 2, patients in the same disability level varied with 
respect to their specific abilities. Based on this finding and feedback from 
family members (reported in Chapter 6), I report that describing, and 
communicating prognosis expressed in terms of specific abilities may be 
more appropriate rather than using terms such as dependency or disability 
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(based on patient outcome scales such as mRs) which may have varied 
meanings to people. However, in the presence of different measures and cut-
offs to define each specific ability, a standardised approach would need to be 
agreed. Dichotomising outcomes to ‘good’ and ‘poor’ based on how 
outcomes are reported in trials may not reflect individual preferences and 
therefore, further co-production work with adequate patient involvement 
would be required.   
Prediction of specific abilities at six months after major stroke 
In Chapter 7 I described the development and external validation of new 
prognostic models to predict specific abilities after major stroke. I showed 
that we could predict some specific abilities (to walk, to eat normally, to live 
without major anxiety/depression and to live at home) at six months after 
major stroke reasonably well. I reported models performances at accuracies 
(PPV 50%, 80%, 90%) chosen by family members (n=24). (Chapter 4) 
As I reported in Chapter 1, although there are existing prognostic models 
which predict specific abilities after stroke e.g. mobility, recovery of arm 
function and depression, many have limited use due to lack of external 
validation.(94–97) 
My models would require further evaluation as I described in Chapter 7. In 
the future, they may have some uses to doctors, patients and family 
members.  
For instance, 
If the models are found to be as good as an experienced stroke physician’s 
estimate of prognosis, doctors may use these models as a ‘sense-check’ of 
their judgement of the patient’s prognosis before approaching patients or 
family members to discuss the patient’s likely prognosis. This would reduce 
variation in communication of information between different doctors. 
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Patients may find the information sufficient to provide them with hope. It is 
possible that the knowledge of a possible chance (e.g. 50%, 80% or 90%) of 
having a specific ability at six months may offer them hope. By providing 
patients a quantifiable chance of an outcome, doctors may be able to 
balance their communication of hope with being realistic.  
Family members may find predictions helpful to understand the impact of 
major stroke, discuss patient preferences and participate in shared decision-
making or maintain hope that the patient may survive the major stroke.  
9.8 Strengths and limitations 
Within each chapter (1 to 8), I detailed the strengths and limitations of my 
work relevant to that chapter. Below, I describe some broader strengths and 
limitations of my work. 
9.8.1 Strengths 
By using a combination of research methodologies, my work has provided 
both a broad and deep understanding of various aspects relating to treatment 
decision-making after major stroke. The insights I gained into patients’ and 
families’ experiences and needs could not have been obtained from a purely 
quantitative study.  
9.8.2 Limitations 
A major limitation of my work is generalisability; the study was performed in a 
single site and patients with minor stroke were excluded. The latter was due 
to my inclusion criteria and aim of my study. Those who opted into qualitative 
interviews may also have been patients or family members who felt they 
were more able to discuss their experiences. Furthermore, conclusions and 
recommendations from these interviews were based on self-reporting by 
participants rather than by direct observations. 
Time constraints of my fellowship meant that both the qualitative and 
quantitative aspects of my study were performed concurrently. Therefore, 
some theories or hypothesis were developed based on expert opinion (of 
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stroke professionals in the hospital where recruitment took place) before the 
start of the study (e.g. likely importance of predicting patient specific abilities 
after major stroke) rather than emerging from my data. In hindsight, if I were 
not restricted by the duration of my fellowship, I would have performed the 
qualitative aspect of my research first and used this to inform my quantitative 
work. 
9.9 Personal reflection 
In the last three years, I have developed skills in different research 
methodologies. I have learnt that qualitative and quantitative methodologies 
can complement each other and result in stronger evidence when 
interventions are being developed to promote patient care. I have learnt to 
appreciate that narrative can add meaning and context to numbers while 
numbers can be used to add precision to words and narrative. 
As a clinical doctor, I initially thought that qualitative interviewing would be 
simple as I communicate with patients and family members on a daily basis 
and have obtained positive formal and informal feedback of my 
communication skills over the last ten years. However, as I progressed in my 
learning, I grew to realise that conducting qualitative interviews was very 
challenging.  
The change in my role from a doctor to a researcher meant that I could not, 
and also was no longer expected, to provide information, test results or 
management plans. My role had changed to one where I listened, explored 
experiences and needs and in many instances, provided a shoulder to cry 
on. Furthermore, I had to ensure that my pre-conceived views as a doctor did 
not influence the interpretation of my data or the way I conducted the 
interviews. This meant that I paid extra attention to my verbal and non-verbal 
communication, trying to ensure that I was not influencing the narrative 
participants were giving me. I had not previously anticipated how emotional it 
may be to gain such in-depth insight into people’s lives and experiences; and 
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by keeping a reflexive diary, I was able to reflect on my experiences on a 
regular basis.  
Through my quantitative work, I have developed data management and 
statistical analysis skills. I feel more comfortable working with numbers and 
using statistical programs to perform basic analyses.  
Performing a mixed methods study required a lot of organisation on my part. 
As I have described, I single handed-ly recruited over 400 patients into a 
cohort study while performing qualitative interviews, administering 
questionnaires, doing data entry and checking and analysing my data. I did 
find this quite overwhelming at times, but ensured that I kept on top of my 
tasks by setting daily achievable goals. The encouragement and support I 
obtained from my supervisors was immensely helpful. I can say for sure that 
this period of research has improved my prioritisation and organisational 
skills.  
Writing is something that I have always found challenging. Therefore, to take 
on a mixed methods study where the style of reporting quantitative and 
qualitative data are so different was a daunting task. I have not found this 
easy, and appreciate the guidance, support and patience my supervisors 
have endured through my programme of work.  
9.10 Future related research 
Several further areas of research arise from this thesis. I have summarised 
these below:  
1. Future work should find a way of standardising the definitions of each 
specific ability. An online survey to health professionals looking after 
patients with major stroke may be an appropriate first step. Co-
production work with people who have had a stroke and their family 
members to understand their definition of ‘good’ and ‘poor’ outcomes 
would also be useful. 
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2. Future qualitative research could consider investigating the views and 
needs of stroke patients and family members from different socio-
economic and ethnic minority backgrounds who may have different 
experiences, information and support needs. Interviews with patient-
family member pairs (where the patient has retained capacity after 
major stroke) may also provide insight into the similarities and/or 
differences in their experiences. 
3. Work needs to focus on the psychological needs of patients and family 
members. This may involve further qualitative interviews or focus 
groups with patients (at an appropriate time) and family members to 
elicit how best their needs may be met in hospital and the community. 
Once this is identified, opinions of health economists and NHS health 
service managers would need to be sought on how best current 
services may be adapted or expanded to facilitate patient and family 
member needs. 
4. Qualitative interviews with doctors who look after patients with major 
stroke could give us important insight into the challenges they face in 
involving patients and family members in decision-making and how 
they currently cope with these challenges. This could allow 
development of strategies to support doctors in undertaking 
challenging discussions. 
5. By observing communication between doctors and patients/ family 
members and performing interviews with both parties based on the 
provision of real time information, we would gain more useful 
information on how some treatment decisions were made and how 
communication may be improved between them.  
6. Future prognostic models may be developed with specific predictors 
(e.g. prior history of anxiety/depression to predict anxiety/depression 
at six months after major stroke) and consider predicting anxiety and 
depression separately. Models may also consider adding data on 
change in patient functional status. 
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7. The models we have developed may be externally validated in larger 
cohorts of patients with major stroke and evaluated against predictions 
made by experienced stroke physicians.  
9.11 A brief summary and future plans 
Shared decision-making in the early period after major stroke can be 
challenging especially when many patients may not be able to engage in this 
process early on, patients and family members may look for hope and 
certainty at a time when prognosis is uncertain and the clinical condition of 
the patient may change rapidly. While there are no easy answers or a perfect 
approach to shared decision-making in major stroke, my work has highlighted 
some challenges and we have provided some recommendations to facilitate 
this process. The key is effective communication especially that of prognostic 
uncertainty, and of reassessment of decisions based on the patient’s clinical 
condition.  
Based on the results from this study and the review of existing literature, we 
propose the development of a communication tool to improve information 
provision to patients and families. This tool would contain information in 
different formats to suit different individuals. For example, the presentation of 
diagnosis of stroke in pictures (including brain scans) and words, the 
presentation of prognostic information in words, ratios, percentages and 
pictographs, the communication of uncertainty with prompts of structure for 
doctors and that of treatment choices, focusing on patient preferences. 
With the advice and help from IT experts, we have developed a prototype of 
this communication tool to deliver tailored information to patients and families 
called ‘Tailored talks’. To further develop this tool, we would require input 
from patients and family members and use co-production techniques. To do 
so, we have received a grant from the Lothian Health Board Endowment 
fund.  
Once developed, the tool would need to be evaluated in a trial. Outcomes 
measured may include patient and family member satisfaction with 
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communication and achieving outcomes in keeping with their preferences. 
Measuring these outcomes may require a variety of techniques including 
HRQoL assessments, focus groups and further qualitative interviews. Over 
the next year, I will play an active role in the development of this tool and 
later, apply for post-doctoral fellowships to evaluate this tool. 
9.12 A final note 
My research has explored various aspects relating to shared decision-making 
regarding treatments in major stroke. I have highlighted several implications 
for clinical practice and indicated areas for future research. An intervention 
that may optimise information provision to patients and families is the use of 
a communication tool to deliver tailored information that is easily 
communicated and understood. As I described, over the next year, I will 
focus on developing and refining this tool. 
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